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Advances in technology are an important weapon in the fight against anthelmintic 
resistance. Improved diagnostics are therefore crucial to enable targeted selective 
treatments and avoid unnecessary anthelmintic use. In common with other grazing 
animals, equines are at risk of infection with intestinal parasites, and it is crucial that 
effective control measures are maintained. Evidence suggests the re-emergence of 
large Strongyles such as Strongylus vulgaris given reduced treatment of 
cyathostomins.  Thus, minimising cyathostomin anthelmintic exposure, and 
controlling the pathogenic large strongyles is a key balancing act. 
Faecal egg counts (FECs) are the standard method of diagnosing the level of 
parasitic infection in horses and other grazing animals. Testing before treatment is an 
important factor in slowing the appearance of anthelmintic resistance in nematode 
parasites of horses. The FECPAK
G2
 allows farmers to perform FECs on their own
sheep and cattle, without the need for any specialist parasitology knowledge. The 
current work has optimised the FECPAK
G2
 (G2) method for horses, and validated
this against the original FECPAK (G1), using faecal samples from 114 horses in 
Wales and New Zealand. No significant difference was observed between the FECs 
obtained using the two methods (rmANOVA: F1,37 = 0.052, p = 0.821, ŋ2p = 0.001) 
with no effect noted linked to the country of origin.  In addition, the accuracy of the 
G2 method was not affected by FEC level (r = -0.251 (CI: 0.030, -0.472) p= 0.124 n 
= 39). Further improvements to the G2 method such as a lower detection limit are 
possible with planned improvements in the imaging process. 
Following validation, the FECPAK
G2
 approach was used to identify anthelmintic




anthelmintic treatment. DNA from twelve paired faecal samples, pre- and post-
treatment with Fenbendazole were sequenced using the MinION (Oxford Nanopore 
Technologies Ltd.). Six major cyathostomin species were identified across all equine 
nemabiomes. The most numerous species was Cyathostomum catinatum (39% of 
pre-treatment sequences) with this species displaying consistent resistance to 
Fenbendazole with 96% still remaining after treatment. It was noted that BZ 
resistance is potentially linked to predilection site within the GI tract. These findings 
are consistent with the idea that anthelmintic resistance develops more quickly when 
sub-lethal doses are administered, and suggests that there is insufficient 
Fenbendazole remaining in the gut to effectively control helminths towards the end 
of the gastro-intestinal tract. 
FECPAK
G2
 and MinION nemabiome sequencing were also trialled and found to be 
effective for helminth monitoring in zebra.  The work also demonstrated that the 
cyathostomin nemabiome sequencing method was effective even at low FEC levels. 
The zebra in this study harboured the same species of cyathostomin as had been 
found in the equine samples. However, the zebra nemabiomes suggests that the 
history of repeated BZ administration may have influenced the host nemabiomes 
towards those species least responsive to BZ treatment. 
Given the work conducted the FECPAK
G2
 represents an acceptable method for 
equine FECs. It is hoped that the user-friendliness of the method will increase the 
uptake of FECs amongst horse owners, either by direct use of the technology or 
through their veterinary practice, hence slowing the development of anthelmintic 
resistance. It was also concluded that MinION sequencing offers a useful method of 
determining which species of strongyle are present, facilitating a differential 




decisions to be made. Interestingly, the entire process of FEC and nemabiome 
sequencing are portable for use in the field, and thus could be utilised to monitor 
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It has long been recognised that horses harbour parasites and since the Roman 
civilisation this has been identified as a source of disease (Kaplan and Nielsen, 
2010). A key group of gastro-intestinal (GI) parasites are the helminths which 
includes the parasitic nematodes. Therefore, medicinal compounds used to treat them 
are termed anthelmintics. The first specific anthelmintic compound for horses was 
Phenothiazine, introduced in the 1940s (Swales, 1942) although reports of resistance 
to this compound occurred as early as the 1950s (Poynter and Hughes, 1958). The 
only alternative anthelmintic at the time of resistance emergence, Piperazine, was 
only 50% effective against species including Strongylus vulgaris and was not 
effective at all against other large Strongyle species (Downing et al., 1955). Modern 
over-the counter anthelmintic compounds appeared on the scene in the 1960s with 
the introduction of the Benzimidazoles (Kaplan, 2004) with further compound 
discoveries during the 1970s and 80s. Initially, horse owners were advised to treat all 
animals routinely every two months with one of these anthelmintics on a schedule 
designated as interval dosing (Drudge and Lyons, 1966). Where anthelmintics are 
available the interval dosing approach has been successful in effectively controlling 
the major large strongyle species Strongylus vulgaris, once the most important 
parasite of managed equines (Kaplan and Nielsen, 2010). However, cyathostomin 
species, small strongyles, have filled the intestinal niche vacated by the three 
common  Strongylus species and are now considered to be the primary nematode 
parasites of horses (Herd et al., 1981; Lyons et al., 1999). Despite successes, there is 
recent evidence to suggest a resurgence of the large redworm S. vulgaris due to 
attempts to slow anthelmintic resistance within cyathostomins through reduced 
application of anthelmintic treatments (Nielsen et al., 2012; Scare et al., 2018b). 




Therefore, the equine industry does not currently have the answer to effective and 
sustainable parasite control.   
Parasitic helminth egg shedding is over dispersed in definitive hosts, including 
horses, with a few individuals shedding the majority of eggs. In common with other 
pathogens, such as HIV, Malaria and Measles (Galvani and May, 2005), this over 
dispersion follows the 80/20 rule,  where 20% of individuals are responsible for 
disseminating 80% of the disease (Galvani and May, 2005). The 80/20 rule was 
effectively illustrated by Laugier et al. (2012)  who demonstrated that 66.9% of foals 
infected with Parascaris equorum had faecal egg counts (FECs) of 200 epg (eggs 
per gram) or lower, whereas 14 of the 139 foals had FECs of 1,000 epg or over, up to 
a maximum of 7,800 epg. Furthermore, in a large U.S. based study, over 70% of 
horses over 3 years of age were found to be in the low to moderate egg shedding 
category requiring only two anthelmintic treatments per year (Nielsen et al., 2018b). 
Despite over dispersion, many owners continue to follow the blanket interval-dosing 
regimen introduced fifty years previous, treating all animals regularly, likely 
bimonthly, despite unknown infection levels and worm burdens (Slater, 2017). Such 
practices are not only wasteful but also hasten the development of anthelmintic 
resistant parasites as each new generation of parasites is the offspring of those that 
survived previous anthelmintic treatment (Shalaby, 2013). 
Control of parasites, including GI nematodes, is an important part of horse 
husbandry and is essential to ensure good health and optimum performance. This is 
especially pertinent given helminth infections have been demonstrated to be the 
direct cause of 30% of chronic weight loss syndrome in Europe of which 75% were 
attributed to larval cyathostominosis (Tamzali, 2006). Furthermore, gastrointestinal 
impaction linked to high Ascarid burdens is a serious health risk for young horses, 




with a one year survival rate of typically less than 30% (Cribb et al., 2006). 
Unfortunately, due to the onset of anthelmintic resistance in P. equorum, it can no 
longer be assumed that such parasites will be controlled with simple routine 
anthelmintic use (Cribb et al., 2006). Therefore, new sustainable strategies for the 
control of equine helminths must be developed. However, the presence of 
cyathostomins was demonstrated to correlate negatively with the risk of colic in an 
Italian study (Stancampiano et al., 2017) suggesting positives to helminth infections 
as observed earlier with human infections as part of the hygiene hypothesis 
(Yazdanbakhsh et al., 2002). Despite the potential benefits, Stancampiano and 
colleagues suggest that this correlation is likely due to the fact that grazing horses are 
less likely to suffer colic than stabled horses yet they are also more likely to harbour 
parasites therefore suggesting correlation but not causation. Alternatively, 
Stancampiano et al. (2017) suggested a possible protective effect of luminal 
cyathostomins against larval emergence.  Either suggestion supports the practice of 
leaving animals with low helminth infection levels untreated without increasing the 
risk of disease. 
It is frequently advised by the equestrian press (health guidance information) that 
owners should rotate the classes of anthelmintic within medications in order to delay 
the appearance of resistance (Elder, 2017).  However, such suggestions are despite 
research evidence that such an approach is not effective (Uhlinger and Kristula, 
1992). Moreover, this problematic advice further leads to complacency, with many 
owners following programmes of anthelmintic rotation and routine treatment in the 
absence of diagnostic testing that delineates if these treatments are either necessary 
or successful (Relf et al., 2011).  Furthermore, slow rotation (alternating classes of 
anthelmintic on an annual basis) also remains a recommendation to support the delay 




in development of resistance (Kaplan, 2002). In contrast, computer modelling of 
helminth control strategies suggests that treating simultaneously with two different 
anthelmintic classes could be the most effective method (Kaplan, 2002). However, a 
case study testing the proposed Kaplan hypothesis observed that after the initial 
increased efficacy, likely due to elimination of single-anthelmintic resistant 
parasites, the efficacy of a combined treatment with oxibendazole and pyrantel 
pamoate decreased with subsequent doses (Scare et al., 2018a). Furthermore, Scare 
et al. concluded that due to the lack of effective anthelmintic classes available for 
use in equids the combination approach is likely to be less useful in horses than in 
ruminant species.  
Anthelmintic control of helminths in horses is likely to be enhanced through 
effective pasture management including removing faeces from grazing areas, which 
results in a lower infection rate (Tzelos et al., 2017). A combined strategy of correct 
targeted anthelmintic administration and pasture cleanliness offers the most 
sustainable prospect for continued helminth control in the future (Coles, 2002). 
1.2 ANTHELMINTICS AND ANTHELMINTIC RESISTANCE 
Anthelmintic resistance in nematode parasites is proposed to develop in a similar 
manner to antibiotic resistance in bacteria with frequent dosing and sub-lethal doses 
applying a selection pressure that increases anthelmintic resistant alleles 
(World_Health_Organisation, 2019). Thus, a chemotherapeutic that is not 100% 
effective will kill most individual pathogens but leaves those resistant to its activity 
to reproduce and produce the next generation of individuals. An important method to 
mitigate this is to leave a population of nematode parasites untreated, or “in refugia”. 
The refugia population can comprise nematode parasites in animals harbouring only 




low levels of infection, nematode parasite life-stages that are unaffected by the 
anthelmintic utilised and nematode parasites located outside the treated animal, such 
as eggs or free-living stages on the pasture (Nielsen et al., 2007) (Figure 1-1). 
 
Figure 1-1 Anthelmintic exposed nematode parasites vs Refugia population of parasites (NB encysted 
L3s are included in anthelmintic exposed population in the case of Moxidectin treatment). 
 
Importantly, when using an anthelmintic such as Ivermectin or Moxidectin, which 
have a high level of effectiveness in cyathostomins, treating only horses with an 
infection level over 200 epg can reduce total egg shedding in the herd by 96%, with 
98% of these eggs being shed by nematodes in refugia within untreated horses, 
substantially reducing the selection pressure for resistance (Figure 1-2). Thus, 
maintenance of a refugia population helps to preserve the susceptible alleles within 
the overall parasite gene pool. 





Figure 1-2 The effect of selective treatment on the refugia population of nematode parasites in horses 
adapted from Kaplan and Nielsen (2010). a) FECs from horses on 12 farms (n = 261) plotted in FEC 
magnitude order from left to right, with FEC on the y axis and individual horses on the x axis. It 
demonstrates the over-dispersion of egg shedding, with most horses having low FECs and only a few 
having very high FECs. b) Replication of the FEC data in a) but with the y axis broken for better 
visualisation of the data. Horses are divided into low egg shedders (green: under 200 epg), moderate 
egg shedders (orange: 200 – 500 epg) and high egg shedders (red: over 500 epg). c) The expected 
FEC distribution after treatment with an anthelmintic with high efficacy (99.9% e.g. Ivermectin or 
Moxidectin). Total egg shedding is decreased by 96% despite only half the horses being treated and 
98% of eggs are now being shed by nematodes in refugia in untreated horses. 
 
There are currently three major classes of anthelmintic used to control nematode 
parasites in horses: benzimidazoles (BZ; example active compounds Fenbendazole 
and Oxibendazole), Tetrahydropirimidines (THPs; active as Pyrantel salts), and 
macrocyclic lactones (ML; example active compounds Ivermectin and Moxidectin). 
In addition to nematode control, the cestocide Praziquantel is used for the control of 
tapeworm only, and although not licensed for use in horses, the flukicide 




Triclabendazole, given the increase in fluke infections (Quigley et al., 2017), can be 
used off-label where necessary to control liver fluke in horses. These anthelmintics 
are however outside the scope of this review. 
The mode of action of the Benzimidazole anthelmintics is quite well understood. 
Micro-tubules which form the cytoskeleton of all eukaryotes are formed of dimers of 
α- and β- tubulins, and BZ anthelmintics work by disrupting isotype 1 of the β-
tubulin gene (Gilleard, 2006) which inhibit polymerisation of the tubulins and hence 
the formation of the microtubules, damaging the cell structure and killing the 
parasite (Lacey, 1990). THPs like Pyrantel work by disrupting nematode neuro-
transmitters. They bind to receptors for acetyl-choline on the body wall muscles, 
which causes spastic paralysis in the nematodes, resulting in them being expelled 
from the host (Abongwa and Martin, 2017). Macrocyclic lactones also act on 
nematode neuro-transmitters, in this case glutamate-gated chloride channels, causing 
paralysis and blocking pharyngeal pumping, with Ivermectin also being an 
antagonist for 4-aminobutyric acid (GABA) and nicotinic receptors which are 
expressed on  the somatic muscle cells of parasitic nematodes (Abongwa and Martin, 
2017). 
It is often quoted in the scientific literature that parasite populations which become 
anthelmintic resistant are unlikely to revert to susceptibility (Jackson et al., 1998; 
Sangster, 1999). However, a summary of P. equorum anthelmintic resistance to the 
three major classes of anthelmintics documented in the literature demonstrate that, 
along with an increase in resistance to Ivermectin, there seems anecdotally to be a 
return to efficacy of benzimidazoles, particularly Oxibendazole (Table 1-1). It should 
be noted that the two studies noting resistance to Pyrantel (Lyons et al., 2008; Lyons 
et al., 2011) were both accounts from the United States, where use of PYR tartrate 




daily de-wormer is common practice. Such an apparent return to efficacy of the BZ 
anthelmintics is statistically demonstrated only (i.e. it is not specifically the same 
population of parasites in all studies). Nevertheless, it is reassuring that there is at 
least one class of anthelmintic that remains reasonably effective against P. equorum 
(90% or over at the time of writing), albeit that evidence for this is anecdotal.  
It is thought that reversion to susceptibility is not long-lived, as nematodes with 
alleles for resistance quickly multiply upon reintroduction of the anthelmintic 
(Leathwick, et al. 2001). However, a recent study in sheep, using combinations of 
different classes of anthelmintics in conjunction with methods to maximise refugia 
populations of parasites demonstrated an unexpected return to efficacy of 
anthelmintics that had previously been ineffective due to resistance (Leathwick et 
al., 2015). Therefore, as recommendations for the anthelmintic treatment of horses 
aim to maximise refugia populations (Nielsen et al., 2007) this offers  hope that 
careful management strategies could extend anthelmintic efficacy even after the 
development of resistance. 
  




Table 1-1 Summary of anthelmintic efficacies against P. equorum noted in the literature, 
demonstrating a development of resistance to Ivermectin (IVM) and simultaneous reversion to 
susceptibility to Benzimidazoles (BZ).Pyrantel (PYR) data included for completeness.  






Vandermyde et al. 1987   As 5 day course only  
DiPietro et al. 1987 100%   
French et al. 1988 100%   
Austin et al. 1991 98.2% 74.2% 44.5% 
Gawor  1996   50% 
Boersema et al. 2002 No Yes  
Hearn and Peregrine  2003 No   
Lyons et al. 2006 Low  High 
Lyons et al.  2007 
Published 2008 
Zero Very little 94% 
Slocombe et al. 2007 33.5% 97.6% 97.6% 
Molento et al. 2008 95% 94% 100% 
Veronesi et al. 2009 63% (2 
farms) 
100%  
Lind and Christensson  2009 Very low Over 90% Over 90% 
Veronesi et al. 2010 ineffective effective  
Näreaho et al. 2011 52%   
Lyons et al. 2011  2% 80% & 97% 
Bishop et al. 2013 
Published 2014 
0% - 69%   
Beasley et al. 2015 65%   
 
It is noticeable that different nematode species are developing resistance to different 
classes of anthelmintic suggesting that in order to treat both ascarids and 
cyathostomins successfully in young horses it is necessary to use more than one 
broad spectrum compound. In support, during a study in Kentucky in 2007 BZ 
wormers were effective against ascarids but not against cyathostomins, whereas the 
reverse was true for IVM (Lyons et al., 2008). Furthermore, PYR was not found to 
be effective against either species (Lyons et al., 2008). Thus, using any single class 




of anthelmintic exclusively would potentially fail to control both species of 
nematode and risk failing to control either species. 
In addition, in Brazil only Fenbendazole was fully effective against P. equorum and 
none of the MLs gave adequate control to cyathostomins. Furthermore, none of the 
three classes of anthelmintic were effective at 28 days post-treatment (Molento et al., 
2008). Thus, multi-drug resistance is a serious potential problem and must be 
guarded against by strategic application of anthelmintic compounds. 
As most anthelmintic compounds are broad spectrum, the dose needed to control 
different species of nematode may not be the same. The nematode species which 
requires the highest dose to be effective is generally known as the Dose Limiting 
Parasite (DLP). The ascarid species P. equorum is often the DLP in horses for most 
anthelmintic compounds (Reinemeyer, 2009). Therefore, the ascarid parasites 
present are more likely to receive a dose only just effective in concentration, whereas 
other species are receiving a dose which is more than sufficient. This will likely have 
the effect of hastening the development of resistance in the DLP compared to other 
species (Reinemeyer, 2009). Fortunately, P. equorum is rare amongst equid parasites 
in that most host animals develop absolute acquired immunity to infection over time, 
meaning that infection is a problem only in young animals (Clayton and Duncan, 
1979; Reinemeyer, 2009). Nevertheless, as ascarid infection can be fatal in foals and 
weanlings (Laugier et al., 2012) it is important to control these parasites. Therefore it 
is particularly imperative to ensure that the correct dosages of anthelmintics are 
administered to populations of foals and young horses accounting for the bodyweight 
of the animals. This will likely ensure that under-dosing is avoided and delay the 
development of anthelmintic resistance (Matthee, 2003). 




Moreover, exploiting anthelmintics which are less effective (for example, efficacies 
of 80% rather than 98%) may surprisingly delay the development of resistance, 
while retaining a measure of parasite control (Coles, 2002). Conversely, 
anthelmintics such as Moxidectin, that target all developmental stages of a parasite 
rather than leaving encysted larvae as a refugia population, will likely cause 
resistance to develop more rapidly (Coles, 2002) as there will be no new generation 
of untreated worms to appear when the larvae excyst. Such effects are somewhat 
mitigated by the fact that the efficacy of Moxidectin against encysted larval stages of 
cyathostomins is only 63.6% (EL3) and 85.2% (LL3/L4) respectively (Reinemeyer 
et al., 2015) meaning that there is the potential for a substantial number of treatment 
survivors to emerge and form a new parasite population.   
The previously recommended practice of treating animals and then moving them to 
clean pasture also hastens the development of resistance as all larvae deposited on 
the pasture will have been exposed to anthelmintic treatment, so it is recommended 
that this be discontinued (Coles, 2002). However in a regime of targeted, selective 
treatment (TST) where only high egg shedding animals are treated with 
anthelmintics, the movement of horses to clean pasture after treatment is less 
problematic as most nematode eggs deposited on the pasture will come from 
untreated animals (Kaplan and Nielsen, 2010). 
Frequency of treatment with anthelmintic compounds increases the speed with which 
resistance develops. PYR resistance in cyathostomins is more common in farms in 
the U.S.A. where a small daily dose of Pyrantel tartrate is fed (Kaplan, 2002). 
Paradoxically, this daily treatment leads owners to believe that their horses are fully 
protected against nematode parasites, hence regular sufficient doses of anthelmintics 




are rarely given. Thus, those horses in greatest need of parasite control are actually 
receiving the poorest treatment (Kaplan, 2002). 
In order to prolong the efficacy of anthelmintic compounds, it has been 
recommended to test for resistance against all anthelmintics used, only treating 
animals with a FEC of 200 epg or greater (see Table 1-2) and testing horses 
introduced into a yard for IVM resistance before allowing them to graze with others 
(Coles, 2009).  
 
Table 1-2 Equine FEC levels and action required (Westgate Laboratories, 2020) 
 FEC level Action  
Low <200epg No action required 
Medium 200 – 1199 epg Treat with anthelmintic 
High <1200 epg Treat with anthelmintic and review worming / 
pasture control programme. 
 
In addition, it is recommended to collect manure from the pasture, weekly in winter 
and twice weekly in summer (Coles, 2009), to cross graze with sheep where possible 
and not to graze foals on pasture used by foals the previous year (Coles, 2009). It has 
also been suggested that treating only those animals with physiological signs of 
infection, in addition to maximising refugia populations and delaying the 
development of resistance, could also select for those endoparasites that minimise 
their pathological effect on the host (Beech et al., 2011). Development of 
anthelmintic resistance is significantly reduced in premises where targeted treatment 




plans based on FECs are implemented (Sallé et al., 2017) underlining the importance 
of FEC testing as an aid to parasite control. 
1.3 LARGE STRONGYLES 
When modern anthelmintics first became available during the 1960s, the major 
nematode parasites of clinical importance in horses worldwide were the large 
Strongyles, primarily Strongylus vulgaris, with prevalence reported worldwide of 
between 80 and 100% (Nielsen et al., 2012). After having been ingested by the 
horse, the larvae of large strongyles penetrate the gut wall, and migrate through the 
blood vessels to the heart – causing oedema of the gut mucosa, and dilation of the 
small arteries, veins and capillaries (McCraw and Slocombe, 1976). Thrombosis can 
occur in the ilieo-caeco-colic and cranial mesenteric arteries due to migrating fourth 
stage larvae with infiltration of neutrophils (Duncan and Pirie, 1972), and thickening 
of the cranial mesenteric artery and its branches due to fibrin tracks which become 
overgrown with endothelium (Duncan and Pirie, 1972). With the introduction of the 
first anthelmintics, and the subsequent wholesale adoption of the interval-dosing 
regime (Drudge and Lyons, 1966), S. vulgaris has become rare in managed horse 
populations (Herd et al., 1981).  As a result, S. vulgaris has now been superseded as 
the principle nematode parasites of importance in infections of horses, by the small 
Strongyles, also known as the cyathostomins (Herd et al., 1981; Lyons et al., 1999).  
1.4 CYATHOSTOMINS (SMALL STRONGYLES) 
Cyathostomins are considered less pathogenic than large strongyles as the former do 
not migrate parenterally but only through the mucosa and occasionally the 
submucosa (Lyons et al., 1999). However, they are unique among parasites of horses 
in that they can enter a state of arrested development at the third larval (L3) stage 




and encyst in the intestinal mucosa (Eysker et al., 1984). The cyathostomin lifecycle 
has alternate development options for infective L3 larvae ingested from the pasture, 
which may develop into adults in the lumen of the intestine, or enter a period of 
arrested development as encysted larvae in the gut wall (Figure 1-3). 
  





Figure 1-3 Lifecycle of cyathostomins. Alternate options for ingested infective L3 larvae are available 
including the development of L3 larvae directly into L4 larvae or L3 larvae encystment in the gut wall 
(Corning, 2009). 
 
Cyathostomins are pathogenic at all life stages. In addition to the nutritional 
demands of large infections of adult worms, the fact that the early L3 stages invade 
the gut wall and encyst can cause serious damage to the gut mucosa, compromising 
the horse’s ability to absorb nutrients from its food (Collobert-Laugier et al., 2002). 
After entering the gut wall, the early L3 mature into late L3 and then L4 larvae 
which then emerge en masse back into the lumen of the gut. Emergence of large 
numbers of encysted cyathostomin larvae from the gut wall can cause larval 
cyathostominosis (Love et al., 1999) resulting in severe diarrhoea and weight loss in 
addition to colic, which can be fatal in as many as 50% of cases (Stratford et al., 




2011). As such, cyathostomins became recognised as important equid parasites 
(Love et al., 1999).  
A heavy infestation with adult and encysted L4 cyathostomins can cause 
neutrophilia, hypoalbuminaemia, hyperglobulinaemia, in particular beta-globulin, 
consistent with a protein-losing enteropathy (Corning, 2009). On a cellular level, 
histopathology shows an inflammatory response to cyathostomin larvae involving 
mononuclear cells, eosinophils and epithelial cells (Abbott, 1998). 
 Cyathostomin anthelmintic resistance 1.4.1
There is widespread resistance to BZs amongst cyathostomins recognised across the 
globe (Peregrine et al., 2014) such that these anthelmintics are rarely used as a 
routine control measure (Slater, 2015). Furthermore, although to a lesser extent, 
widespread resistance of cyathostomins to PYR exits globally, along with evidence 
of developing resistance to MLs (Peregrine et al., 2014). Worryingly, resistance to 
all three classes of anthelmintic has been discovered within the UK (Traversa et al., 
2009). 
Currently the most common anthelmintics administered by horse owners are the 
MLs: Ivermectin and Moxidectin (Slater, 2015). However, following the later 
introduction of Moxidectin there are fears that its widespread use is likely to hasten 
the development of resistance to Ivermectin in cyathostomins. Such suggestions are 
based upon the action of Moxidectin on the encysted larval stages which represent a 
refugia population when treated with Ivermectin (Sangster, 1999). A reduced egg 
reappearance period (ERP) is considered to be a precursor to the development of 
anthelmintic resistance (Shea Porr et al., 2017). Recent work has observed a reduced 
ERP for Moxidectin of four to five weeks as opposed to the 16 – 22 weeks 




historically reported when the anthelmintic was  first introduced (Bellaw et al., 
2018). Both ML anthelmintics are known to target a group of glutamate-gated Cl
−
 
channels within parasitic nematodes and therefore, given the similarity in their mode 
of action, resistance to one compound may also confer resistance to the other 
(Sangster, 1999). 
A recent computer modelling study predicted that reducing anthelmintic treatments 
by selectively treating horses would reduce the development of anthelmintic resistant 
nematode populations, and that this effect was greater in temperate climates like the 
UK (Nielsen et al., 2019). This hypothesis was borne out by a  Danish study, which 
observed Ivermectin to be 100% effective against cyathostomins, likely a direct 
consequence of the country’s policy of restricting anthelmintic use to those horses 
identified by a veterinary surgeon as requiring treatment (Larsen et al., 2011). This 
illustrates the potential success of a policy of targeted treatment only as a means of 
preserving anthelmintic efficacy. 
Owing to the potentially serious nature of larval cyathostominosis, owners are 
recommended to administer an anthelmintic effective against encysted larvae, either 
a five day course of BZ or a single dose of Moxidectin, in the autumn or early winter 
(Westgate Laboratories, 2018). Despite such advice for a BZ or Moxidectin based 
approach, recent studies have reported resistance to the five day BZ regime (Bellaw 
et al., 2018; Steuer et al., 2018) leaving only Moxidectin as an effective treatment 
against encysted cyathostomin larvae. However, the comparative efficacy of a five 
day course of BZ against early L3s at two and five weeks post treatment was found 
to be 50.4% and 51.3% respectively with Moxidectin only showing 73.8% and 
71.8% efficacy (Bellaw et al., 2018) suggesting that neither treatment regime is 
particularly effective. At the time of writing a diagnostic blood test to identify an 




encysted cyathostomin burden in horses has just been introduced (BVA, 2019) , and 
work is underway to develop a saliva based test ((Mitchell et al., 2016)). Better 
diagnostics will inform treatment decisions against encysted cyathostomin larvae, 
avoiding un-necessary anthelmintic treatments for these parasite life stages thus 
helping to delay the development of anthelmintic resistance. 
1.5 PARASCARIS EQUORUM 
A nematode from the family Ascaridae, Parascaris equorum, is an important 
parasite of foals (Clayton and Duncan, 1979). P. equorum follow the recognised 
hepatic-tracheal route of migration within the definitive host (Figure 1-4). 
 
Figure 1-4 Lifecycle of P. equorum (www.studyblue.com), showing hepatic tracheal migration of 
larvae. PPP = Prepatent Period, SI = small intestine 
 




Adult P. equorum lay eggs in the small intestine of infected horses and these are 
passed out with the faeces. The larvae develop within the eggs and undergo two 
moults become infective, larvated (L3), after approximately ten days and can remain 
in this state on the pasture for five to ten years (Lindgren et al., 2008). Foals and 
young horses ingest these infective eggs whilst grazing, and the eggs then hatch and 
migrate through the liver and the lungs for approximately one month.  From the 
lungs, P. equorum larvae are coughed up and swallowed to reach their predilection 
site in the small intestine and mature into adults reaching patency at 75-80 days after 
infection (Clayton, 1986). 
Equids usually build up immunity to P. equorum from 5-6 months of age so 
infection is rare in adult horses (Laugier et al., 2012). Infected foals can suffer from 
respiratory symptoms, stunted growth, ill-thrift, rough coat, diarrhoea and colic 
(Clayton and Duncan, 1978). A heavy P. equorum infection can cause intestinal 
blockage or rupture from large numbers of adult worms. In addition, as a 
consequence of larval migration, lesions in the liver, fibrosis and infiltration by 
oeosinophils and lymphocytes can occur (Brown and Clayton, 1979). As infection in 
older horses is rare, foals become infected through ingesting eggs from the pasture, 
deposited by previous generations of foals (Schougaard and Nielsen, 2007). For this 
reason, foals at stud farms are at particular risk, as out of necessity they are grazing 
land that foals have grazed previously. 
 Parascaris equorum anthelmintic resistance 1.5.1
In a critical study in 1991, it was observed that Ivermectin had 98.2% effectiveness 
against P. equorum, PYR pamoate 74.2% and Oxibendazole only 44.5% 
effectiveness (Austin et al., 1991). However, Table 1-1 demonstrates that these 
figures are not consistent in different regions and have not remained constant over 




time. P. equorum are highly fecund and produce a large quantities of eggs (Clayton, 
1986), which are extremely robust and can survive on pasture for many years. As 
these eggs represent a substantial refugia population and ML anthelmintics, such as 
Ivermectin, are highly effective against the luminal stages of the parasite, it was once 
thought that resistance was unlikely to develop (Boersema et al., 2002). It has 
therefore become common practice for stud farms to dose all foals routinely with 
Ivermectin as the sole method of control of these parasites. Unfortunately, this has 
not proven to be the case, with reports of resistance appearing very shortly 
afterwards (Boersema et al., 2002). 
The first report of possible P. equorum resistance to MLs occurred in the 
Netherlands (Boersema et al., 2002). Foals on this farm were routinely dosed with 
Ivermectin at 10 days, three weeks and six weeks and then bimonthly thereafter. The 
authors suggested that such frequency of treatment had contributed to the resistance 
observed, despite the previous belief that P. equorum were unlikely to develop 
resistance (Boersema et al., 2002). Resistance to Ivermectin was then reported in 
Canada in 2002 and 2003 (Hearn and Peregrine, 2003; Slocombe et al., 2007) and in 
Kentucky, Germany and Denmark in 2004 (Lyons et al., 2006; Schougaard and 
Nielsen, 2007; von Samson-Himmelstjerna et al., 2007b) and Sweden in 2006 
(Lindgren et al., 2008). A later Danish study found that Ivermectin had 96.9% 
efficacy against P. equorum. However, the mean age of horses in this study was 2.1 
years, meaning that there was a possible confounding effect of acquired immunity 
(Larsen et al., 2011). 
The first report of a UK infection with Ivermectin resistant P. equorum came in 2006 
with the death of a foal from severe P. equorum infection despite anthelmintic 
treatment every four weeks with Ivermectin (Stoneham and Coles, 2006). Additional 




foals from this farm were subsequently successfully treated with a five day course of 
Fenbendazole. In 2008 P. equorum resistant to Moxidectin, yet susceptible to PYR, 
were discovered by a UK veterinary surgeon in a horse imported from the 
Netherlands (Peaty, 2008) and, in a letter published in answer to this report, a 
representative of Fort Dodge Animal Health (manufacturers of the Moxidectin based 
anthelmintic “Equest”) stated that MLs were not the anthelmintic of choice for use 
against P. equorum (Traill, 2008). Despite this advice, the data sheet for “Equest” 
stated that it is effective against P. equorum (Zoetis Ltd, 2013) although this has now 
been amended to refer to Moxidectin sensitive strains (Zoetis Ltd, 2019). 
Ivermectin resistance in P. equorum was later observed in other European countries 
(Veronesi et al., 2010; Veronesi et al., 2009); (Lind and Christensson, 2009); 
(Laugier et al., 2012; Näreaho et al., 2011) and in New Zealand and Australia 
(Beasley et al., 2015; Bishop et al., 2014). Furthermore, P. equorum populations 
resistant to PYR were found in Kentucky (Lyons et al., 2011). A 2014 study of foals 
on Australian stud farms detected resistance to all three classes of anthelmintic in P. 
equorum, with some farms having multi-drug resistance populations. Fortunately, 
none of the farms tested showed resistance to all three classes simultaneously 
(Armstrong et al., 2014). These studies illustrate that monitoring of anthelmintic 
efficacy against P. equorum is essential to ensure effective treatment of these 
nematodes. 
 




1.6 NEMATODES AND ANTHELMINTIC RESISTANCE IN SPECIFIC 
EQUID POPULATIONS 
 Donkeys 1.6.1
Donkeys can be asymptomatic vectors of the nematode lungworm Dictyocaulus 
arnfeldi which has been known to infect horses (Soulsby et al., 2004). In horse 
infections, D. arnfeldi cause severe coughing and breathing difficulties often 
accompanied by chronic pneumonia and secondary bacterial infections. Patent 
infections in adult horses do not occur, so only those horses co-grazed with donkeys 
are at risk (Soulsby et al., 2004). In addition, in common with horses, donkeys can 
suffer from large Strongyles, Cyathostomins and P. equorum (Soulsby et al., 2004).  
Resistance to all three classes of anthelmintic compounds, including triple-drug 
resistance, has been found in cyathostomins infecting donkeys (Lawson et al., 2015). 
Targeted treatment plans can be hampered where large numbers of donkeys are kept 
together, such as the Donkey Sanctuary (Sidmouth, U.K.) which has over 3,000 
resident donkeys (Soulsby et al., 2004), making it impractical to perform FECs on 
each individual animal. In contrast, anthelmintic resistance in the parasites of 
donkeys is rarer in the developing world, as the use of anthelmintics is decreased 
owing to lack of availability and refractive costs (Soulsby et al., 2004). 
Cyathostomin ERP was found to be shorter in donkeys (42-55 days) than in horses 
following Moxidectin treatment (Matthee et al., 2002), suggesting that greater care 
needs to be taken with donkey herds to prevent the development of full-scale 
anthelmintic resistant parasites. 





Relatively few studies have looked at the mule population.  However, research in 
Mexico on working equids demonstrated that mules were more likely to be infected 
with nematode parasites than horses or donkeys (Valdéz-Cruz et al., 2006). Mules 
also displayed higher levels of infection than either horses or donkeys when assessed 
via FEC epg (Valdéz-Cruz et al., 2006). Of the few studies that have investigated 
parasite levels in mules, the results are not always reported separately from results 
obtained from horses (Foster, 1937; Pereira and Vianna, 2006) making it difficult to 
draw comparisons for this group of equids. 
 Zebras 1.6.3
Free ranging wild zebra have typically higher worm burdens than do managed 
animals and in the absence of anthelmintic treatment are still commonly infected 
with large strongyles, which are now rare in domestic horse populations (Wambwa 
et al., 2004). A nematode commonly observed in both ranched and free ranging 
zebra is Crossocephalus viviparous from the family Atractidae which does not 
appear to infect horses even when sharing the same habitat (Krecek et al., 1995) and 
is often found in high levels (Wambwa et al., 2004). 
The majority of cyathostomin species infect all equids. However, there are some 
species particular to one host such as Cylicocyclus triramosus which is known to 
infect only zebra (Kharchenko et al., 1997). Confirmation using scanning electron 
microscopy has revealed that the ascarid species infecting both wild and captive 
zebra is the same one that infects the domesticated horse, namely P. equorum (Ansel 
et al., 1974). 




1.7 METHODS OF NEMATODE DETECTION 
 Faecal egg counts 1.7.1
A number of methods of performing faecal egg counts (FECs) exist, which are useful 
in determining the presence and level of nematode egg shedding and hence which 
horses should be treated. In all methods, samples of fresh faeces are diluted in a 
flotation solution and examined microscopically to count the number of eggs per 
gram (epg) present. Historically, the most commonly used FEC method was the 
McMaster technique (MAFF, 1986). The McMaster method has been adapted to 
include counting the entire McMaster slide chamber in an attempt to increase 
sensitivity (Torgerson et al., 2012). However, due to egg aggregation at the centre, of 
the slide it is actually more accurate to count only the grids as intended by the 
designers (Godber et al., 2015). Although many flotation solutions can be used, a 
saturated saline solution (specific gravity 1.20) should be sufficient to float all three 
commonly found species of helminth eggs in equine samples – strongyles (specific 
gravity 1.05), the tapeworm Anoplocephela perfoliata (specific gravity 1.06) and 
Parascaris equorum (specific gravity 1.09)  (Norris et al., 2018). 
One recommendation is to use the FECPAK version one system (FECPAK
G1
), as it 
is more sensitive (25 epg) than the McMaster method (50 or 100 epg), which was 
originally developed for sheep but adapted for equids (Coles, 2009). The FECPAK
G1
 
system utilises a microscope slide in a similar manner to that of the McMaster test 
but allows for a larger volume of faeces to be examined, thus improving sensitivity 
and rendering the test able to estimate mean egg density more accurately over a wide 
range of infection levels (Presland et al., 2005). Additional FEC methods that are 
more sensitive than the McMaster such as the Mini-FLOTAC (10 epg) or FLOTAC 




(1 epg) are also preferable, particularly where egg counts are low (Levecke et al., 
2012b; Rinaldi et al., 2014). 
 Use of technology in FECs 1.7.2
In November 2017 an alternative automated FEC system, the Poop2Proof system 
(later renamed Parasight), launched onto the market, initially for Veterinary surgeons 
only (MEP_Equine_Solutions, 2019). This system analyses faecal samples using 
fluorescent staining of nematode eggs followed by imaging and analysis via 
computer aided programmes. However, the performance of the system is 
questionable, having an overall accuracy of only 32.5% when tested on spiked 
samples (Scare et al., 2017). Of particular concern is the fact that the system only 
detected 25% of the eggs in samples spiked at 500 epg and 29% of the eggs in 
samples spiked at 1000 epg. In reality, this suggests that a treatable infection (>200 
epg) would likely not have been diagnosed until the actual infection level was 1000 
epg (Scare et al., 2017).  
1.7.2.1 FECPAKG2 method 
A system that is currently in development for equines, the FECPAK
G2
, aims to 
produce automated FEC images without the need for a separate microscope. This 
system will have a similar sensitivity (26 epg) to its predecessor the FECPAK
G1
 
method, and will produce images that can be stored or transmitted via the internet 
(Unpublished data, 2016). The FECPAK
G2
 system is currently in use for sheep and 
cattle (Techion Ltd, Pers. comm), it has been tested in alpacas (Rashid et al., 2018) 
and is also being optimised for use in humans (Ayana et al., 2018). Although in its 
infancy for equine faecal samples, the FECPAK
G2
 system was successfully used in a 
small study at the Royal Welsh agricultural show which found that horses whose 




owners did not include FECs in their parasite treatment regime had FECs over four 
times higher than horses who received FECs (Tyson et al., 2017). 
Nevertheless, the use of technology in developing new FEC methodologies, 
particularly those that require little in the way of specialist knowledge, should 
encourage the use of FECs as part of a parasite management programme in domestic 
horses and other species. Such engagement across the equid sector is necessary as 
recent surveys demonstrate that FECs are still not widely used in the equine industry, 
with a recent study reporting only 22% of establishments using FECs at all and only 
10% using them on a regular basis (Nielsen et al., 2018a). 
 
 Faecal egg count reduction tests 1.7.3
The most accurate method of studying levels of parasitic helminth infection in 
livestock and hence anthelmintic resistance is termed ‘dose and slaughter’ 
(Schougaard and Nielsen, 2007).  However, as horses are not regularly slaughtered 
for consumption in the UK, critical studies in which the subjects are necropsied to 
determine the level of parasitic infection are uncommon. Therefore, the faecal egg 
count reduction test (FECRT) is considered to be the most effective technique for 
measuring anthelmintic resistance in equids (Kaplan, 2002). In brief, one FEC test is 
performed on the day of treatment and a further FEC performed fourteen days after 
treatment with the reduction in eggs recorded signifying the efficacy of the 
anthelmintic delivered. A reasonable and often applied definition of anthelmintic 
resistance would be: i) percentage reduction in egg count less than 95% and ii) lower 
limit of 95% confidence level less than 90% (Coles et al., 1992). These criteria were 
proposed by the World Association for the Advancement of Veterinary Parasitology 




(WAAVP) in order to define anthelmintic resistance in 1992. More recently, it has 
been suggested that different resistance alert levels should be designated depending 
on the anthelmintic actually utilised  (Kaplan, 2002). To this end, the American 
Association of Equine Practitioners (AAEP) parasite control guidelines advise that 
BZ resistance should be assumed with FECRT of <90%, THP resistance with <85% 
and ML resistance with <95% (Nielsen et al., 2013). However, research comparing 
different methods of assessing FECRTs suggests that current WAAVP guidelines for 
assessing anthelmintic efficacy, as described in Coles et al. (1992), remain the most 
appropriate (Levecke et al., 2018). 
Researchers are currently aware that significant caution must be taken in interpreting 
the results of a FECRT since an apparent reduced efficacy of the anthelmintics 
administered can simply be due to the sensitivity of the FEC method used, as well as 
a potentially incorrect or ineffective dosing (El-Abdellati et al., 2010). Further 
confounding factors for FECRT interpretation can be the relative level of 
aggregation of infection within the host population and often the alarming absence of 
a direct relationship between the level of nematode infection and the level of egg 
excretion (Levecke et al., 2012a). However, this said, the FECRT remains the most 
utilised and effective tool for determining anthelmintic resistance levels in equine 
nematode parasites. 
Thus, in order to test accurately for decreased anthelmintic efficacy, it is desirable to 
exploit the most sensitive test available, e.g. the FLOTAC technique which is 
sensitive to 1 epg (Coles, 2009). This is clearly important where infection levels can 
imply a relatively low burden (Levecke et al., 2011). However, this method is time-
consuming and technically demanding, requiring 11 separate steps including two 
centrifugations (Levecke, 2016 personal conversation). In field situations, where 




resistance is present, as defined by the WAAVP, all tests trialled, including a 
modified McMaster with a sensitivity of 10 epg, have been found to be effective at 
detecting anthelmintic resistance (Levecke et al., 2012b). Furthermore, where either 
egg counts are high or an approximate count is needed to determine whether or not 
treatment is required,  then any of the FEC tests would be appropriate (Bosco et al., 
2014). Thus whilst highly sensitive FEC methods may be required for research 
purposes, routine diagnostics can be accomplished using tests with lower diagnostic 
sensitivity. 
An alternative method, rather than highlighting the mean FEC reduction from a 
number of animals, is to treat the egg as the experimental unit, rather than the horse 
(Dobson et al., 2012). Performing repeat counts on high shedders until, for example, 
200 eggs have been counted (actual eggs seen rather than computed epg figures) can 
also be used instead of a single count from each animal available (Levecke, 2016, 
personal conversation). Dobson et al. (2012) also recommended the use of Jeffreys 
confidence intervals to estimate the precision of the FECRT in cases where 
anthelmintic efficacy is estimated to be 100%, as other statistical methods cannot 
generate confidence intervals under such circumstances (Dobson et al., 2012). 
Jeffreys confidence intervals should only be used when efficacy is 100% however, 
not under any other circumstances, where they may distort results (Levecke, 2016, 
personal conversation). 
In sheep, it has been demonstrated that using pooled samples from several animals is 
as effective as using individual FECs for the estimation of mean level of infection 
and for testing anthelmintic efficacy (Rinaldi et al., 2014). However, due to the level 
of over dispersion of helminth parasite burdens in horses (Laugier et al., 2012), it 




may be a less useful method in this species. Nevertheless, pooled sample testing has 
been found to be beneficial for pre-screening in horses (Eysker et al., 2008). 
1.8 MOLECULAR GENETICS 
 Diagnostics and species identification 1.8.1
Molecular tests are now available to support comprehensive diagnostics by both 
quantifying and speciating the parasitic nematode populations infecting a host 
animal, termed the ‘nemabiome’. This was initially achieved in cattle, although also 
applicable to horses, by culturing nematode larvae from the eggs in the host faeces 
and undertaking Next Generation Sequencing (Avramenko et al., 2015). Further 
research in equines has realised the possibility of performing such tests directly on 
faecal samples, thus saving the time consuming larval culture step (Mitchell et al., 
2019) Furthermore, molecular genetic techniques have been employed for 
determining the change in the nemabiome following anthelmintic treatment in cattle 
(Avramenko et al., 2017).  
 Detection of anthelmintic resistant nematodes 1.8.2
As long ago as 2004 it was stated that there was an urgent need to develop and 
validate molecular assays for the detection of anthelmintic resistant nematodes in the 
field in order to replace treatment failure (phenotypic detection) as the sole option 
(Kaplan, 2004). One route towards a molecular assay is to explore the genetic basis 
of anthelmintic resistance by embracing the candidate gene approach. Thus, based on 
our understanding the mode of action for each anthelmintic, we can identify the 
genes involved and potentially identify mutations in these genes that occur in 
resistant nematodes. This approach has been successful in identifying the isotype-1 
β-tubulin locus as the most important indicator of BZ resistance in a number of 




parasitic nematode species (Gilleard, 2006) across ruminants and equids. It is not 
thought that the isotype-2 β-tubulin locus is implicated in BZ resistance in 
cyathostomins, as no polymorphisms have been consistently observed in the analysis 
of resistant and susceptible populations (Hodgkinson et al., 2008). The role of the β-
tubulin 200 codon mutation is not as strongly linked with the resistance phenotype in 
cyathostomins as in other helminths such as the trichostrongylids (Coles et al., 2006; 
Hodgkinson et al., 2008). However, a non-synonymous A/T polymorphism causing 
and amino acid shift at residue 167 is likely to be implicated in BZ resistance in 
Cyathostomins (Drogemuller et al., 2004; Pape et al., 2003; von Samson-
Himmelstjerna et al., 2007a). In a 2008 study, homozygous mutations causing amino 
acid substitutions at either residue 200 or residue 167 conferred BZ resistance yet, in 
158 parasites genotyped, none had homozygous mutations at both loci underlying 
these key residues. This suggests that a double mutation may be lethal (Hodgkinson 
et al., 2008). Recent work in Brazil has also identified a potential SNP in the codon 
encoding for residue 172 which results in a serine to threonine substitution that may 
also be related to BZ resistance (Ishii et al., 2017). 
The candidate gene approach is far more complex in the case of Ivermectin 
resistance, as a number of different gene mutations have been associated with the 
resistance phenotype (Gilleard, 2006). Under these circumstances a genome-wide 
approach would be more successful once whole genome data are available for equine 
nematodes (currently genomes for the cyathostomin Cylicostephanus goldi and the 
large strongyle Strongylus vulgaris are available on Wormbase Parasite). 
Nevertheless, a number of genes have been identified that are associated with 
resistance to different classes of anthelmintic (Table 1-3). 
  




Table 1-3 Genes associated with nematode resistance to four different classes of anthelmintic. (Beech 
et al., 2011). 
For each gene, the molecular change associated with the appearance of anthelmintic resistance is 
indicated, along with the type of diagnostic test typically used to identify mutations associated with 
resistance: SNP-PCR, PCR based test that identifies specific single nucleotide polymorphism as 
indicated in the text; QT-PCR, quantitative PCR that can estimate the relative abundance of different 
RNA transcripts, PCR, indicates a test where the specific size of a PCR product, or the presence or 
absence of a specific product forms the basis of the test. AchR = Acetylcholine Receptor, Glu/GABA 
channel = Glutamate or GABA gated channel 
Anthelmintic Target  Resistance 
gene 
Molecular change Molecular 
test 
BZ beta-tubulin -tubulin F200Y SNP-PCR 
   E198A SNP-PCR 
   F167Y SNP-PCR 
LEV AchR unc-38 Decreased expression QT-PCR 
  unc-63 Altered transcript PCR 
  acr-8 Altered transcript PCR 

















avr-14 L256F SNP-PCR 
  lgc-37 K169R SNP-PCR 
  glc-5 A169 V SNP-PCR 
  ggr-3 Decreased expression QT-PCR 
  pgpA Increased expression QT-PCR 
 
Thus far, although polymorphisms in ML anthelmintic-uptake receptors have been 
identified in several studies, no mutations have yet been identified which explain the 




resistance found phenotypically in parasites in the field (Kotze et al., 2014). It is 
therefore likely that the mechanism of resistance in the field is multi-genic (Kotze et 
al., 2014). Recent work has strongly implicated P-glycoproteins (P-gps), components 
of Phase III detoxification, as being at least partly responsible for reduced sensitivity 
to Ivermectin (Peachey et al., 2017) raising the possibility of the use of P-gp 
inhibitors to enhance the efficacy of the anthelmintic and reverse resistance. 
Furthermore, although causality has not been established, a link has been observed 
between survival of ML treatment and BZ resistance suggesting that treatment with 
MLs could also select for BZ resistant nematodes (Blackhall et al., 2008; de Lourdes 
Mottier and Prichard, 2008).  
Genes for anthelmintic resistance may occur in one of four ways. Mutations 
conferring resistance may be ancient, pre-existing the start of anthelmintic use; new 
mutations could arise immediately before, or during, the period of anthelmintic use; 
mutations may occur recurrently; or they may be introduced as a result of a new 
animal being brought to the premises (Gilleard and Beech, 2007). Genetic diversity 
in parasitic nematodes is high, due to their large population size and high mutation 
rate (Nadler, 1987). It has been demonstrated that this diversity includes alleles for 
resistance even before the first exposure to anthelmintics (Coles et al., 2005).  
Applying a high selection pressure has been demonstrated to produce anthelmintic 
resistant Haemonchus contortus, an important parasitic nematode of sheep, in only 
three generations (Coles et al., 2005).   
In order to obtain anthelmintic resistant parasites for genetic analysis, one of two 
methods are required to be employed. Firstly, it is necessary either to produce 
resistant strains experimentally in the laboratory, or to harvest naturally resistant 
parasites on farms where resistance has previously been confirmed. Laboratory 




selection typically incorporates lower doses of anthelmintics than would be 
administered in the field as sufficient parasites are required to remain alive in order 
to produce successive generations. Therefore, resistance alleles produced under 
laboratory conditions may not have a major effect or, more importantly, may not 
reflect the infield situation (Gilleard and Beech, 2007). However, resistant parasites 
obtained from the field are harder to compare with non-resistant strains as there may 
be substantial underlying genetic variability not connected to anthelmintic resistance 
(Gilleard and Beech, 2007). An added layer of complexity is due to the diversity of 
cyathostomin species that infect horses, which number more than 50 with a typical 
infection consisting of more than five different species (von Samson-Himmelstjerna, 
2012), sometimes many more (Mitchell et al., 2019).  
As noted previously, molecular genetic techniques have demonstrated that there is a 
correlation between ML exposure and an increase in the codons implicating 
resistance to benzimidazoles (de Lourdes Mottier and Prichard, 2008) suggesting 
that use of MLs could predispose parasites to BZ resistance. Such a predisposition 
has serious implications for anthelmintic rotation regimes, as anthelmintic resistance 
alleles could be selected for even in the absence of drug exposure. In addition, if 
anthelmintic resistance occurs due to the evolution of efflux mechanisms in parasitic 
nematodes, multi-drug resistance could easily occur (James and Davey, 2009). 
In the sheep sector, DNA based testing is able to identify benzimidazole resistant 
strains of H. contortus, allowing alternative anthelmintics to be used instead (Kotze 
et al., 2014). However, it is questionable whether such tests would be useful in 
horses as widespread knowledge of resistance to BZ anthelmintics in cyathostomins 
means that they are seldom used routinely (Slater, 2015). 




A recent study using reverse line blot observed that this technique was a useful semi-
quantitative method for detecting different cyathostomin species in pooled samples - 
a substantial reduction in work from individual testing. Reverse line blot thus 
represents a potentially suitable method for differentiating the species present in 
groups of horses, although less accurate for larval culture of a single horse 
(Kooyman et al., 2016). Next generation PCR techniques could also be used for such 
assays, and an investigation into the equine nemabiome, and how this changes before 
and after anthelmintic treatment, could yield useful information about the exact 
species of cyathostomin most resistant to treatment. This technique has already been 
successfully deployed in cattle (Avramenko et al., 2017). It has been observed that 
fewer than ten horses need to be sampled in order to determine the species 
composition of cyathostomins at a single premises (Sallé et al., 2018). There is some 
evidence that the developmental stage of strongyle eggs may affect the quantity of 
DNA present and hence the efficacy of PCR assays (Andersen et al., 2013). 
Therefore, it is important to determine which tests will be performed on a faecal 
sample, in order to determine the optimal storage conditions. 
It has been suggested that, rather than using molecular techniques to identify 
resistant strains of parasite, detecting those that are susceptible to anthelmintic 
treatment would instead be a useful practice (Beech et al., 2011). Assays to predict 
anthelmintic susceptibility would inform treatment decisions and indicate the most 
useful anthelmintic treatment to apply, rather than guesswork followed by testing for 
resistance. 
 Reappearance of S. vulgaris 1.8.3
A side effect of targeted anthelmintic treatment in the equid sector is the 
reappearance of S. vulgaris, once considered to be virtually eliminated in managed 




horses (Nielsen et al., 2012). In a Danish study, it was noted that 2% of colic cases 
admitted to a veterinary hospital were due to non-strangulating infarctions caused by 
S. vulgaris (Pihl et al., 2017). Over ninety percent of these cases were fatal, 
including 100% of cases that weren’t treated surgically (Pihl et al., 2017). It is 
impossible to differentiate large Strongyle species, such as S. vulgaris, from less 
pathogenic cyathostomin species using egg morphology (Lichtenfels et al., 2008b). 
Previously, larval hatch assays were required to enable species diagnosis from faecal 
samples, yet as genetic sequencing becomes more available, the potential for species 
identification from eggs becomes possible. Using molecular techniques as a 
diagnostic aid, targeted anthelmintic treatments could potentially include differential 
diagnosis between S. vulgaris and cyathostomin infections, thus helping prevent 
serious disease.  
1.9 CONCLUSION 
It is clearly of the utmost importance that each premises monitors the susceptibility 
of its helminth parasite populations to different classes of anthelmintics. At present, 
such an aim in nematode parasites is best achieved by FECRTs, although molecular 
genetics may yield more efficient methods in the near future. New methods of 
detecting anthelmintic resistance in P. equorum are particularly necessary as the 
FECRT method has not been validated in this species, neither has a correlation 
between high FECs and a high worm burden been demonstrated (Reinemeyer, 2009).  
In addition to ensuring that effective chemicals are used, dosing frequency should be 
reduced as far as possible. Thus, targeted selective treatment plans based on dosing 
only those horses with the highest parasite burdens will help balance the need to 
avoid parasitic disease and pasture contamination, with the absolute essential of 




reducing the development of anthelmintic resistance. Historically, a figure of 200 
epg has been used as the level at which treatment should be given, but it has been 
suggested that raising this to 500 epg would help delay the development of resistant 
worms (Molento et al., 2008; Veronesi et al., 2009). As the relationship between 
parasite burden and pathology is not precisely known, treating only those horses 
shedding high levels of eggs or those showing signs of parasitic disease is 
recommended (Coles, 2002). Finally, non-chemical approaches to avoiding parasite 
infection, such as removal of dung regularly from pasture, must be regarded as 
essential for 21
st
 Century equine management, as such measures are correlated with 
reduced parasitic infection (Tzelos et al., 2017). 
 
1.10 AIMS 
The aims of this PhD are to support the development of new technologies in the 
monitoring of infection level and anthelmintic resistance in nematode parasites of 
horses. Firstly, given that the FECPAK
G2
 faecal egg counting platform has not 
previously been evaluated for the equid sector, the FECPAK
G2 
will be assessed and 
optimised for use in horses.  Furthermore, the FECPAK
G2
 will be validated against 
currently recognised and accepted FEC methods. It is envisaged that by 
demonstrating that the diagnosis of nematode parasite infection is simpler and easier 
through the application of technology, owners will be encouraged to monitor 
infection level and treatment efficacy. Importantly, moving away from a blanket 
interval dosing treatment regimen will help delay the development of anthelmintic 
resistance and moreover, diagnostics are essential in a move toward targeted 
selective treatment (TST).  




Anthelmintic resistance in a number of horse establishments will be monitored by 
performing FECs both before and after treatment. During this phase, samples will be 
retained and DNA extracted. Next Generation DNA sequencing will be carried out to 
investigate the equine nemabiome and how this changes in the face of treatment with 
anthelmintics. It is hoped that this relatively simple, non-invasive method of 
discovering which species are present and which are more resistant to anthelmintic 
treatment, will increase knowledge of the equine nemabiome, and provide a “proof 
of concept” that will inspire further studies of how this changes in various 
circumstances. 
Aims: 
 Assess and optimise FECPAKG2 for equine samples (Chapter 2). 
 Validate optimised FECPAKG2 protocol for equine samples (Chapter 3). 
 Assess level of anthelmintic resistance in areas of the UK and monitor 
nemabiome shift in the face of anthelmintic treatment (Chapter 4). 
 Investigate application to exotic equids (Chapter 5). 
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2 DEVELOPMENT OF THE FECPAKG2 FOR EQUINE USE 
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The fundamental component for successful Targeted Selective Treatment (TST) of 
nematode parasites in horses is a diagnostic test to identify which animals are the 
high egg shedders that should be selected for anthelmintic treatment. Faecal egg 
counting or FEC remains the mainstay of diagnostic testing for nematode parasites.   
Importantly,  studies show that the use of FECs as a management tool can lead to 
lower egg counts (Tyson et al., 2017) and thus less need for anthelmintic treatment, 
yet other studies demonstrate that the majority of horse owners do not utilise FECs at 
all, or do not perform them with the recommended frequency (Slater, 2017). It is 
hoped that by improving the ease with which FECs can be performed, horse owners 
will be encouraged to use them more regularly.  
 The FECPAKG2 system 2.1.1
The FECPAK
G2
 system (Techion Ltd) is currently commercially available for 
counting gastro-intestinal nematode eggs in sheep faeces. This system involves the 
owner performing simple preparation steps on a sample of faeces, then loading it into 
an imaging device which captures an image and uploads it via the internet where it 
can be evaluated by trained technicians. The egg count is then electronically returned 
to the owner, together with support on deciding whether or not to treat the animal 
with anthelmintics. The problem to overcome in developing the FECPAK
G2
 system 
for equine use is that the volume and consistency of equine faeces differs 
significantly from that of sheep faeces (Fritz et al., 2009), which, coupled with the 
potentially different level of nematode egg shedding in horses, requires each stage of 
the FECPAK
G2 
preparation of the faecal samples to be optimised to ensure that the 
FECPAK
G2
 test will perform acceptably for the new host species. Therefore, it was 
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hoped to devise a standard operating procedure (SOP) for equine faecal sample 
preparation so that the FECPAK
G2
 could successfully be used to perform egg counts 
on nematodes in horse faeces. This approach would have the dual benefit of 
providing a novel method of faecal egg counting for the equine sector, and 
additionally opening up a new market for the Techion FECPAK
G2 
system.    
The original FECPAKG2 protocol for sheep samples is as follows: 
 Mix faeces with water in the ratio 1:3 and mix to form a uniform slurry 
 Spoon 12 ml slurry into a sedimentor and fill with water, invert three times to 
mix 
 Allow to stand for 30 minutes, then discard the supernatant 
 Add 80 ml saturated NaCl solution to the sediment and pour into a 
FECPAK
G2
 cylinder fitted with 600 µm and 425 µm (sliver) filters, invert 
three times to mix 
 Fill both wells of the FECPAKG2 cassette from the cylinder, mixing between 
each aliquot 
 Allow the cassette to stand for six minutes for the eggs to accumulate, then 
image using the Micro-I  
Initial work using equine samples in the Techion Ltd laboratory had determined that 
the initial dilution of the sample needed to be 1:4 to produce a faecal slurry of the 
required consistency. In addition the liquid in the sedimentor needed to be filtered 
through a 1mm mesh prior to the sedimentation to remove large debris. These two 
steps were added to the sheep protocol when working with equine samples. 
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2.2 CHAPTER AIMS 
 Devise a SOP for the FECPAKG2 for use with equine samples 
2.3 OPTIMISATION OF THE FECPAKG2 FOR EQUINE USE 
The optimisation steps which were followed are outlined in Figure 2-1. These steps 
were included in order to determine if equine faeces would behave in a different way 
to sheep faeces in the different stages of the FECPAK
G2
 preparation and to ensure 
that any differences in the faecal consistency and the concentration of nematode eggs 
therein did not introduce errors into the test. 
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Figure 2-1 Optimisation steps undertaken in order to determine the best protocol for processing 
equine samples for the FECPAK
G2 
Sedimentation refers to the process whereby the faeces are diluted 
with water and left to stand in a sedimentation device, until the nematode eggs and heavier debris 
have settled to the bottom, and any lipids or light debris have floated to the top where they can be 
poured off and discarded. Accumulation refers to the process of allowing the nematode eggs to float 
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2.4 INVESTIGATING SLURRY FRACTIONS 
 Slurry fraction investigation - introduction 2.4.1
In order to optimise the FECPAK
G2
 for equine use, the initial optimisation was 
focused on investigating the initial sampling of the faecal slurry so as not to 
introduce error into the FEC process through the dilution of the faecal sample. 
Following dilution of the faeces with water, a faecal slurry is produced, which by its 
nature is a mixture of small particles suspended in liquid, and thus may provide 
varying FECs dependent on the sampling method chosen. 
Prior to the development of the FECPAK
G2
 (FECPAK second generation, or G2), 
Techion Ltd. marketed FECPAK (protocol in Appendix 7.1), a faecal egg counting 
methodology, and subsequently referred to as the FECPAK
G1
 (G1) to distinguish it 
from the FECPAK
G2
. The initial step of both the G1 and the G2 Techion Ltd. 
methods for equine samples involved diluting the faecal sample in a 1:4 ratio with 
water in a Ziploc bag (Figure 2-2). The diluted sample was recommended to be 
poured from the Ziploc bag into the receptacle for the next stage of the sample 
preparation protocol (45 ml slurry in the case of the G1 method and a reduced 
volume of 12 ml slurry in the case of the G2 method).   
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Figure 2-2 Ziploc bag used for initial sample dilution showing closure mechanism which was trapping 
the solid matter from the faeces. (www.togopackaging.com ) 
 
It was noted that when dispensing a large volume of slurry for the G1 method, the 
initial watery fraction was followed by more solid matter. However, in the case of 
the G2 sample, requiring a reduced volume of slurry, the zip of the Ziploc bag 
trapped any solid matter and, coupled with the small volume dispensed this meant 
that the initial watery sample was not immediately followed by solid material. Thus 
this process for the G2 gave cause for concern that the resulting aliquot of faecal 
slurry would not be representative of the sample as a whole, both the liquid and the 
solid fractions.   
In sheep, for which both the FECPAK methods were originally developed, the faeces 
produced a uniform faecal slurry  as ruminant digestion breaks the food matter down 
into very small particles (Fritz et al., 2009). However, as hindgut fermenters, horse 
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faeces generally contain much larger particles of solid matter (Fritz et al., 2009). 
Consequently, in the initial step of both the G1 and G2 preparation, it proved 
impossible to produce a faecal slurry which did not separate into watery and more 
solid matter, despite how well mixed the faeces and water had been. Given the 
challenges with non-uniform faecal slurry it is likely that nematode eggs maybe 
released into the watery fraction, with the risk of over-stating the egg count, or 
retained in the solids potentially under-stating. 
 Slurry fraction investigation - materials and methods 2.4.2
Faecal slurry preparation was replicated on three different biological samples, once 
on a sample with a high FEC and twice on more average ones. For each faecal slurry, 
20 g of faeces from a horse with a natural strongyle infection were mixed with 80 ml 
water in a Ziploc bag. The resulting slurry was mixed until it was of uniform 
consistency. Twenty grams of faeces and 80 ml of water gave a workable quantity of 
slurry whilst ensuring that a larger sub-sample of faeces were used compared to the 
standard McMaster method (MAFF, 1986). The use of a larger sub-sample is an 
important improvement, as it helps to mitigate the effects of nematode egg 
aggregation within the faecal pile (Denwood et al., 2012).  
Following faecal slurry generation, slurry was poured from the Ziploc bag into the 
Techion Ltd. sedimentor (see Figure 2-3) up to the slurry line (12 ml), followed by 
80 ml of saturated NaCl solution. In this range finder experiment, the samples were 
not sedimented, as the goal was to determine the distribution of eggs in the slurry. 
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Figure 2-3 Techion Ltd. FECPAK
G2
 sedimentor, highlighting 12 ml slurry line. 
 
The sedimentor lid was fitted and the sedimentor inverted three times to mix the 
slurry and NaCl solution. The slurry and NaCl solution was then pre-filtered using a 
1,000 µm filter then poured into a FECPAK
G2
 filter cylinder fitted with a 600 µm 
and a 425 µm filter, (Figure 2-4) the two standard filter sizes used for the 
FECPAK
G2
 sheep protocol. The cylinder was inverted three times to mix the solution 
well, and an aliquot used to fill a FECPAK
G1
 slide, which was counted using light 
microscopy at 40 × magnification. 
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 cylinder and filter system. a) shows the two filters and the cylinder separately, 
b) shows the filters nested inside each other and fitted within the cylinder. 
 
The remaining faecal slurry was remixed in the Ziploc bag, and treated as before 
until all slurry was used. The consistency of slurry used for each preparation was 
noted. 
In addition, further technical replicates were performed as above except that faecal 
slurry was spooned into the Techion Ltd. sedimentor up to the slurry line. As above, 
faecal slurry post preparation was imaged under light microscopy at 40 × 
magnification this time counting two slides from each preparation. A control value 
for each spooned sample was also obtained by making a standard G1 preparation and 
counting it four times to provide a mean value. 
 Slurry fraction investigation - results  2.4.3
The initial step of the FECPAK methodology involves diluting the faecal sample 
with water to produce a slurry. In equine samples, this slurry is not uniform, due to 
the fibrous nature of horse faeces. Instead, the slurry separates into a watery fraction 
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and a more solid fraction, regardless of how well mixed it is. In order to ensure that 
the initial slurry step did not introduce error into the sample preparation, five 
replicates were undertaken. The first three replicates were prepared by pouring the 
slurry into the sedimentor, which resulted in the first sedimentors prepared using the 
watery fraction of the slurry, and the later ones using the more solid fraction.  
Replicate one (Figure 2-5a) used a sample from a highly infected horse (3550 epg). 
The first five sub-samples were watery in consistency, and sub-samples six to eight 
were more solid. The egg counts clearly demonstrate that for this sample the watery 
fraction of the slurry (Figure 2-5a blue data points) had fewer eggs in it than the solid 
fraction (Figure 2-5a red data points).  
Replicate two (Figure 2-5b) used a sample from a horse with a more average 
infection level (228 epg). This animal was chosen in case the results from the first 
replicate were due to the very high infection level. This sample yielded seven sub-
samples, with the first four being watery and the next three being more solid. The 
experiment was inconclusive, due to the third sub-sample returning an unusually 
high result. It was possible that this was just due to an outlier, so a third replicate was 
made using a sample from another horse with an average infection level (266 epg).  
Replicate three (Figure 2-5c) again produced eight sub-samples, with the first four 
being watery, the fifth being of intermediate consistency, and sub-samples six to 
eight being more solid. This sample did not produce any outliers, and generated 
comparable results to replicate one in that there were more eggs contained in the 
solid part of the slurry than in the watery part. 
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Figure 2-5 Comparing different slurry fractions. a) using high epg faecal sample, b) and c) using 
average epg faecal samples. Watery sub-samples shown as blue data points, solid sub-samples shown 
as red data points. Egg recovery in solid fractions up to double that of watery fractions (Sub-sample 5 
in c) was intermediate consistency between watery and solid).. 
 
Two more replicates were prepared by spooning the well-mixed slurry into the 
sedimentors, ensuring as representative a sub-sample as possible. 
Replicates four (Figure 2-6a) and five (Figure 2-6b) demonstrated that when the 
slurry was stirred and spooned into the sedimentor ensuring that the slurry was of an 
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even consistency across all the subsamples, the repeat counts were more consistent 
with each other rather than rising with each subsequent aliquot used.  
 
Figure 2-6 Repeated counts from spooned sample a) replicate 4 and b) replicate 5, both using uniform 
sub-samples of the faecal slurries. Control value is the mean of four G1 counts, shown by yellow line 
. 
The data from replicates four and five were re-presented to demonstrate the separate 
G1 counts rather than the mean of the four counts (Figure 2-7a and Figure 2-7c), and 
only the first count from each spooned sub-sample (Figure 2-7b and Figure 2-7d). 
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The repeated spooned sub-samples, which contained both watery and solid matter, 
gave repeatability similar to that of the G1 counts.  
 
Figure 2-7 a) and b) Replicate 4, and c) and d) Replicate 5. Comparing repeated G1 counts with 
spooned sub-samples. Separate G1 counts shown (blue bars), compared to single counts from the 
spooned sub-samples (orange bars) to demonstrate the level of repeatability rather than the counts 
rising as the sub-sample consistency changed  
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 Slurry fraction investigation - discussion  2.4.4
In order to ensure that the initial sampling of the faecal slurry did not introduce an 
over or under estimation of eggs into the FEC process the dilution of the faecal 
material and resulting sampling was assessed. Faecal slurry sampling is of key 
importance to accurately reflect the distribution of eggs within the slurry of faeces 
and water which is more challenging as slurry, by its very nature, is a suspension 
rather than a solution.  
Pouring the faecal slurry from the slurry Ziploc bag, demonstrated that the initial 
watery fraction of the slurry contained fewer eggs than the more solid fraction.  A 
switch from fewer eggs to more eggs is likely due to the eggs being trapped within 
the solid matter as described in O'Grady and Slocombe (1980). Therefore, as the 
final FECPAK
G2
 test would involve a single test from each faecal sample, this would 
always contain the initial watery fraction of the faecal slurry, potentially understating 
the egg count. 
When the slurry was well mixed and repeated subsamples taken by spooning the 
slurry from the bag rather than pouring it, the counts obtained did not rise with 
subsequent sub-samples. As nematode eggs are randomly distributed in a faecal 
sample, some degree of variability is to be expected (Torgerson et al., 2012), 
however this can be mitigated by thorough mixing of the faecal sample (Morgan et 
al., 2005). The repeatability of the spooning method was comparable to the 
repeatability of repeated G1 slides taken from a single preparation.  
The concern that a small sample poured from a Ziploc bag would not be 
representative of the sample as a whole was confirmed. Given the challenges 
discovered with pouring slurry from a Ziploc bag, an alternative method of 
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dispensing a small aliquot of slurry was chosen.  Aliquoting slurry using a spooning 
method from the Ziploc bag into the sedimentor rather than pouring it ensured that 
both watery and solid fractions were sampled. Given the success of the spooning 
approach this protocol was followed throughout the rest of the optimisation and 
validation work. 
Of note in this initial work, the samples were not sedimented. This was because the 
purpose of the experiments was solely to determine the distribution of eggs in the 
slurry, and decide the very first step of the protocol. All further work used a 
sedimentation step following the initial sub-sampling of the slurry. 
2.5 SEDIMENTORS FOR CONCENTRATING EGGS  
 Concentration of eggs – introduction 2.5.1
A combined sedimentation-flotation technique involves diluting the faecal sample 
with water and allowing the nematode eggs to gravity sink, before discarding the 
supernatant and diluting the sediment with a flotation solution. Sedimentation-
flotation has been found to be more effective than flotation alone, particularly for 
cyathostomin eggs (Becker et al., 2016). The SOP for the FECPAK
G2
 test in sheep 
includes a sedimentation step, and it was decided to assess its usefulness for equine 
samples also.  
Therefore, given the potential importance of sedimentation to improve egg recovery 
the aim of this section of research was to determine if a greater volume of faecal 
slurry could be utilised in the sedimentor without the loss of eggs. In doing so, there 
is an opportunity to concentrate weak samples with a low egg density which would 
lead to a more sensitive FEC based test. 
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After a sub-sample of the slurry has been prepared, the next step in the existing 
FECPAK
G2
 protocol (for sheep) is to dilute the sub-sample with water, and allow it 
to stand so that the eggs settle to the bottom of the sedimentor. The supernatant 
containing floating debris is discarded, as well as any lipids that have floated to the 
top that may subsequently impact on the collection of eggs in the meniscus, and also 
soluble green pigment that may cloud the final image. The design of the sedimentor 
traps the bottom 15 ml of liquid, with the eggs and heavier debris, once the 
supernatant is discarded. When adding 12 ml of slurry to the sedimentor, this ensures 
that all eggs and debris with a higher specific gravity than water are retained.   
 Concentration of eggs - materials and methods 2.5.2
The impact of increased faecal slurry volume on sedimentor function was assessed 
using 50 g of faeces from a horse with a naturally acquired strongyle infection that 
was mixed with 200 ml water to form the test faecal slurry. The dilution rate of the 
faecal sample was kept constant with previous work, but a greater total volume of 
slurry was required to be sufficient for this experiment. A G1 preparation was 
performed on the slurry according to the manufacturer’s instructions (Techion Ltd.) 
with four slides counted to act as a control. 
The faecal slurry was then spooned from the Ziploc bag into four replicate 
sedimentors. A total of 12 ml, 24 ml, 36 ml and 48 ml of slurry were added to 
separate sedimentors representing 1×, 2×, 3× and 4× the specified volume of faecal 
slurry for the sheep procedure (Techion Ltd.). All sedimentors were filled with water 
and the faecal slurry/water mix was filtered using a 1,000 µm filter and returned to 
the sedimentor. Each of the sedimentors was allowed to stand for three hours to be 
confident that all nematode eggs had settled to the bottom of the sedimentor. The 
supernatant was discarded from each sedimentor and the remaining sediment diluted 
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with 80 ml of saturated NaCl solution. The sediment/NaCL solution was then filtered 
in a FECPAK
G2
 cylinder fitted with both 600 µm and 425 µm filters, before being 
counted using a FECPAK
G1
 slide in triplicate under light microscopy at 40 × 
magnification.  
 Concentration of eggs - results. 2.5.3
Following the faecal slurry preparation above, the mean of the triplicate G1 counts, 
acting as the control, was recorded at 475 epg. It was observed that up to three times 
the intended volume of slurry could be utilised whilst still producing FECs 
comparable to the G1 control results (Figure 2-8). The mean FEC for the 12 ml 
slurry preparation was 520 epg, the mean FEC for the 24 ml slurry was 462 epg and 
for the 36 ml slurry the mean FEC was 425 epg, which all compared well with the 
475 epg control value. At 48 ml slurry preparations the mean FEC dropped to 358 
epg. 
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 slide counts from sedimented samples, produced using 1×, 2×, 3× and 4× the 
usual volume of equine faecal slurry. Individual counts shown by blue data points, mean of the 
triplicate counts shown by the orange line and the control value (mean of three standard un-
sedimented G1 counts) shown by the black line. 
  
 Concentration of eggs - discussion 2.5.4
The eggs concentrated comparably well up to three times the intended volume of 
slurry, with 12 ml of slurry giving a mean result of 109% of the control value, 24 ml 
of slurry giving a mean result of 97% of the control value and 36 ml of slurry giving 
a mean result of 89% of the control values. Four times the usual volume of slurry (48 
ml) gave a mean result of 75% of the control value, suggesting that the limit of 
concentration using the FECPAK
G2
 sedimentor was around three times the intended 
sensitivity. It has been found that a combined sedimentation-flotation technique was 
more effective at identifying nematode-positive samples of many nematode species, 
particularly cyathostomins (Becker et al., 2016) although at the time of writing it is 
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believed that this method is not routinely used in quantitative FEC tests other than 
the FECPAK
G2
.   
From this proof of concept study, it was clear there was potential for a test with a 
greater level of sensitivity if a higher volume of slurry was exploited. This concept 
was explored further when the FECPAK
G2 
protocol was adapted to use 20 ml of 
slurry rather than 12 ml, which would give the FECPAK
G2,
 test a sensitivity of 26 
epg rather than 43 epg if using 12 ml slurry. The use of 20 ml slurry would render 
the sensitivity of the FECPAK
G2
 test similar to that of the FECPAK
G1
, which stands 
at 25 epg, and therefore produce a more commercially valuable test.   
2.6 VOLUME OF SEDIMENTORS 
After the faecal sample has been diluted to make a slurry, the next step in the 
FECPAK
G2
 methodology is to measure 12 ml into a sedimentor for the 
sedimentation process. Thus, having ascertained that a more accurate test would be 
achieved by spooning the slurry into the sedimentor, the next stage was to determine 
if the sedimentors were an accurate way of measuring a 12 ml aliquot. 
The 12 ml slurry line on the sedimentors used for measuring the slurry represents a 
wide, flat measuring area, and the level itself is marked by a sticker applied to the 
outside of the sedimentor (Figure 2-9). The aim of this experiment was to determine 
if the sedimentors were accurately marked at the 12 ml slurry line, as the slurry 
aliquot was to be measured by spooning in faecal slurry up to this line. 
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Figure 2-9 The FECPAK
G2
 Sedimentor (Techion Ltd, Dunedin NZ).  The 12 ml faecal slurry line is 
highlighted with an arrow. Also highlighted is side A (circled) for discarding supernatant and side B 
(boxed) for pouring off the final sample preparation prior to imaging on the Micro-I or slide. 
 
 Volume of sedimentors - materials and methods 2.6.1
Nine sedimentors had been supplied for research use, to enable multiple experiments 
to be performed. Each sedimentor was filled with water up to the 12 ml slurry line, 
and then the water removed using a serological pipette, quantifying the volume 
removed from each sedimentor.  
 Volume of sedimentors - results 2.6.2
In total, the volume of water required to reach the fill line was measured in nine 
sedimentors.  For these nine sedimentors the mean volume of water required to fill 
was 13.4 ml ± 1.17, with a range of 12 – 16 ml. With the 16 ml sedimentor discarded 
from analysis (and excluded from further use), the remaining sedimentors  had a 
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mean volume of water required to fill of 13 ml ± 0.7, representing a percentage 
accuracy of 91% ± 5.9  (Sedimentors measured 109 % ± 5.9 of the 12 ml required). 
 Volume of sedimentors - discussion 2.6.3
Although not specific to the equine version of the FECPAK
G2
 test, it was considered 
a useful experiment to determine the accuracy of the sedimentors. The line used to 
measure the 12 ml of slurry to be added to each sedimentor in the final test was 
indicated by a sticker applied to the outside of the sedimentor. It was observed that 
these stickers were not always correctly applied, or had perhaps become dislodged, 
resulting in some of the sedimentors not being accurately marked – one significantly 
so. This sedimentor was excluded from further use. Techion was notified of this 
discrepancy, and it was decided that alternative methods of marking the sedimentors 
would be investigated, for example printing rather than using stickers. 
As section 2.4 “Investigating slurry fractions” had determined that spooning the 
slurry was the preferred method, consideration was given to the use of a scoop 
measure instead of measuring using the sedimentors. This would eliminate any 
variability and potential error due to inaccurate positioning of the sedimentor sticker 
whilst the optimisation and validation took place.  
 
2.7 SEDIMENTATION TIME TRIAL 12 ML SLURRY 
 Sedimentation time trial 12 ml - introduction 2.7.1
During the FECPAK
G2
 process, after faecal slurry has been measured into the 
sedimentor, topped up with water, mixed and then pre-filtered, the G2 protocol 
requires the sedimentor to stand so that the nematode eggs can sediment which likely 
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removes any lipids which might impede the imaging process. When first using the 
FECPAK
G2
 test on lambs, the accuracy compared to the G1 was poor, and Techion 
Ltd (NZ) postulated that this may have been caused by lipids in the samples 
(Techion Ltd, personal communication). In addition, little research has been 
performed on sedimenting nematode eggs and given it has previously been shown 
that nematode egg recovery is improved with a sedimentation step (Becker et al., 
2016)  it is possible that improved egg recovery due to the sedimentation could be 
increased. 
Therefore, the aim of this set of experiments was to determine the optimal 
sedimentation time that would collect all of the nematode eggs within the equine 
faecal slurry sample. By investigating reducing the sedimentation time of nematode 
eggs during equine FECs there is the potential to yield improvements for the 
FECPAK
G2
 to perform as quickly as possible without sacrificing accuracy. 
 Sedimentation time trial 12 ml - materials and methods 2.7.2
The protocol for the original experiment was supplied by Techion NZ, and involved 
generating a “master mix” of slurry and water in a bucket, and then filling the 
sedimentors from this bucket. Subsequently, it was decided to run an extra 
experiment which measured the slurry into individual sedimentors as in the final G2 
protocol, in order to ensure that the procedure tested during the optimisation phase 
was as close as possible to the final test protocol. 
Sedimentation time was first assessed using a Techion Ltd. NZ derived protocol.  
Briefly, a sample of 100 g faeces from a horse with a natural strongyle infection was 
mixed with 400 ml water to produce a uniform faecal slurry. From this faecal slurry 
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a G1 preparation was prepared according to the manufacturer’s instructions (Techion 
Ltd. NZ) with three replicate slides counted to produce a control FEC. 
A total of 380 ml of the faecal slurry was mixed with 6.27 l of water to replicate the 
dilution factor used in the sedimentors (normally 12 ml faecal slurry and 198 ml 
water). From this slurry/water mix, three replicate sedimentors for each time point 
were filled to the water line. The slurry/water mixture was stirred well between each 
filling of a sedimentor. The liquid collected in each sedimentor was pre-filtered 
using a FECPAK
G2
 cylinder fitted with a 1,000 µm filter and returned to the 
sedimentor which was left to stand for between five and 180 minutes, with an 
additional sedimentor left to stand overnight. The supernatant was then discarded 
from each sedimentor and the resulting sediment diluted with 80 ml saturated NaCl 
and transferred to a FECPAK
G2
 cylinder fitted with 600 µm and 425 µm filters. A 
FECPAK
G1
 slide was filled from each cylinder and counted using a light microscopy 
at 40 × magnification.  
In addition, sedimentation was also assessed directly following the proposed 
FECPAK
G2
 methodology.  Briefly, a sample of 100 g faeces from a horse with a 
natural strongyle infection was mixed with 400 ml water to produce a uniform slurry 
and a G1 preparation was produced in triplicate to act as a control as previously 
described. 
From this faecal slurry, 12 ml was spooned into three replicate sedimentors for each 
time point.  Each sedimentor was filled to the fill line with water. The experiment 
was then continued as before. 
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 Sedimentation time trial 12 ml - results 2.7.3
In order to assess sedimentation of nematode eggs for equine FECs two 
methodologies were employed: a Techion Ltd. NZ derived protocol and one 
reflecting the FECPAK
G2
 protocol.  The Techion Ltd. NZ derived protocol 
demonstrated that a 30 minute sedimentation time was adequate to recover all the 
eggs ( 
Figure 2-10) as the FEC at 30 minutes reached the control value and did not 
fluctuate. In fact, with the exception of an outlier at the 90 minute time point, all the 
FEC results from 30 minutes on exceeded the FEC from the G1 control value. The 
sedimented results represent the mean result from the three slides from each time 
point (one from each cylinder). 
 
 
Figure 2-10 Mean FECs for 12 ml protocol with different sedimentation times – Techion protocol. 
Red bars show the mean of three sedimented counts for each sedimentation time, blue line shows the 
mean of three G1 counts to act as a control value.  
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When the faecal slurry was measured using individual sedimentors the average FECs 
did not reflect the sedimentation pattern of the Techion Ltd. NZ derived protocol 
(Figure 2-11). The only time point where the mean sedimented FEC reached the 
control value was after 45 minutes. All additional time points produced FECs lower 
than the G1 average including fewer eggs recovered at sedimentation times longer 
than 45 minutes. A line for the mode of the G1 control FECs was included owing to 
the fact that one of the three counts was much higher than the other two (550 epg 
compared to 375 epg), and thus may have skewed the results. 
 
Figure 2-11 Mean FECs for 12 ml protocol with different sedimentation times – measured with 
sedimentors. Red bars show the mean of three sedimented counts for each sedimentation time, blue 
line shows the mean of three G1 counts to act as a control value, green line shows the mode of the 
three G1 counts (included as one of the three was high compared to the other two). 
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 Sedimentation time trial 12 ml - discussion 2.7.4
Optimising sedimentation time for performing equine FECs is potentially of great 
importance for producing a diagnostic that is both quick and accurate.  Therefore, 
sedimentation of nematode eggs was assessed for equine FECs using two 
methodologies.  When performing the sedimentation time trial according to the 
protocol from Techion Ltd. NZ, making a faecal master mix prior to filling 
sedimentors, the results obtained were consistent with the results obtained in the NZ 
laboratory (Techion NZ Ltd, personal communication), in that a 30 minute 
sedimentation time was adequate for the majority of eggs to descend to the sediment, 
in common with other research (Becker et al., 2016).  The results from following the 
FECPAK
G2
 protocol, where individual sedimentors were used to measure the faecal 
slurry, demonstrated that a 45 minute sedimentation time could be necessary. 
However, as other literature supported the 30 minute sedimentation time (Becker et 
al., 2016) and this had been found sufficient in the Techion NZ laboratory for 
strongyle eggs (Techion NZ, personal communication) the further work was 
performed using the 30 minutes’ sedimentation time. Given the varied results when 
using the sedimentors to dilute the faecal slurry with saline, the mode of the G1 
counts was included.  As the three G1 counts were recorded as 550 epg, 375 epg and 
375 epg it was likely that the first count may have been unusually high and thus 
skewed the results. As it happened, only the 45 minute sedimentor showed a FEC 
(481 epg) as high as the mean G1 control value. Further work on sedimented 
samples found that a 30 minute sedimentation time was adequate to produce FECs 
comparable with the control values, so it was likely that this particular experiment 
was anomalous, rather than showing a trend peculiar to the sedimentor preparation. 
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2.8 ACCUMULATION TIME TRIAL 12 ML SLURRY 
 Accumulation time trial 12 ml slurry - introduction 2.8.1
The FECPAK
G2
 cassette, which holds the faecal sample to be imaged by the Micro-I, 
consists of two wells with a central glass rod through which light passes from 
underneath (Figure 2-12).  
 
Figure 2-12 Micro-I cassette (Techion Ltd., Dunedin New Zealand) showing a) side view and b) top 
view. 
This process results in a circular illuminated area of 3 mm diameter which forms the 
final Micro-I captured image. The nematode eggs float to the surface of the saline 
solution in the cassette, and, due to the domed shape of the meniscus, collect in the 
central illuminated area (Cooke et al., 2016; Sowerby et al., 2016). This process of 
nematode eggs floating to the meniscus is termed accumulation. Thus, the 
accumulation of nematode eggs from equine faecal samples represents an additional 
area to investigate for suitability for equine FECs. Therefore, the aim of this 
experiment was to determine the minimal time period required for all nematode eggs 
to accumulate to the central field of view in the Micro-I cassette.  
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In addition, one of the equine faecal samples came into the laboratory with an 
infection of Parascaris equorum. In order to capture images of P. equorum eggs for 
Techion Ltd to use in the mark-up training, several cassettes were prepared from this 
faecal samples, and the opportunity was taken to monitor the accumulation time 
needed to image P. equorum eggs. 
 
 Accumulation time trial 12 ml slurry - materials and methods 2.8.2
A sample of 20 g faeces from a horse with a natural strongyle infection was mixed 
with 80 ml of water to form a uniform faecal slurry. A G1 preparation was produced 
according to the manufacturer’s instructions (Techion Ltd. NZ) counted six times to 
provide a control value epg. The sample gave variable results, so six replicates were 
used to form the control value rather than the usual three. 
From the faecal slurry, a G2 preparation was performed by spooning 12 ml of faecal 
slurry into a sedimentor, filling with water and pre-filtering using a 1,000 µm filter 
before returning the liquid to the sedimentor and allowing it to stand for 30 minutes. 
The supernatant was discarded, and the sediment mixed with 80 ml of saturated 
NaCl solution. This liquid was poured into the FECPAK
G2
 cylinder fitted with both 




 Micro-I software was programmed to capture eight images at 2 
minute intervals, imaging immediately and after 2, 4, 6, 8, 10, 12 and 14 minutes. 
The process of filling the cassette and imaging was repeated in triplicate.  All images 
were examined to determine when all nematode eggs had accumulated to the visible 
area of the well. 
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In addition, a sample of 40 g faeces from a one year old horse with a natural 
strongyle and P. equorum infection was mixed with 160 ml water to form a uniform 
slurry. A G2 preparation was made as above, and used to fill five FECPAK cassettes. 
The cassettes were allowed to accumulate for 6, 10, 15, 20 and 25 minutes 
respectively, before being imaged using the Micro-I. A FECPAK
G1
 slide was also 
filled using the same preparation, and counted to give a control value. 
 
  Accumulation time trial 12 ml slurry - results 2.8.3
Accumulation time for nematode eggs from equine faecal samples was investigated 
in order to optimise the FECPAK
G2
 protocol for equine use.  A representative image 
captured from the Micro-I can be seen in Figure 2-13.  The control value, a mean of 
six G1 counts, was recorded as 179 epg. Following image capture, after altering 
accumulation times, no further nematode eggs appeared in any replicate after six 
minutes (Table 2-1).  This corresponded to 172 epg for two replicates or 86 epg for 
the third.  In the first replicate, the second egg became out of focus at the ten minute 
point and therefore disappeared. 
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Figure 2-13 Representative image captured from the FECPAK
G2
 Micro-I of an equine faecal sample 
(Replicate 3 at 6 minutes accumulation). Image represents the central 3 mm of the well, which is the 
visible field of view. Red cross marks the centre of the image (added by Micro-I software), strongyle 
eggs marked by red arrows, examples of debris marked by green arrows. 
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Table 2-1 Accumulation time trial experiment for 12 ml slurry. Repeat images taken at two minute 
intervals up to 14 minutes, recording the number of eggs that had floated to the centre of the meniscus 
and into the field of view. 








0 1 86 1 86 1 86 
2 1 86 1 86 1 86 
4 1 86 1 86 1 86 
6 2 172 1 86 2 172 
8 2 172 1 86 2 172 
10 1 86 1 86 2 172 
12 1 86 1 86 2 172 
14 1 86 1 86 2 172 
 
The results of the P. equorum accumulation experiment are provided in Table 2-2. 
The same preparation counted on a slide gave a FEC value of 429 epg for strongyle 
eggs, and 468 epg for P. equorum. G2 cassettes allowed to accumulate for ten 
minutes or longer did appear to image more P. equorum eggs than the one with the 
standard accumulation time of six minutes, although the cassette that accumulated 
for the longest time did not follow this rule. 
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Figure 2-14 Representative image captured from the FECPAK
G2
 Micro-I of an equine faecal sample 
with a mixed strongyle and P. equorum infection. Image represents the central 3 mm of the well, 
which is the visible field of view. Blue cross marks the centre of the image (added by Micro-I 
software), strongyle eggs marked by red arrows, P. equorum eggs marked by yellow arrows. Blue and 
red dots added by FECPAK mark-up software. 
 
Table 2-2 Accumulation time trial experiment for Parascaris equorum. Five cassettes accumulated 
for different lengths of time, then imaged using the Micro-I and number of eggs observed recorded. 






6 14 630 5 225 
10 6 270 18 810 
15 6 270 12 540 
20 4 180 14 630 
25 8 360 5 225 
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 Accumulation time trial 12 ml slurry - discussion 2.8.4
In order to ensure as accurate a test as possible, sufficient time has to be allowed for 
all the nematode eggs within the sample to float to the surface of the solution, and up 
the curve of the meniscus into the central 3 mm field of view. The possibility existed 
that an equine faecal sample may not perform in exactly the same way as a ruminant 
sample. Therefore, the optimum accumulation time was investigated. It appeared that 
all the eggs that were going to become visible had done so by six minutes. In the first 
replicate, the second egg that appeared at six minutes lost focus at ten minutes. The 
Micro-I captures images at different focal planes, and then stacks them together so 
that the whole surface of the meniscus is in focus. In the second replicate, the image 
was badly stacked and difficult to read, so this replicate was not a good one to use to 
draw a conclusion. 
The section would likely have been improved if it had been replicated with a greater 
number of samples, specifically samples with higher egg counts. However, as the 
optimum accumulation time reached matched with that used for sheep, and also with 
the results from the New Zealand laboratory, it was considered to be sufficient for 
the purpose of optimising the preparation of samples for the G2 method.  Recent 
research has demonstrated that eggs which have floated in a flotation solution can 
sink again (Norris et al., 2019), a point which is worth noting when preparing a 
number of samples which may unavoidably accumulate for much greater times than 
six minutes. Potential causes for this sinking effect have been postulated as 
temperature differences in the flotation solution (Norris et al., 2019), relevant owing 
to the light source at the base of the Micro-I. It appeared from this preliminary work, 
that an accumulation time of longer than six minutes might improve P. equorum egg 
accumulation. However, no further samples with a P. equorum infection came into 
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the lab during the optimisation work and so further work to investigate this was not 
possible. The specific gravity of P. equorum eggs is slightly higher at 1.09 compared 
to 1.05 for strongyle eggs (Norris et al., 2018) and given P. equorum eggs are larger 
than strongyle eggs they must displace a larger amount of fluid in order to float. 
Recent research confirms that P. equorum eggs float more slowly than strongyle 
eggs, although in the case of both species the speed of flotation would allow them to 
rise nearly 2 cm in six minutes, double the distance required to accumulate in the 
centre of the meniscus of the FECPAK
G2
 cassette (Norris et al., 2019). In addition, 
current recommendation is to treat foals for P. equorum as a matter of routine due to 
the pathogenicity of pre-patent infection (Rendle et al., 2019), so a quantitative 
diagnosis for these helminths is less important. Nevertheless, P. equorum eggs can 
still be observed in the FECPAK
G2
 test, providing positive diagnosis of infection. 
 
2.9 COMPARING 12 ML SLURRY WITH 20 ML SLURRY 
 Increasing slurry volume - introduction 2.9.1
Techion highlighted that the sensitivity of the G2, at 43 epg, made it an inferior test 
to their G1 (sensitivity of 25 epg) and thus were keen to investigate an increased test 
sensitivity. Earlier work had demonstrated that increased amounts of faecal slurry 
could be used in the sedimentors without losing eggs, so the potential to match the 
G1 test sensitivity existed. Thus, a protocol using 20 ml slurry rather than 12 ml was 
chosen as it that should deliver a sensitivity of 26 epg in the final protocol, similar to 
that of the G1. Additionally, using the same amount of slurry (12 ml) but using less 
saline – 50 ml instead of 80 ml was also investigated. Therefore, the aim of this 
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investigation was to determine if the sensitivity of the test could be increased. This 
was important because greater sensitivity would mean a more valuable test. 
 Increasing slurry volume - materials and methods 2.9.2
To investigate different combinations of faecal slurry and saline volumes, a 50 g 
faecal sample from a horse with a natural strongyle infection was mixed with 200 ml 
water to make a uniform slurry. A G1 preparation was made from this slurry, and 
counted on a FECPAK
G1
 slide in triplicate to give a control value. Two sedimentors 
were prepared with 12 ml slurry, and one with 20 ml slurry, spooned into the 
sedimentors. Each sedimentor was filled with water, pre-filtered using a 1,000 µm 
filter, then left to stand for 45 minutes. The supernatant was then discarded and 
saturated NaCl solution was added to produce one sedimentor with 12 ml slurry and 
80 ml saline, one with 12 ml slurry and 50 ml saline, and one with 20 ml slurry and 
80 ml saline. These solutions were each added to a FECPAK
G2
cylinder fitted with 
425 µm and 250 µm filters and used to fill three FECPAK
G1
 slides each, which were 
counted using light microscopy at 40 × magnification. 
To compare 12 ml slurry with 20 ml slurry, a 60 g sample of faeces from a horse 
with a natural strongyle infection was mixed with 240 ml water to make a uniform 
slurry. A G1 preparation was made according to the usual protocol, apart from the 
fact that the slurry was spooned into the cylinder instead of being poured. Three 
FECPAK
G1
 slides were counted to produce a control value. Three sedimentors were 
prepared with 12 ml slurry, and sedimented for 30 minutes, and three were prepared 
with 20 ml slurry and sedimented for 45 minutes. All preparations were pre-filtered 
using 1,000 µm filter prior to sedimentation, then the sediment mixed with 80 ml 
saturated NaCl, and filtered in the FECPAK cylinder fitted with 425 µm and 250 µm 
filters. Each preparation was counted in triplicate using the FECPAK
G1
 slide, at a 
Chapter 2 – Development of the FECPAK
G2




magnification of 40 ×. A second replicate was performed, with the exception that the 
standard G1 protocol was followed, pouring the initial faecal slurry rather than 
spooning it. 
To compare different sedimentation times, samples of faeces from two horses with 
natural strongyle infections were mixed with water (30 g faeces in 120 ml water for 
sample one, and 50 g faeces in 200 ml water for sample two) to produce a uniform 
slurry. For each sample a G1 preparation was made (spooned as before). This 
preparation was counted in triplicate using the FECPAK
G1
 slide at a magnification of 
40 ×. Six sedimentors were prepared for each replicate, each using 20 ml slurry and 
filled with water, then pre-filtered using a 1,000 µm filter. Three sedimentors were 
left to stand for 30 minutes and three for 45 minutes, then the supernatant was 
discarded and the sediment mixed with 80 ml saturated NaCl solution. These 
solutions were filtered in the FECPAK cylinder with 425 µm and 250 µm filters, and 
counted using the FECPAK slide at 40 × magnification. (NB There was insufficient 
slurry to fill six sedimentors for sample one, so three were sedimented for 30 
minutes and two for 45 minutes). 
 Increasing slurry volume – results 2.9.3
When comparing different combinations of faecal slurry volume and saline volume, 
all the combinations produced mean FECs of above the G1 control value. The G1 
mean control FEC was 293 epg, the mean of the 12 ml slurry / 80 ml saline counts 
was 442 epg, the mean of the 12 ml slurry / 50 ml saline was 396 epg and the mean 
of the 20 ml slurry / 80 ml saline combination was 383 epg (Figure 2-15). Paired 
sample t-tests demonstrated that the mean of each combination was not significantly 
different to the mean of the G1 control value in any case (two tailed p >0.05). 
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Figure 2-15 Comparing different volumes of slurry and saline – Slurry:Saline (ml:ml) ratios for each 
sedimentor were as follows; Sedimentor 1- 12:80, Sedimentor 2 - 12:50 , Sedimentor 3 - 20:80. G1 
control mean shown by orange line. 
 
When comparing 12 ml slurry sedimented for 30 minutes with 20 ml slurry 
sedimented for 45 minutes, two replicates were performed. The mean of the triplicate 
spooned G1 counts was 300 epg, the mean of the 12 ml preparation sedimented for 
30 minutes was 286 epg and the mean of the 20 ml preparation sedimented for 45 
minutes was 233 epg (Figure 2-16 a). The mean of the triplicate poured G1 counts 
was 217 epg, the mean of the 12 ml preparation sedimented for 30 minutes was 327 
epg and the mean of the 20 ml preparation sedimented for 45 minutes was 299 epg 
(Figure 2-16 b). Paired samples t-tests showed that the mean of the G1 counts was 
not significantly different to the sedimented preparations in either case (two tailed p 
> 0.05), and that in neither case was the mean of the 12 ml preparation  significantly 
different to the mean of the 20 ml preparation (two tailed p > 0.05). 
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Figure 2-16 FECs produced from 12 ml slurry and 80 ml saline when sedimented for 30 minutes (red 
bars) or 20 ml slurry and 80 ml saline when sedimented for 45 minutes (blue bars). G1 control mean 
shown by yellow line. a) First replicate with G1 controls produced by spooning the faecal slurry, b) 
second replicate with G1 controls prepared in the standard manner (pouring the faecal slurry). 
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To compare sedimentation times, two replicates were prepared using 20 ml of faecal 
slurry and 80 ml of saline, with three sedimentors left for 30 minutes and three for 45 
minutes (only two were left for 45 minutes in replicate one due to insufficient faecal 
slurry available). There was no clear benefit in sedimenting for 45 minutes. Mean G1 
control value in the first replicate was 250 epg, with 30 minutes sedimentation 
giving a mean of 253 epg and 45 minutes sedimentation a mean of 288 epg. Mean 
G1 control value in the second replicate was 267 epg, with 30 minutes sedimentation 
giving a mean of 258 epg and 45 minutes sedimentation a mean of 238 epg (Figure 
2-17). Paired sample t-tests on the data from the second replicate showed no 
significant differences between the mean FECs from the 30 minute sedimentation or 
the 45 minute sedimentation, and neither was significantly different from the mean 
G1 control (two-tailed p > 0.05). Paired sample t-tests could not be performed on the 
data from the first replicate because only two data points for 45 minutes’ 
sedimentation were available. 
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Figure 2-17 FECs produced from 20 ml slurry and 80 ml saline when sedimented for 30 minutes (red 
bars) or 45 minutes (blue bars). G1 control mean shown by yellow line. a) and b) represent two 
replicates (NB there was insufficient faecal slurry to prepare the sixth sedimentor for the first 
replicate) 
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  Increasing slurry volume - discussion 2.9.4
When comparing different combinations of faecal slurry volume and saline volume, 
all the combinations produced mean FECs of above the G1 control value. However, 
following the results, the 20 ml slurry and 80 ml saline protocol was chosen to 
investigate further given it gave greater sensitivity than either 12 ml / 80 ml or 12 ml 
/ 50 ml. In addition, it was easier to work with a greater amount of liquid, as the 12 
ml / 50 ml protocol did not produce sufficient sample to be easily pipetted from the 
FECPAK
G2
 cylinder. The 12 ml slurry and 50 ml saline was not investigated further 
for these reasons. 
Following selection, the original 12 ml protocol was compared with the improved 
sensitivity 20 ml protocol, which demonstrated that the 20 ml protocol produced 
comparable results to the 12 ml protocol. It had been decided to spoon the slurry into 
the G1 cylinder in order to be consistent with the G2 protocol. This spooned G1 
protocol produced higher FECs compared to the G2 preparations from the same 
slurry. When this was mentioned to Techion, the advice was to discontinue this 
practice, as the G1 method had been validated using the pouring method, so this 
should be regarded as the correct protocol. In the first replicate, because the G1 
protocol had been changed, the results were poorer than the G1 control results. When 
a second replicate was performed following the original G1 protocol, the 20 ml 
protocol produced higher FECs than the control results, and it was decided to 
investigate the 20 ml protocol further. 
It was proposed that a greater amount of faecal slurry used might need a longer 
sedimentation time, so initial work compared a 30 minute sedimentation time with a 
45 minute sedimentation time. In the first replicate, the first two sedimentors gave 
higher FECs after 45 minutes sedimentation. However, the initial slurry did not 
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provide sufficient volume to prepare three sedimentors for each sedimentation time 
period, so a second replicate was performed. This replicate had three sedimentors 
from each preparation counted in order to produce mean values. As FECs naturally 
vary between counts taken from the same horse, mean values would help smooth out 
these variations and better inform which protocol was preferable. Initially, it was 
thought that it might have been necessary to sediment a 20 ml sample for longer than 
the 12 ml samples (45 minutes instead of 30 minutes), but this initial work did not 
demonstrate a consistent increase in FEC following 45 minutes sedimentation. 
Paired sample t-tests showed that there was no significant difference between the 
different slurry volumes or the different sedimentation times (two-tailed p>0.05), 
meaning that any differences in the mean counts observed could be explained by 
chance variation in the FECs obtained. 
This initial work comparing the original 12 ml G2 protocol with a more sensitive 20 
ml G2 protocol demonstrated the potential to increase the sensitivity of the G2 test 
by using a greater amount of faecal slurry. It was decided to repeat the sedimentation 
and accumulation time trials using the new 20 ml protocol. 
 
2.10 SEDIMENTATION TIME TRIAL 20 ML FAECAL SLURRY 
 Sedimentation time trial 20 ml - introduction 2.10.1
Having previously ascertained that the potential existed to develop a more sensitive 
G2 test, the measuring of optimal sedimentation time was repeated using the new 20 
ml protocol. The aim of this set of experiments was to determine the minimal 
sedimentation time that would trap all of the eggs in a 20 ml faecal slurry sample.  
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 Sedimentation time trial 20 ml - materials and methods 2.10.2
This work was an exact replicate of the experiments performed in Section 2.7 
Sedimentation time trial 12 ml slurry, except that in the first experiment 700 ml of 
the faecal slurry was mixed with 6.65 litres of water to replicate the dilution rate in 
the sedimentors when 20 ml of slurry and 190 ml water are used. In the second 
experiment, each sedimentor was prepared by spooning in 20 ml of faecal slurry and 
filling to the fill line with water and, to save time, only time points of 5, 30, 45 and 
1,000 minutes were tested. In both of the two experiments, the 425 µm and 250 µm 
filters were used in the FECPAK
G2
 cylinder. 
 Sedimentation time trial 20 ml - results 2.10.3
Two methodologies were again used to assess the length of time needed to sediment 
faecal samples for the 20 ml G2 FEC protocol. The Techion Ltd. NZ protocol 
demonstrated that a 30 minute sedimentation time was sufficient for all eggs to be 
recovered, as the FEC at 30 minutes reached the G1 control value and did not 
continue to increase with further sedimentation time (Figure 2-18). The sedimented 
results represent the mean result from the three slides from each time point (one from 
each cylinder). 
Chapter 2 – Development of the FECPAK
G2





Figure 2-18 Mean epg for 20 ml protocol with different sedimentation times – Techion protocol. Red 
bars show the mean of three G2 counts for each sedimentation time, the blue line shows the mean of 
three G1 counts to act as a control value. 
 
When the faecal slurry was measured using individual sedimentors, no advantage 
was observed from sedimenting for 45 minutes over 30 minutes, although more eggs 
were recovered by the sedimentors left overnight (Figure 2-19). 
 
Figure 2-19 Mean FEC for 20 ml protocol with different sedimentation times – measured with 
sedimentors. Red bars show the mean of three sedimented counts for each sedimentation time, the 
blue line shows the mean of three G1 counts to act as a control value. 
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 Sedimentation time trial 20 ml - discussion 2.10.4
This work confirmed that a thirty minute sedimentation time was still sufficient and 
that the time did require an increase to 45 minutes for the 20 ml protocol. It was 
interesting to note that the results from FECs measured using the 20 ml scoop into 
the sedimentors produced lower FECs than the control figures, whereas measuring 
using a “master mix” in a bucket produced higher FECs than the control figures. 
However, it is possible that the control figures were where the difference occurred. 
The mean G1 count for the bucket experiment was 267 epg and the mean G1 count 
for the sedimentor measured experiment was 450 epg, despite the samples having 
come from the same horse only four days apart. The mean value for the sedimented 
samples after 30 minutes’ sedimentation time was 422 epg for the bucket measure, 
and 399 epg for the sedimentor measure, so the sedimented values were more 
consistent with each other than was the case with the control values. 
2.11 ACCUMULATION TIME TRIAL 20ML SLURRY 
 Accumulation time trial 20 ml – introduction 2.11.1
Therefore, having confirmed that the potential existed to develop a more sensitive 
G2 test, the previous work determining optimal accumulation time was repeated 
using the new 20 ml protocol. The aim of this new set of experiments was to 
determine the shortest accumulation time required for all nematode eggs in a 20 ml 
faecal slurry sample to accumulate in the central  field of view in the Micro-I 
cassette. 
 Accumulation time trial 20 ml – materials and methods 2.11.2
This work was an exact replicate of the work performed in section 2.8 Accumulation 
time trial 12 ml slurry except that the initial faecal slurry was prepared from a 
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sample of 40 g faeces from a horse with a natural strongyle infection was mixed with 
160 ml of water, to give a larger volume of faecal slurry to work with. A G1 
preparation was made and three slides counted to give a control value. 
From the slurry, a G2 preparation was made by spooning 20 ml of slurry into a 
sedimentor, and then the experiment continued as described in section 2.8 
Accumulation time trial 12 ml slurry. 
 Accumulation time trial 20 ml – results 2.11.3
Accumulation time for nematode eggs from faecal samples prepared with 20 ml of 
faecal slurry was investigated in order to optimise the FECPAK
G2
 protocol for 
equine use. The control value, a mean of three G1 counts as recorded as 400 epg. All 
eggs that were going to appear were visible by the time four minutes had passed (two 
minutes in the case of replicate three), as shown in Table 2-3. This corresponded to 
208 epg for replicate one and 468 epg for replicate three. Replicate two produced 
images with bad stacking images, which could not be read. At the 12 minute time 
point, a stacking issue also obscured one of the previously visible eggs in replicate 
one. 
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Table 2-3 Accumulation time experiment, 20 ml slurry. Repeat images taken at two minute intervals 
up to 14 minutes, recording the number of eggs that that had floated to the centre of the meniscus and 
into the field of view. NB The images on replicate 2 had bad stacking issues, and could not be read. 
NB O/F = Out of Focus, 3* = 3 eggs visible and one obscured 








0 1 52 0 0 0 0 
2 O/F O/F 0 0 9 468 
4 4 208 0 0 9 468 
6 4 208 0 0 9 468 
8 4 208 0 0 9 468 
10 4 208 0 0 9 468 
12 3 * 156 0 0 9 468 
14 4 208 0 0 9 468 
 
 Accumulation time trial 20 ml – discussion 2.11.4
In order to ensure as accurate a test as possible, sufficient time has to be allowed for 
all the nematode eggs within the sample to float to the surface of the solution, up the 
curve of the meniscus and into the central 3 mm field of view. The possibility existed 
that the preparation made using 20 ml of faecal slurry might behave differently to 
that made with 12 ml slurry, and thus the experiment was repeated. 
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Although the images produced in this experiment were not of very good quality, the 
results did not suggest that an accumulation time of longer than six minutes would 
be required with the 20 ml protocol, and so this figure was retained. The software 
supplied with the Micro-I to customers (as opposed to that supplied for laboratory 
use to test the machine) includes an automatic delay to allow eggs to accumulate. 
Because this delay is set at six minutes for sheep samples, it was decided that this 
would be retained for the horse protocol, as it was more than sufficient for all eggs to 
accumulate. 
 
2.12 COMPARING FILTER SIZES AND PREPARATION METHODS 
 Preparation methods - introduction 2.12.1
Part way through the optimisation, a new set of filters were supplied by Techion Ltd. 
NZ, (referred to in the text as the black filters), for insertion into the FECPAK
G2
 
cylinder. These were 425 µm and 250 µm, replacing the silver filters that had 
previously been supplied that were 600 µm and 425 µm. The finer black filters had 
been produced for use in the FECPAK
G2
 test for human samples, and it was 
necessary to determine which filters would be most suited to the FECPAK
G2
 system 
for equine use. It was decided to compare the results with the different slurry 
volumes and with the different filter sizes to determine which protocol worked 
optimally when FEC samples were imaged using the Micro-I and cassette. 
Therefore, the aim of this investigation was to ensure that the filter size and slurry 
volume selected for the final protocol also performed well when imaged using the 
Micro-I and cassette. This was important in order that any vagaries caused by the 
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imaging process were accounted for, in case a preparation which performed well 
when viewed under a slide did not perform well when imaged using the cassette. 
 Preparation methods - materials and methods 2.12.2
A sample of 80 g faeces from a horse with a natural strongyle infection was mixed 
with 320 ml water to give a uniform slurry. A G1 preparation was made, and three 
slides counted to give a control value. 
The filters used in this experiment were: White = 1,000 µm (used consistently as a 
pre-filter), Silver = 600 µm and 425 µm and Black = 425 µm and 250 µm. Six 
sedimentors were prepared using this same slurry, by pre-filtering either once or 
twice, sedimenting for 30 minutes, then adding 80 ml of saturated NaCl to the 
sediment and filtering through either the black or the silver filters. Details of the 
filter sizes and slurry volumes used for each sedimentor are contained in  
Table 2-4. 
Table 2-4 Slurry volumes and filter sizes used, giving the size of the first and second pre-filter (if two 
pre-filtration steps used), and size of final filters in FECPAK
G2
 cylinder. 
Sedimentor Slurry volume First pre-filter Second pre-
filter 
Filters for final 
solution 
1 20 ml White - Black 
2 20 ml White - Silver 
3 12 ml White - Black 
4 12 ml White - Silver 
5 20 ml White Silver Black 
6 12 ml White Silver Black 
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Each preparation was used to fill two FECPAK
G2
 cassettes and counted using the 
Micro-I. Preparation five was used to fill three cassettes, because the second cassette 
produced few eggs.  
 Preparation methods - results 2.12.3
Six preparations were produced with differing amounts of faecal slurry, filtered with 
the different sizes of filter. Preparations one to six were used to fill two FECPAK
G2
 
cassettes each, with the exception of preparation five mentioned above, which was 
used to fill three cassettes. The results given are the mean of the counts for each 
preparation. 
No clear difference was observed between any of the methods performed (Figure 
2-20). It appeared that the 20 ml preparation performed to a higher standard with the 
black filters whilst the 12 ml preparation performed optimally with the silver filters. 
Furthermore, introducing a second pre-filter step did not provide consistently better 
results over the two different faecal slurry volumes. 
 
Figure 2-20 Different slurry volumes and filtration steps, imaged using the G2 cassette and Micro-I. 
Mean G2 cassette FEC values for each preparation method shown by blue bars, G1 control mean 
shown by orange line. 
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 Preparation methods - discussion 2.12.4
Filtering the faecal slurry is an important step in the FECPAK
G2
 sample preparation, 
as the process concentrates both nematode eggs and floating debris in a 3 mm field 
of view for imaging. If too much floating debris is present, there is the possibility of 
it obscuring the eggs, so a much clearer image is required for imaging in the cassette 
and Micro-I than would be required to count the preparation using a slide. Thus, this 
experiment was designed to see if there were any easily visible differences between 
the different filtration methods. However, the result was inconclusive as no filtration 
method performed consistently better with both slurry volumes. When analysing the 
captured images from the cassette, all of them suffered from a wetting issue, defined 
as the liquid failing to adhere to the light rod, and thus there was no clear difference 
between either the amount of debris on the images or the accumulation of the eggs to 
the centre of the field of view with each filter size. This issue was discussed with 
Techion Ltd, who suggested soaking the light rod in Virkon disinfectant (Dupont 
Ltd) which cured the wetting issue in subsequent imaging work. More work was 
required in order to determine separately the best slurry volume, and then the best 
filter size to use with the selected volume, described in Sections 2.13 and 2.14. 
 
2.13 COMPARING 12 ML VS 20 ML USING CASSETTE 
 Comparing slurry volume in cassette – introduction 2.13.1
As there was no easily visible difference between the different preparation methods 
in the experiment described in Section 2.12 above, it was decided to treat the two 
variables (slurry volume and filter size) separately. Firstly, the slurry volumes were 
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compared and imaged using the Micro-I to determine which protocol was better for 
the full test – the more sensitive 20 ml protocol, or the less sensitive 12 ml one. 
Thus, the aim of these experiments was to determine which slurry volume performed 
best when imaged using the cassette and Micro-I. This was important in order to 
ensure that the test was as sensitive as possible, whilst maintaining accuracy. 
 Comparing slurry volume in cassette - materials and methods 2.13.2
A sample of 60 g of faeces from a horse with a natural strongyle infection was mixed 
with 240 ml water to produce a uniform slurry. Two G1 preparations were made, the 
first was counted three times and the second counted once. These values were used 
to produce a mean value as a control, with the second G1 count taken so that the 
results could potentially be used as part of the validation, depending on which 
protocol was selected as the final method. 
Four sedimentors were prepared, two with 12 ml slurry and two with 20 ml slurry. 
These were pre-filtered using a 1,000 µm filter, then left to stand for 30 minutes. The 
supernatant was discarded, and 80 ml saturated NaCl was added to the sediment. 
This liquid was  filtered using the FECPAK
G2
 cylinder fitted with 425 µm and 250 
µm (black) filters, and two FECPAK
G2
 cassettes filled from each preparation and 
imaged using the Micro-I.  
Two more replicates were performed, using faecal samples from different horses. A 
further four replicates were also processed in the same way, aside from the fact that 
the FECPAK
G2
 cylinder was fitted with the 600 µm and 425 µm (silver) filters.  
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 Comparing slurry volume in cassette - results 2.13.3
Each replicate of the different slurry volumes was imaged using the cassette and 
Micro-I and Figure 2-21a provides the epg returned from each combination of 
sample and method (height on the y axis of the boxes) and also the repeatability for 
each method with each sample (the size of each box plus whisker). 
Height of the boxes on the y axis in Figure 2-21b demonstrates the epg figures from 
all samples for each method; size of the boxes plus whiskers shows the repeatability 
of each method across all samples. 
Both methods of comparing the data (Figure 2-21) demonstrated that the 12 ml 
protocol returned a higher egg count than the 20 ml protocol in the majority of the 
samples. The mean of the counts from the 20 ml protocol represented 77% of the G1 
control values, whereas the mean of the counts from the 12 ml protocol were 105% 
of the G1 control values. However paired sample t-tests on the mean count for each 
method showed no significant difference between the G1 and either the 12 ml or the 
20 ml FECs, or between the 12 ml FECs and the 20 ml FEC (two-tailed p> 0.05). 
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Figure 2-21 Comparing slurry volumes, imaged using the G2 cassette and Micro-I a) Data comprises 
each G2 count: epg returned from each combination of sample and method (height on the y axis of the 
boxes) and also the repeatability for each method with each sample (the size of each box plus 
whisker) b) Data comprises the total counts for all samples: epg returned from each method (height on 
the y axis of the boxes) and also the repeatability for each method (the size of each box plus whisker)  
 
 Comparing slurry volume in cassette - discussion 2.13.4
Thus, increasing the sensitivity of the FECPAK
G2
 test would clearly deliver a more 
valuable assessment when performing a faecal egg count reduction test (FECRT) as 
is required to measure anthelmintic resistance. FECRT  involves testing both before 
and after treatment and calculating the percentage reduction in FEC (Kaplan, 2002), 
and can only be achieved at low infection levels by using sensitive test 
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methodologies  (Coles, 2009; Levecke et al., 2011). Initial work comparing the more 
sensitive 20 ml protocol with the original 12 ml protocol using the G1 slide to 
perform the counts demonstrated that the two protocols were similar in their ability 
to recover nematode eggs. However, despite not being statistically significant, it was 
clear from this work that when imaging these preparations using the cassette and 
Micro-I, there was a trend for the less sensitive 12 ml protocol to produce higher egg 
counts than the 20 ml protocol. On average, the 12 ml protocol also gave results that 
were more consistent with the G1 control results, with a mean accuracy level of 
105% of the G1 control values, compared to 77% in the case of the 20 ml protocol. 
Given these results, the decreased sensitivity of the 12 ml protocol was outweighed 
by a greater accuracy when imaging using the G2 cassette and Micro-I, although the 
20 ml protocol counted on a FECPAK
G1
 slide was utilised in later work on 
anthelmintic resistance monitoring. 
2.14 COMPARING STANDARD SILVER AND FINER BLACK FILTERS  
 Filter sizes - introduction 2.14.1
As previously mentioned, the FECPAK
G2
 cassette concentrates the nematode eggs 
and floating debris into a small 3 mm diameter field of view in order to produce 
small images that can be transmitted via the internet for diagnosis by specialist 
technicians. This requires as much of the floating debris as possible to be filtered out, 
whilst retaining all the nematode eggs in the sample. Previous work had failed to 
determine whether there was an improvement using the finer, black filters. After 
having decided on the 12 ml protocol as the optimal version for imaging using the 
cassette, it was then necessary to determine if the black or the silver filters produced 
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higher quality images. Therefore, the aim of this section was to determine the 
optimum filter size for the selected 12 ml protocol. 
 Filter sizes - materials and methods 2.14.2
A sample of 60 g of faeces from a horse with a natural strongyle infection was mixed 
with 240 ml water to produce a uniform slurry. Two G1 preparations were made 
from this slurry, the first being counted in triplicate and the second counted once, 
using the FECPAK
G1
 slide. These values were used to produce a mean value as the 
control. The second G1 preparation was included so that the results could be used as 
part of the validation of the final protocol. 
Four sedimentors were prepared by pouring 12 ml slurry, pre-filtering using the 
1,000 µm filter and sedimenting for 30 minutes. The supernatant was discarded, 80 
ml saturated NaCl added to the sediment and then the liquid added to a FECPAK 
cylinder. Two of the cylinders were fitted with the 600 µm and 425 µm (silver) 
filters and two with the 425 µm and 250 µm (black) filters. Two cassettes from each 
cylinder were imaged using the Micro-I. Seven replicates were performed, using 
faeces from different horses. 
 Filter sizes - results 2.14.3
FECPAK
G2
 preparations were made using the selected 12 ml faecal slurry protocol, 
and filtered using either the standard silver filters or the finer black filters. The FECs 
obtained are given in Figure 2-22. Height on the y axis of each box plus whisker in 
Figure 2-22a shows the epg figures returned for each sample with each filter size, 
and size of the boxes plus whiskers shows the repeatability for each sample and filter 
size combination. Height of the boxes on the y axis in Figure 2-22b shows the epg 
figures from all samples for each filter size, size of the boxes plus whiskers shows 
Chapter 2 – Development of the FECPAK
G2




the repeatability of each filter size across all samples. The mean of the FECs 
obtained by the G2 counts was 99% of the G1 controls in the case of the black filters, 
and 102% of the G1 controls in the case of the silver filters. 
 
 
Figure 2-22 Comparing filters imaged using the G2 cassette and imaged with the Micro-I a) Data 
comprises each G2 count: epg returned from each filter size (height on the y axis of the boxes) and 
also the repeatability for each filter size with each sample (the size of each box plus whisker). b) Data 
comprises the total counts for all samples: epg returned from each filter size (height on the y axis of 
the boxes) and also the repeatability for each filter size. 
 
The results in Figure 2-22a show no clear difference between filter sizes. Figure 
2-22b demonstrates that the silver filters were more consistent with the control 
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values, yet Figure 2-23 confirms that the percentage accuracy of the two filter sizes 
was almost identical, running at approximately 100% of the G1 control values across 
a wide range of FEC levels. 
 
Figure 2-23 Percentage accuracy of black vs silver filters imaged using the G2 cassette and Micro-I. 
Each pair of data points represents the mean of two G2 counts for each filter size, for each sample, 
with the percentage accuracy compared to the mean G1 control for that sample plotted against the 
FEC as determined by the G1 control. 
 
 Filter sizes - discussion 2.14.4
In four out of the seven horses, the black filters gave higher FECs than the silver 
filters, with the reverse being true for the remaining three horses. When comparing 
all the results, the silver filters gave results that were slightly more consistent with 
the G1 control values. The mean G2 results for each horse expressed as a percentage 
of the G1 mean for that horse, showed that both filter sizes gave, on average, similar 
results to the G1 values therefore it was concluded that there was no clear benefit to 
using the finer black filters over the silver filters. In fact, the silver filters showed a 
slightly better performance over the black filters (102% of G1 control values for the 
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silver filters, 99% of the G1 control values for the black filters). Given the existing 
FECPAK
G2
 kits are supplied with silver filters, it was decided that there was no 
reason to change this. It was decided that the protocol to go forward for validation 
would use the silver filters. 
2.15 CONCLUSION 
In order to inform anthelmintic treatment decisions in horses, a method of detecting 
parasitic nematode infections is necessary. The most commonly used method is the 
faecal egg count, or FEC. Many protocols for performing FECs currently exist, most 
of which involve mixing a sample of equine faeces with a flotation solution and 
visualising the nematode eggs via light microscopy, such as the McMaster method 
(MAFF, 1986), FLOTAC (Rinaldi et al., 2014) and Mini-FLOTAC (Levecke et al., 
2012b). Alternative FEC methods have recently been developed that avoid the need 
to visualise FEC preparations under a separate microscope, such as the Parasight 
system (MEP_Equine_Solutions, 2019) and the FECPAK
G2 
currently in use in 
ruminants (Rashid et al., 2018) and humans (Ayana et al., 2018). The FECPAK
G2
 
involves mixing a faecal sample with a flotation solution as in the other methods 
mentioned but the preparation produced is then imaged in a cassette specifically 
developed for the Micro-I imaging device. The images are uploaded via the internet 
where they are counted by specialist technicians and the FEC returned to the 
customer electronically. Given the requirement to improve equine FECs, the aim of 
this Chapter was to determine a protocol for preparing equine faeces, that would give 
optimum results when imaged using G2 cassette and the Micro-I.  
Compared to the McMaster method, which was the original faecal flotation method 
(MAFF, 1986), the FECPAK
G2
 method uses a larger faecal volume, which is 
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important as it reduces the error rate caused by the random distribution of helminth 
eggs within the faeces (Denwood et al., 2012). The earliest work described in this 
section confirmed that care should be taken with the initial sub-sampling of this 
faecal slurry, as equine faeces behave slightly differently than those of sheep. This 
was an important finding, as it prevented errors being introduced in the very first 
step of the protocol. Spooning the sub-sample rather than pouring it was found to 
produce a more representative sub-sample, and therefore gave more accurate results. 
The volume of slurry to be used, which affected the sensitivity of the final test, was 
investigated. The initial idea of varying the volume led to comparisons between the 
selected volumes of 12 ml and 20 ml. These were compared using slides and using 
the G2 cassette in the Micro-I. Although the more sensitive 20 ml preparation 
performed well when counted using a slide, it did not perform as well when counted 
using the G2 cassette and Micro-I and so the 12 ml preparation was decided upon for 
the final protocol. 
The optimum sedimentation time and accumulation time were decided upon for the 
12 ml preparation, with some additional work on sedimentation and accumulation 
times performed for the 20 ml preparation which ended up not being used at this 
point. A sedimentation time of 30 minutes, and an accumulation time of six minutes 
were settled on for the final protocol. Finally, the optimum choice of filter sizes from 
those provided by Techion was determined and it was decided that the silver filters 
should be used. 
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From the work carried out described above, it was decided that the final protocol for 
a G2 test would be as follows: 
 Mix faeces with water in the ratio 1:4 and mix to form a uniform slurry 
 Spoon 12 ml slurry into a sedimentor and fill with water, invert three times to 
mix 
 Pre-filter using the FECPAK cylinder fitted with a 1,000 µm filter and return 
to the sedimentor 
 Allow to stand for 30 minutes, then discard the supernatant 
 Add 80 ml saturated NaCl solution to the sediment and pour into a 
FECPAK
G2
 cylinder fitted with 600 µm and 425 µm (sliver) filters, invert 
three times to mix 
 Fill both wells of the FECPAKG2 cassette from the cylinder, mixing between 
each aliquot 
 Allow the cassette to stand for six minutes for the eggs to accumulate, then 
image using the Micro-I  
This protocol then went forward to the validation stage, to be tested against the G1 
protocol for multiple samples. 
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3 VALIDATION OF THE FECPAKG2 FOR EQUINES 
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3.1 INTRODUCTION  
The FECPAK
G1
 method (Presland et al., 2005) is a commercial faecal egg counting 
(FEC) method based on similar principles to the McMaster method (MAFF, 1986). 
FECPAK
G1
 differs from the McMaster method by exploiting a larger microscope 
slide in order to improve sensitivity. The sensitivity of a FEC method refers to the 
multiplication factor applied to each helminth egg observed within the count and 
represents the lowest infection level that can be detected by a single test. The 
FECPAK
G1
 method was initially developed for use in ruminants and has been 
successfully utilised in the ruminant sector since its launch in 1993 (Godber et al., 
2015; McCoy et al., 2005)  The FECPAK
G1
 has since been adapted for equines from 
2004, and is now widely utilised in the equid sector (Presland et al., 2005).  
Therefore, the FECPAK
G1
 (G1) represents an excellent tool as a comparative FEC 
system for validating the FECPAK
G2 
(G2) with the Micro-I automated imaging 
system and cassette. If the FECPAK
G2
 performed as well as the FECPAK
G1
, it would 
represent an important improvement since it would enable owners to perform FECs 
on their animals whilst avoiding the common problem of mis-identification of eggs, 
which can lead to a significant over-estimation of strongyle egg counts as noted by 
McCoy et al. (2005). 
Earlier optimisation work in this thesis (Chapter 2) had determined that the initial 
faecal slurry was best spooned into the FECPAK
G2 
sedimentor, in order to account 
for the different consistency of equine faeces compared to ovine faeces. A 
sedimentation time of 30 minutes was determined to be the optimum for nematode 
egg recovery, and filtering with 600 µm and 425 µm filters in the FECPAK
G2
 filter 
cylinder was deemed to be sufficient for removing debris to allow the nematode eggs 
to be imaged using the Micro-I and cassette. An accumulation time of six minutes 
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was noted to be sufficient to allow all the nematode eggs to float into the 3 mm field 
of view of the Micro-I. Two different concentrations of faecal slurry preparation 
were investigated during the optimisation work, one based on the sheep protocol 
which used 12 ml of the faecal slurry, and a more sensitive protocol which utilised 
20 ml. Initially, the more sensitive 20 ml protocol was chosen for validation. This 
would be a more valuable test, with a sensitivity of 26 epg, than the 12 ml protocol 
(43 epg), and would therefore enable resistance monitoring to be undertaken using 
fewer replicates. However, when attempting to validate the FECPAK
G2
 cassette 
system using the 20 ml protocol, the initial results were poor. The validation work 
was re-attempted using the 12 ml protocol after discussion with the industry partner 
Techion Ltd, who feared that the more concentrated 20 ml preparation may have 
been unsuitable for imaging using the Micro-I. 
The FECPAK
G2
, like the G1, was initially developed for use in ruminants albeit in 
this case specifically for sheep and has since been successfully employed for FEC 
analysis. Therefore, in order to determine if the use of the FECPAK
G2
 would be as 
accurate for monitoring parasite infections in horses as the G1 method, faecal 
samples from horses from both the UK and New Zealand were processed using each 
of the two methods. Repeat counts on each faecal sample were performed with each 
method, to determine the repeatability of the G2 method and how this compared to 
the G1. The two methods were then compared for each sample, to assess the relative 
accuracy of the G2 method over the range of egg shedding levels. If variability and 
FECs produced were similar between the two methods, the G2 would represent an 
improvement over the slide-based G1 method due to its ease of use for the end user. 
The aim of this chapter therefore, is to validate the FECPAK
G2
 as an acceptable 
method of performing faecal egg counts on horses. This task would be accomplished 
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by comparing FECs produced by the G2 method with those produced from an 
existing FEC method, the G1. 
 The validation initially commenced with the 20 ml protocol, but as this performed 
poorly when imaged in the cassette and Micro-I compared to when counted on a 
FECPAK
G1
 slide, the procedure was changed to validate using the 12 ml protocol 
instead.  
3.2 CHAPTER AIMS 




3.3 MATERIALS AND METHODS 
 Validation 12 ml protocol  3.3.1
Faecal samples were collected from 92 horses in Wales which had been volunteered 
as participants by their owners. From each horse, 60 g of faeces was mixed with 240 
ml water to produce a uniform slurry. A G1 preparation was made from each faecal 
slurry and two slides counted. Forty two of these horses had FECs of zero epg and 
thus their samples were discarded. Fifteen samples were also discarded due to their 
having FECs of less than 90 epg, which would represent only one egg on the G2 test. 
It was decided that at least two eggs should be expected in the G2 test before it 
would be a useful comparison to the G1 for validation purposes, as two images are 
produced for each test. For the remaining 40 samples a further G1 preparation was 
made and again two slides counted. The means of these four G1 counts were 
calculated and formed the control values. 
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From each sample two G2 preparations were made using 12 ml of faecal slurry. The 
first 26 samples were measured by spooning the slurry into the sedimentor up to the 
slurry line and the final 14 samples were measured using a 12 ml scoop which 
became available during the latter part of the validation. The faecal slurry was 
spooned into the sedimentors as the most accurate method developed during the 
optimisation work to ensure accurate subsampling of the faecal slurry. All 
sedimentors were filled with water to the fill line, pre-filtered using a 1,000 µm filter 
and left to stand for 30 minutes. The supernatant was then discarded and the 
sediment mixed with 80 ml saturated NaCl solution and poured into a FECPAK
G2
 
cylinder fitted with 600 µm and 425 µm (silver) filters which had been selected as 
the best ones to use during the optimisation work. An aliquot was used to fill each 
well of two FECPAK
G2
 cassettes and these were image captured and marked up 
using the Micro-I.  
 Statistical analysis  3.3.2
The aim of this work was to prove that the G2 method produced results comparable 
to those of the G1, in order to validate the test as an effective tool for performing 
equine FECs. 
At this point, a power equation was performed to determine the minimum number of 
samples needed for a statistically significant validation. 
𝑛 ≥ (





In the above equation: 
 n = sample size needed 
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t1 = t value for (P<0.05, error d.f.) = 2 
t2 = t value for (P=2(1-p), error d.f.) where p = the chance of success. Aiming for a 
90% chance of success, thus p = 0.9 and t2 = 1.3 
CV = coefficient of variation, and the figure for CV of the G1 counts was used 
(78%). 
d = “treatment success” i.e. if G2 was 95% of G1 that would be considered a 
success. 
Substituting numbers into the equation gives: 
𝑛 ≥ (





giving n ≥ 14.68  Therefore, to give a 90% chance of identifying at least a 95% 
similarity between the G1 and G2 counts with p < 0.05, at least fifteen replicates 
should be used. After having discarded the results from nine samples that were over 
seven days old when tested, there were 17 sedimentor measured replicates and these 
were considered sufficient to proceed with the validation statistics.  In order to 
increase the statistical robustness of the analysis, additional data were obtained from 
Techion Ltd.NZ. Faecal samples from 22 horses were processed in the same way as 
the UK samples described in section 3.3.1 “Validation 12 ml protocol ” with the 
exception that the G1 preparations were counted only once.  
Statistical analysis was carried out using SPSS version 22.0 (IBM computers Ltd). A 
Pearson correlation was calculated on the UK data, the New Zealand data and the 
combined data to test the correlation between the G1 egg counts and the G2 egg 
counts. Repeated measure ANOVA (rmANOVA) was used to determine the 
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repeatability of the FEC within each method in the U.K. and New Zealand samples. 
A rmANOVA was then performed to compare the mean G1 epg with the mean G2 
epg (within-subject factor) and the UK and NZ data (between-subject factor) to 
determine whether the sampling methods differed and if the country in which they 
were tested affected this outcome. Effect size is reported as partial eta squared (ŋ
2
p). 
Mauchly’s Test of Sphericity was used to determine homogeneity of variance for 
rmANOVA, when heterogeneity was found the more conservative Greenhouse-
Geisser correction was used.    
Percentage deviation from the mean G1 count of a sample was calculated separately 
for each G2 count using the formula (G2 eggs expected – G2 eggs seen)/ G2 eggs 
expected × 100, where G2 eggs expected was: mean G1 eggs seen in that sample / 45 
× 25 to take account of the different sensitivity of the G2 versus the G1 test. The 
percentage deviations were converted to positive values, so that an under-reading test 
would not compensate for an over-reading test. A Pearson correlation was performed 
on these percentage deviations against FEC from the original G1 egg count to 
determine if the relative accuracy of the G2 method differs with different levels of 
egg shedding. 
 Validation 20 ml protocol  3.3.3
Faecal samples were taken from nine horses. From each horse, a sample of 50 g 
faeces was mixed with 200 ml water to make a uniform slurry. From this faecal 
slurry, two G1 preparations were made according to the standard Techion Ltd 
protocol (Presland et al., 2005)  (Appendix one). Each preparation was used to fill 
three replicate G1 slides and these were counted using light microscopy at 40 × 
magnification. The mean of these six counts for each of the 9 equine faecal samples 
formed the control values. 
Chapter 3 – Validation of the FECPAK
G2




From each slurry, two FECPAK
G2
 sedimentors were prepared using 20 ml slurry and 
filled with water to the fill line. The liquid from each was pre-filtered with a 1,000 
µm filter, returned to the sedimentors and allowed to stand for 30 minutes. After 30 
minutes sedimentation the supernatant was discarded. Eighty ml saturated NaCl 
solution was added to the sediment and the liquid transferred to a FECPAK
G2
 
cylinder fitted with 425 µm and 250 µm filters. An aliquot from each was used to fill 
a G1 slide which was counted using light microscopy at 40 × magnification and also 
a G2 cassette which was imaged using the Micro-I. All Micro-I images were 
marked-up for helminth eggs and all marked up images were independently verified 
by Techion New Zealand. 
 G2 cassette imaging assessment  3.3.4
Initially, G2 cassette imaging issues were detected by repeatedly feeding the same 
cassettes through the Micro-I. Whilst optimising the 20 ml protocol, investigation 
into a longer accumulation time was performed. Two G2 cassettes were prepared 
from a single faecal slurry using protocol outlined in Section 3.3.3, allowed to 
accumulate for six minutes and then fed through the Micro-I one after the other. G2 
cassette one was then immediately re-imaged, followed by G2 cassette two. This 
process was repeated resulting in three replicate sets of images for each G2 cassette 
at 6, 12 and 18 minutes accumulation time. 
In addition, a further eight G2 cassettes were prepared as the two above images were 
captured using the ’timed capture‘ software (Techion Ltd) utilised in the 
optimisation work (Chapter 2), to capture eight images of each G2 cassette well 30 
seconds apart. This software also captured the individual focused images used to 
create the final FECPAK
G2
 stacked image, so these could also be examined.  
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 Validation 12 ml protocol 3.4.1
As described in section 3.3.1, the validation samples were initially measured by 
spooning the faecal slurry into the sedimentor up to the slurry line, and later by 
utilising a 12 ml scoop which became available. Figure 3-1 demonstrates the mean 
G1 and G2 cassette counts for each equine FEC performed together with the 
percentage accuracy of the G2 compared to the G1 counts for samples from the forty 
horses. It can be observed that for the first seventeen samples (Figure 3-1 Blue data 
points) the mean accuracy of the G2 test compared to the G1 controls was 
approximately 100%. However, samples 18 to 26 (Figure 3-1 red data points), 
demonstrated the G2 protocol on samples older than 7 days, performed markedly 
worse compared to the G1 controls. As described in 3.4.1.1 (Effect of sample age on 
G2 performance ), these samples were more than a week old, and the decision was 
made to exclude old samples from the validation work. These samples had been used 
owing to the difficulty in obtaining faecal samples from horses with a FEC of 
sufficient magnitude for the validation, as described in section 3.4.4. 
The next fourteen samples, however, showed a sudden drop in G2 relative accuracy 
to approximately 70% of the G1 control values, and analysis was performed to try to 
determine the cause. Initially, it was postulated that the size of the horses may have 
been the cause of this reduction in performance of the G2 test, and the data analysis 
for this hypothesis is included in section 3.4.1.2 (Effect of height of animals on G2 
performance ). However, once the significance of the change in protocol became 
apparent, separate values were produced for the results obtained using the 12 ml 
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scoop versus those obtained by measuring the slurry using the line on the 
sedimentor, as shown by the green data points in Figure 3-1. 
Numerical data is contained in section 7.6 of the appendix. 
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Figure 3-1 The. performance of the optimised 12 ml G2 test compared to G1 controls over the 
validation process for equine faecal samples. Blue data points represent samples measured with a 
sedimentor under seven days old when tested, red data points represent samples measured with a 
sedimentor over seven days old when tested, green data points represent samples measured with 12 ml 
scoop (under seven days old when tested). Black lines represent the mean relative accuracy of each 
set of samples. 
 
Chapter 3 – Validation of the FECPAK
G2





3.4.1.1 Effect of sample age on G2 performance  
The frequency with which samples would return a zero count had been under-
estimated, and hence many of the samples collected were inadequate for the 
validation work. In order to maximise the data available, nine samples retained from 
the anthelmintic resistance testing were re-used for the validation work. These nine 
samples had been stored at 4ºC for eight days or more.  
The G2 data from these older samples produced much lower FECs than the 
corresponding G1 control results, with a drop in G2 relative accuracy from 96% to 
49% of the G1 control values. This represented a significant difference between the 
G1 control values and the G2 counts, (two-tailed t test p < 0.01). It was interesting to 
note that the G2 performance compared to the G1 fell with samples that were over a 
week old when they were tested, not simply the FEC values themselves. Actual G1 
FEC values on the old samples dropped by an average of 16% (±29%), although this 
difference was not significant (two-tailed t test p = 0.2). 
When the comparative G2 accuracy of all faecal samples was tested against the age 
of the sample (storage), the trend was for the G2 accuracy to drop compared to the 
G1 controls as the samples became older (Figure 3-2a). This phenomenon occurred 
despite the fact that the G1 control values were also prepared from the old samples, 
rather than using the FEC data obtained when the samples were fresh. The data were 
re-analysed using only samples up to seven days old (Figure 3-2b) from which it can 
be seen that G2 accuracy compared to the G1 control figure was unaffected by the 
age of the sample. 
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Figure 3-2 Accuracy of G2 count compared to G1 controls plotted against sample age for equine 
FECs. Individual data points represent mean G2 FEC as a percentage of mean G1 FEC for each 
sample, plotted against sample age. a) Using all samples tested. Trendline shows accuracy of G2 
compared to G1 dropping off as sample age increases. b) Using samples up to seven days old. 
Trendline shows accuracy of G2 compared to G1 steady at nearly 100%. 
 
Due to this discovery, it was decided to exclude the data from the validation from the 
nine samples that had been tested at eight days old or older.  After this decision was 
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made, two further fresh samples were processed and the G2 accuracy compared to 
the G1 controls improved back to previous levels. 
3.4.1.2 Effect of height of animals on G2 performance  
After excluding faecal samples stored at 4
o
C for over 7 days, when further samples 
were tested the relative accuracy of the G2 method suddenly dropped to a mean 
70.5% of the G1 control values. This represented a noticeable drop-off in relative 
accuracy, even when using fresh faecal samples. Figure 3-3a demonstrates a trend 
towards greater relative accuracy as the height of the animals increased. Even with 
the older samples excluded from the dataset, this trend was still apparent (Figure 
3-3b). 
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Figure 3-3 Accuracy of G2 compared to G1 controls compared to the height of the animal Individual 
data points represent mean G2 FEC as a percentage of mean G1 FEC for each equine faecal sample, 
plotted against height of animal.  a) Including samples over a week old when tested. b) Excluding 
samples over a week old when tested. Both trendlines demonstrate relative accuracy of G2 compared 
to G1 increasing for larger animals. 
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The datasets were divided into two categories: animals below 15 hh and animals of 
15 hh and above. The mean relative accuracy of the G2 method for animals under 15 
hh was 75% and it can be observed (Figure 3-4a) that the trend line was almost 
horizontal suggesting that this mean was consistent for the different horse heights 
sampled between 11 hh and 14.3 hh. The mean G2 relative accuracy for animals 15 
hh and over was 101% of the G1 control values (Figure 3-4b). Most of these horses 
were actually exactly 15 hh but even so the trend line is still almost horizontal 
showing that the mean G2 relative accuracy of samples from larger horses was also 
consistent with that value regardless of increasing height. 
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Figure 3-4 Accuracy of G2 compared to G1 controls plotted against the height of the animal, 
excluding samples over a week old when tested a) Including only animals under 15 hh. Showing a 
mean G2 relative accuracy of 75% of G1 control figures b) Including only 15 hh and over. Showing a 
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3.4.1.3 Change in protocol – scoop measure vs sedimentor measure  
Another potential cause for loss of relative accuracy of the G2 test was a preserved 
minor change in validation protocol. The existing data were re-examined and it was 
discovered that the decline in performance of the G2 test corresponded with the point 
at which the 12 ml scoop became available for use, in addition to coinciding with a 
drop in the size of the animals providing the samples. The samples processed using 
the 12 ml protocol and measured using the sedimentor returned a mean G2 relative 
accuracy of 96% of the G1 counts, whereas those measured using the scoop had a 
mean relative accuracy of 68% of the G1 (Figure 3-5).  
 
Figure 3-5 Percentage accuracy of G2 compared to G1 control values for samples measured using the 
scoop vs the sedimentor. Blue data points are sedimentor measured samples, showing a mean relative 
accuracy of 96% of the G1 controls, orange data points are scoop measured samples showing a mean 
relative accuracy of 68% of the G1 controls. Both trendlines demonstrate that these accuracies are 
fairly consistent across a range of FEC levels. 
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 Validation 20 ml protocol  3.4.2
During the optimisation phase, a protocol using 20 ml of faecal slurry rather than the 
originally suggested 12 ml was developed. This would deliver a test with a lower 
multiplier (sensitivity) enabling lower infection levels to be detected. As 
demonstrated in Figure 3-6, in every case the G2 preparations gave higher FEC epgs 
when counted on a slide (G2 Slide) following the G2 protocol rather than the G1 
control counts. However, when this same G2 preparation was image captured using 
the Micro-I (G2 Cassette) the FEC epg counts were consistently lower – lower, in 
fact, than those from the controls. 
 
 
Figure 3-6 Validation of the developed 20 ml FECPAK
G2
 protocol for equine FECs.  FECs were 
generated from nine horses using three different methods; Blue bars representing G1 control FECs 
(mean of six counts per horse), orange bars representing a G2 Slide (FEC based on a slide count; 
mean of two counts per horse) and the grey bars representing a G2 Cassette (FEC imaged using the 
Micro-I; mean of two counts per horse). 
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The average FEC expressed as epg across the nine horses was 185 epg (range 0 epg 
to 459 epg) when processed using the G1 control method, and 230 epg (range 8 epg 
to 483 epg) when processed with the G2 slide count.  However, when these same G2 
preparations were imaged using the FECPAK
G2
 Micro-I and G2 cassette, the average 
FEC was only 120 epg (range 0 epg to 286 epg) representing a 35% reduction in epg 
compared with the control values and a 48% average reduction during the G2 
cassette imaging process (difference in egg count when counting using the G2 
cassette versus counting on the slide). These differences were significant in every 
case (two-tailed t-test, p < 0.05).  
 Micro-I imaging assessment  3.4.3
Subsequent to the validation of the FECPAK
G2
 protocol, work was undertaken in an 
attempt to increase the sensitivity of the test. During this work, several cassettes 
were repeatedly imaged by the Micro-I. It became apparent that the same cassette re-
imaged multiple times did not always return the same egg count. Thus, the aim of 
this investigation was to determine the cause. 
Initially, two prepared cassettes of equine FECs were imaged in triplicate being fed 
in turn into the Micro-I. Following the repeat imaging of cassettes it can be noted 
that not all helminth eggs present within the faecal samples were being correctly 
imaged within the Micro-I (Table 3-1). For example, in cassette two of faecal sample 
one, there were at least ten eggs across the two wells, given there were four eggs 
imaged in well one and six eggs imaged in well two captured on different occasions. 
However, despite there being a minimum of 10 eggs present in both wells the 
maximum number imaged at any one time by the Micro-I was six.  
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Table 3-1 FECs from repeat imaging of G2 cassettes, demonstrating different numbers of eggs 
imaged from the same G2 cassettes on when imaging was repeated (image IDs refer to images 
uploaded onto the FECPAK server). 
A
The maximum number of eggs observed in well one and well 
two combined. 
 
 Cassette 1   Cassette 2  
 Well 1 Well 2 Image ID  Well 1 Well 2 Image ID 
 




 4 4 151849  4 2 151850 
Sample 1 3 4 151851  0 6 151852 







 10  
 0 1 151860  8 5 151861 
Sample 2 1 1 151863  9 4 151864 





2   14  
 
After this phenomenon became apparent, every G2 cassette used in the experiment 
was re-imaged in triplicate, and the same problem was observed repeatedly. As this 
problem was not a previously documented issue, a sample of sheep faeces was also 
imaged in order to see if the phenomenon was unique to horse samples and repeat 
images again produced  differing numbers of eggs (data not shown).  
In order to investigate the reason for the variation in egg numbers, G2 cassettes were 
re-imaged using the timed-capture software recording eight images without moving 
the G2 cassette in between image captures. Ten G2 cassettes were re-imaged in this 
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manner and a representative example of the results found is shown in Table 3-2. The 
entire set of results is shown in section 1.7 of the Appendix.  
Table 3-2 Number of eggs observed in a single FECPAK
G2
 cassette, imaged eight times using timed-
capture software (counts presented in consecutive order). Image references are the reference supplied 
when the image was uploaded to the FECPAK server. NB the results from one well only are shown, 
each cassette actually produced two such sets of images. Necessarily later images have a longer 
accumulation time than is standard. 
 










In order to investigate the reason for the differing egg counts, the individual images 
were examined and it was noted that the stacking software underpinning the Micro-I 
image capture was often choosing out-of-focus parts of the images to form the final 
stacked image for image analysis and helminth egg mark up. 
Representative images (Figure 3-7) of the data presented in Table 3-2 demonstrate 
such challenges with the imaging software imaging no eggs initially yet in later 
images of the same well capturing four helminth eggs. Specifically, Figure 3-7a 
demonstrates the centre of the well as seen on the stacked image. The stacked image 
is the only one that is visible when imaging the FECPAK
G2
 cassettes using the 
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normal laboratory procedure. This stacked image for image ID 153552 produced an 
egg count of zero. However, when the individual images that formed the stack were 
examined, it can be observed that there were three helminth eggs in focus within this 
area on one of the images (Figure 3-7b) which the stacking software had missed. 
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Figure 3-7  Image ID 153552 a) Focus stacked image showing no visible eggs. Bubbles and debris are 
visible in centre focus ring but second focus ring is blurred. b) Third image in stack for image 153552 
showing three eggs (highlighted) in second focus ring. Bubbles and debris still visible in centre focus 
ring. 
 
Following the discovery of the G2 cassette imaging challenges, it was decided to re-
visit all existing experimental data where G2 Slide counts and G2 Cassette Micro-I 
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counts of the same preparation were available. For final the validation, the standard 
G1 protocol was used as a comparison to the G2 Cassette on the request of Techion. 
At the time the 20 ml protocol was being investigated, the control values were being 
produced by counting the G2 preparation on a FECPAK slide (G2 Slide). The values 
produced by the G2 Cassette fell short of the control values, and so the 20 ml 
protocol was abandoned. In total there were 67 different experiments where data 
were available for G2 Slide and G2 Cassette counts of the same preparation. Mean 
G2 Cassette value was 56% of the G2 Slide counts across all protocols that had been 
performed. The final 12 ml protocol that went forward for validation against the G1 
control values gave a mean G2 Cassette value of 69% of the G2 Slide counts, and the 
20 ml protocol gave a mean G2 Cassette value of 76% of the G2 Slide counts.  
 
 Statistical analysis  3.4.4
Figure 3-8 provides the fate of the samples from 119 horses recruited for the 
validation work. As some of the optimisation work was done in tandem with the 
validation, this led to ten samples being processed using protocols which differed 
from the final optimised protocol, so these results were not used in the final 
validation figures. Fifty seven of the samples returned FECs of less than 90 epg, 
which were not used for the validation given at least two eggs should be present in 
the FECPAK
G2 
images for comparison to be made. Seven owners who had promised 
samples did not provide them (these are marked “not given”), nine were over a week 
old when used for the validation work and therefore the results discarded, and a 
further five were discarded at over a week old without being tested. This left 31 
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samples, which together with the nine samples discarded due to age, made up the 40 
samples referred to in Section 3.3.1. 
   
Figure 3-8 The fate of equine faecal samples intended for FECPAK
G2
 validation. In total 119 samples 
were recruited demonstrating that almost 50% of samples were unsuitable for validation work due to 
zero or low epg FECs (too low), 8% were processed with protocols which differed to the final 
optimised protocol, 8% were processed at over a week old and the results therefore discarded, along 
with 4% that were discarded at over a week old without being processed. Promised samples which 
were not given by the owners represented 6% of the total, leaving 26% of the samples available for 
the validation work. 
 
There was a significant positive correlation between the mean G1 counts and the 
mean G2 counts for each sample of the combined dataset (r=0.971 (CI:0.956, 0.987), 
n=39, p<0.001) (Figure 3-9). This was also independently true for both the UK FEC 
samples (r=0.963 (CI:0.907, 0.990), n=17, p<0.001) and for the New Zealand FEC 
samples (r=0.974 (CI:0.962, 0.993), n=22, p<0.001). 
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Figure 3-9 Comparison between mean G2 counts and mean G1 control counts for each sample, 
demonstrating a strong positive correlation with G2 counts running at very close to the control values. 
The mean percentage accuracy (mean G2 count as a percentage of mean G1 count, ± SE) was 
determined at 101 ± 4%.  
 
It was important to determine whether FECs performed using the G2 were as 
accurate as those performed using the control method (G1). Using rmANOVA there 
was no significant difference between the repeat samples using the G1 or the G2 
method in either the UK or the NZ data (Table 3-3). Repeatability was therefore 
similar with both methods.   
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. RmANOVA was used to test the repeatability of the G1 and G2 methods on FEC 
replicates of individual equine samples. The analysis demonstrates no differences between repeated 
sampling meaning that average FEC for each individual could be used to compare the G1 and G2 
methods. 
 
It was also important that FEC for each sample was comparable between the two 
methods. Using rmANOVA there was no significant effect of the method used on 
the mean epg per sample (F1,37 = 0.052, p = 0.821, ŋ
2
p = 0.001). Therefore, the G2 
method detected infection levels with efficacy equal to the G1 method.  To examine 
any effect of country of origin of the data, the data from the NZ and UK were 
compared again using rmANOVA. Epg was also not affected by the country of 
origin of the data (F1,37 = 2.084 p = 0.157, ŋ
2
p = 0.053) and there was no significant 
interaction between the method used and the country of origin of the data (F1,37 = 
0.056 p = 0.814, ŋ
2
p = 0.002).  
The overall similarity between FECs on each sample was also calculated. The mean 
percentage accuracy (mean G2 count as a percentage of mean G1 count, ± SE) was 
101 ± 4%. Importantly, relative accuracy of the mean G2 count was not significantly 
affected by FEC level (r = -0.251 (CI: 0.030, -0.472) p= 0.124 n = 39). Therefore, a 
lack of significant correlation between relative accuracy and G1 FEC indicates that 








G1 UK 1.9, 30.2 0.785 0.458 
G2 UK 3, 48 0.743 0.532 
G1 NZ 1, 21 2.253 0.148 
G2 NZ 1, 21 1.115 0.303 
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Egg count per sample was equally consistent between the G1 and G2 methods 
whether looking at the UK data, the NZ data or the combined dataset. Importantly, 
there was no significant difference between egg count repeat samples using either 
method (Table 3-3) providing confidence that both methods were reliable and that 
they were consistently applied.  
 
3.5 DISCUSSION 
 12 ml protocol  3.5.1
In total, 119 samples had been recruited and FECs performed in order to collect 
these 17 biological replicates. Losses were specifically due to low FECs, samples not 
being produced, or changes in the protocol that rendered the results unusable for the 
validation work as the methods used did not reflect the final optimised protocol. 
Total prevalence of positive FECs in this study was 37%, similar to the level of 
infection observed in a later study using the FECPAK
G2
 system on samples from 
horses at the Royal Welsh agricultural show, where 50% of the horses tested had a 
detectable infection (Tyson et al., 2017) and is consistent with other research (Lester 
et al., 2018; Nielsen et al., 2018b; Relf et al., 2013). 
3.5.1.1 Effect of sample age on G2 performance  
When using samples over a week old, it was noted that the relative accuracy of the 
G2 test dropped from 96% to 49% of the G1 control values. It would not be 
surprising if the FECs themselves dropped off as the samples aged, but as 
determining the overall accuracy of the FEC was not important in the re-used 
samples (as a FEC had already been performed on them when they were fresh, to 
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inform the owners) this was not thought to be important. Egg counts have been 
shown to drop with sample storage (Sengupta et al., 2016), however the G1 control 
values for the validation had been prepared on the same day as the G2 results were 
collected, so the phenomenon was not merely due to eggs having hatched. It is 
possible that the sedimentation process was affected once the samples became older, 
and further work to test samples repeatedly on consecutive days could pin-point the 
maximum sample age for which the G2 protocol should be used. However, 
subsequent work on the quality of images produced meant that improvements were 
planned in the imaging device, rendering such work redundant until the improved 
device became available. To the best of the author’s knowledge no work has yet 
been completed on the age of eggs and the ability to sediment. 
As the purpose of the FECPAK
G2
 is to enable on-site imaging of the prepared 
samples, it was decided that there was no reason that imaging of samples over a 
week old would need to be undertaken, so this phenomenon was not considered to 
affect the validation. In fact, the ability of the FECPAK
G2
 system to enable FECs to 
be undertaken by the owner on fresh samples is an important development, 
especially as the recommendation for equine faecal samples is that they be tested 
within four days of collection (Sengupta et al., 2016). 
3.5.1.2 Effect of height of animals on G2 performance  
Other potential sources of variation in the G2 test’s relative accuracy were 
considered, including the size of the animals that provided the faecal samples. The 
re-used samples had come from a rescue centre that had a lot of small ponies, and the 
next set of samples that were tested had come from a showing yard that also had 
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small ponies. Due to this concern, the results were re-analysed taking into account 
the size of the animals concerned. 
One idea which had been considered as a possible contributor to the poorer results of 
the G2 method for smaller animals was a difference in the constituents of the faeces. 
Faeces are not merely composed of indigestible food material, but also contain 
intestinal mucus and sloughed off intestinal cells (Tortora and Anagnostakos, 1987). 
It was postulated that the smaller intestinal diameter of smaller animals may have led 
to a larger proportion of these lipid products due to the higher surface area to volume 
ratio of a smaller diameter intestine. Lipid floating on the meniscus in the Micro-I 
cassette could quite possibly affect the accumulation of eggs due to differing surface 
tension (Yun Xu et al., 2013), and therefore lead to poor performance of the G2 test.  
It was hoped to analyse the constituents of poorly performing samples from smaller 
animals and compare them to analyses of samples from larger animals that had 
performed well in the G2 test.  
When examining the dataset as a whole there was a correlation between the height of 
animal and the accuracy of the G2 test compared to the G1 control. When the data 
were split into animals over 15 hh or under 15 hh, the percentage accuracy of the G2 
test compared to the G1 controls dropped from 101% in the animals over 15 hh to 
75% in the animals under 15 hh. However, later analysis pinpointed the drop in 
comparative accuracy of the G2 test to the introduction of the scoop measure, so the 
effect of height may have been a random artefact. Future work analysing the faecal 
composition of different sizes of horse and pony and how this affects egg 
accumulation on the meniscus of a flotation solution could be performed to 
investigate this potential effect further. 
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3.5.1.3 Change in protocol – scoop measure vs sedimentor measure  
Although the faecal scoop had been observed to provide an improved protocol 
during the optimisation from the comparative ease of scooping a level measure of 
slurry rather than spooning it into the sedimentor up to the slurry line, the results 
produced by using the scoop were poor when compared to the G2 protocol that 
spooned the faecal slurry into the sedimentor up to the slurry line. This was, perhaps, 
unsurprising in retrospect due to the fact that the sedimentors had an average volume 
of 13 ml at the 12 ml mark. The samples measured using the sedimentor returned a 
mean G2 relative accuracy of 96% of the G1control counts, whereas those measured 
using the scoop had a mean relative accuracy of 68% of the G1 controls. After the 
imaging problems identified in Section 3.4.3 were highlighted as the cause of the 
poor performance of the G2 test, it was understood that the increased volume of 
faecal slurry that was used when measuring with the sedimentor was compensating 
for the eggs lost during the imaging process. 
It was decided at this point that the G2 protocol should measure the slurry using the 
sedimentor, as this was standard operating practice for the sheep protocol. As 
Techion set the multiplier for the G2 (equine test) sensitivity to 45 epg this gave a 
mean relative accuracy of 101% for the sedimentor measured samples (the calculated 
multiplier is 43 epg, which has been used to produce the results in this thesis). 
As the point of the validation work was to demonstrate that the FECPAK
G2
 protocol 
produced FECs comparable with the G1 control values when used as directed, 
measuring the slurry using the sedimentor as for the sheep protocol was seen as 
reasonable. When the egg loss due to problems with the imaging software were 
highlighted this provided a potential reason that the multiplier needed to be increased 
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in order to preserve relative accuracy, and also why the samples measured using the 
sedimentor, which had a tendency to include more slurry, performed better than 
those measured using the scoop. Once a device with improved imaging capabilities 
is available, repeating this validation work would identify if a scoop measure could 
again be used for greater relative accuracy. 
 Validation 20 ml protocol  3.5.2
In all equine FECs performed, using the G1, G2 Slide or G2 Cassette, the G2 Slide 
preparations produced higher FECs than the G1 control counts. However, when this 
same preparation was imaged using a G2 cassette and the Micro-I, the FEC epg 
values were significantly lower – lower, in fact, than those from the controls. 
Given that the G2 preparation was imaged through a slide and the Micro-I it is clear 
that the preparation itself is capturing helminth eggs evidenced by the G2 Slide 
counts which were consistently higher than the G1 control values. With the G2 
preparation capturing helminth eggs it is likely that egg losses observed between the 
slide counts and the Micro-I cassettes were being lost at the point of imaging within 
the cassette. The FECs produced from the G2 cassettes were consistently lower than 
those from counting the same preparation using a slide and consistently lower than 
the control results from the G1 protocol.  
 When the imaging process was investigated (Section 3.3.4) it was discovered that 
the stacking software was sometimes choosing out of focus images to produce the 
final stacked image that would be used to identify the helminth eggs. This effect was 
greater where more eggs were present, as a blurry image portion would have the 
potential to hide a greater number of eggs and therefore render the G2 less accurate. 
Because of the greater volume of faecal slurry used in the 20 ml protocol compared 
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to the 12 ml protocol, a greater number of eggs would be expected for a given 
infection level, increasing the likelihood that eggs would be hidden.  This led to a 
comparatively less accurate test when the 20 ml protocol was imaged in the Micro-I 
compared to the 12 ml protocol. 
Despite the challenges with the 20 ml protocol this process was not in vain. The 20 
ml G2 protocol counted with a slide rather than the Micro-I produced consistently 
higher FECs than the G1 control values.  In addition the G2 Slides were 
exceptionally clear and easy to read as there was barely any debris visible when 1 ml 
was spread out over the surface of a slide rather than accumulating within a 3 mm 
circle. Therefore, this protocol (G2 Slides) would likely be useful in the future 
resistance testing work where a more sensitive test increases accuracy (Levecke et 
al., 2011). 
In addition, this work on image analysis has identified the source of the problem as a 
software issue resulting in eggs that were actually visible to the Micro-I being 
missed in the final stacked image produced. Once an improved imaging platform 
was available, it would be worthwhile to repeat this validation of the 20 ml protocol 
to produce a more sensitive FECPAK
G2
 test. 
 Image assessment  3.5.3
The liquid in the FECPAK
G2
 cassette forms a meniscus with a domed shape (Figure 
3-10). In order to form a focused, two-dimensional image of the surface of this 
meniscus, four separate images are taken at different heights. These images are 
computationally “stitched” together to form a stacked image. Thus, the stacked 
image is formed from four concentric circles, one from each image, such that each 
circle represents the portion of that individual image that is in focus. 
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Figure 3-10 Meniscus formed in FECPAK
G2
 imaging cassette (Cooke et al., 2016).The tip of light rod 
is highlighted. The light rod forms the 3 mm field of view visible on the final image captured by the 
Micro-I and where helminth eggs accumulate. 
 
When the G2 cassettes were taken out of the Micro-I and re-inserted again, the 
contained liquid swirled around to a certain extent, meaning that the images looked 
quite different. With the timed capture software, the G2 cassettes were not moved in 
between images. Thus, the debris etc. remained in the same place on each repeat 
image. This provided an easier approach to determine whether the eggs were being 
missed rather than merely having moved to a different part of the well. 
It became apparent from the repeat imaging work that the stitching software was not 
functioning correctly, and it was selecting some poorly focused rings to form the 
final stack. This led to egg counts being understated and variable, as visible eggs 
were not all present in the stacked images. This information was presented to the 
industry partner, Techion NZ, who then performed their own experiments and 
confirmed that the issue also occurred in their laboratory. 
In the interim, while software improvements are being made to counteract this issue, 
it was decided that all imaging should be processed by using the timed-capture 
software. This would enable any experimental protocols to be evaluated in the 
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knowledge that any perceived under-performance was real and not merely eggs 
being missed by focus issues. 
After having re-examined the existing data that compared the same preparations on 
both G2 Slide and G2 Cassette, it was discovered that the more sensitive 20 ml 
protocol actually did not perform any worse than the 12 ml protocol that was decided 
on as the final version. It was decided that once the imaging issues were solved, it 
would be worth re-visiting the validation of the 20 ml G2 Cassette protocol. Likely 
the improved egg recovery of the G2 protocol compensated for the deficiencies in 
the imaging process, and that even though the 12 ml G2 Cassette protocol performed 
as well as the G1 controls, the potential exists to produce an improved G2 Cassette 
test using the 20 ml protocol once the imaging device has been improved. 
 
 Statistical analysis  3.5.4
The significant positive correlation between the mean G2 results and the G1 controls 
was independently true for both the UK and the NZ data, therefore we can be 
confident that the consistency between G1 and G2 methods was independent of the 
laboratory in which they were tested. Egg count per sample was equally consistent 
between the G1 and G2 methods whether looking at the UK data, the NZ data or the 
combined dataset. This illustrates that the G2 method worked consistently regardless 
of the location of sampling or the operative performing the test. Importantly, relative 
accuracy of the G2 method did not significantly change with rising FEC levels.  The 
samples tested ranged from a FEC of 100 epg to over 3,000 epg. Therefore, the G2 
test was found to be accurate over a wide range of FEC levels. Given that the G2 test 
is designed as a diagnostic aid to determine whether anthelmintic treatment is 
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required, and with the accepted threshold for treatment at 200 epg (Coles, 2009), 
improved accuracy at very low infection levels (below 90 epg) is not required.  
3.6 CONCLUSION 
After the imaging issues seen were reported to Techion, company led investigation 
into additional laboratories using the Micro-I and G2 cassette (in New Zealand and 
Belgium) confirmed that it was not an isolated occurrence. As these focus issues 
were not dependent on the protocol being used to prepare the sample, there remains a 
good chance that, once these difficulties are rectified, more sensitive protocols could 
be imaged successfully in the G2 cassette. 
It had previously appeared that the more sensitive protocols were less effective at 
producing results in the G2 cassette. In fact, inaccuracies were caused by eggs being 
missed by the focussing software, rather than by the eggs failing to accumulate into 
the visible field of view. Where more eggs were expected (such as in a more 
sensitive protocol), there was a greater chance that eggs would be missed by 
focusing issues. After this effect was identified, it was decided that there was the 
potential for an ultra-sensitive protocol to be developed, once the focus issues were 
solved. In the meantime, the timed-capture software would be used to capture the 
images, in order to mitigate the focus problems as much as possible. 
Thus, the aim of this work was to compare the G2 system to the existing G1 method 
of faecal egg counting and prove that it performed as well as, or better than, the 
existing validated method. It was noted that the FECPAK
G2
 system represented an 
improved alternative to conventional slide based faecal egg counting for horses, 
producing comparable results, to the FECPAK
G1
 counterpart.  As the FECPAK
G2
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methodology does not require faecal samples to be sent by post or taken to a testing 
laboratory as with other commercially available methods 
(https://www.westgatelabs.co.uk/, https://www.poopost.co.uk/, 
https://www.efecs.co.uk/), it represents a more convenient method of performing 
FECs than others available. In addition, the fact that experienced technicians are 
responsible for identifying the helminth eggs increases accuracy compared to wholly 
owner-performed FECs which have been found to over-estimate egg counts (McCoy 
et al., 2005). It is hoped that the availability of the FECPAK
G2
 method will 
encourage horse owners to perform FECs for targeted selective treatments (Nielsen 
et al., 2014a) and that this will promote the longevity and sustainability of 
anthelmintics for controlling nematode parasites of horses.   
Horse owners intending to use FECs as part of their deworming strategy were more 
confident that they would effectively control helminth parasites in their horses, as 
evidenced by (Rose Vineer et al., 2017). This suggests that owners having the ability 
to perform their own FECs and have them analysed by experts, would have a 
significant, positive effect on the uptake of targeted treatment strategies for worm 
control in horses. 
 




4 MONITORING THE EQUINE NEMABIOME IN RESPONSE 
TO ANTHELMINTIC TREATMENT 
  





New molecular tests termed nemabiome barcoding are now available to support 
comprehensive parasitic nematode diagnostics by both quantifying and determining 
the relative proportions of species in nematode communities infecting a host animal.  
Nemabiome profiling was first developed for  gastro-intestinal nematode (GIN)  
communities  of cattle, by culturing nematode larvae from the eggs in the host faeces 
and undertaking deep amplicon Next Generation Sequencing (metabarcoding) of 
internal transcribed spacer 2 (ITS-2) rDNA (Avramenko et al., 2015). Recent 
research in equines has realised the possibility of performing nemabiome sequencing 
directly on faecal samples via ITS-2 rDNA locus analyses, thus saving the time 
consuming larval culture step (Mitchell et al., 2016). Nemabiome sequencing has 
been demonstrated to be equally effective whether sequencing DNA taken from 
nematode eggs or from larval cultures in ovine samples (Redman et al., 2019). 
Furthermore, molecular genetic techniques have been proposed for measuring the 
change in the nemabiome following anthelmintic treatment in cattle using this same 
deep amplicon sequencing approach (Avramenko et al., 2017).  
Thus, next generation sequencing (NGS) platforms such as Illumina (Meyer and 
Kircher, 2010), SOLiD (Hedges et al., 2011) and the MinION 
(http://www.nanoporetech.com/) offer new potential for  discovery and applied 
parasite  research (Wit and Gilleard, 2017). For example, The Oxford Nanopore 
MinION offers real time direct sequencing of native or amplified DNA / RNA at low 
cost and can read any length strand of nucleic acid, making it a useful tool for 
helminth nemabiome sequencing in relation to anthelmintic exposure. In brief, 
Nanopore technology monitors changes in electrical current as nucleic acids are 




passed through a protein “nanopore” (Figure 4-1; http://www.nanoporetech.com/). 
With nanopore sequencing both 1D and 2D reads, either one or both of the 
complementary strands of the DNA, are possible (Jain et al., 2016). The genetic 
sequences produced from such a sequencing approach can be compared against 
known sequences for the different nematode species, enabling a non-invasive and 
relatively easy method of determining which species are infecting an individual 
horse. 
 
Figure 4-1 Pictorial representation of Nanopore sequencing, showing the ID read of a DNA strand 
through a protein nanopore. Image from (Göpfrich and Judge, 2018).  
 
In order to acquire pre- and post-treatment faecal samples for nemabiome genetic 
analysis, it was first necessary to identify horses which harboured anthelmintic 
resistant helminth parasites. Post-treatment faecal samples from horses with drug 
anthelmintic resistant parasites would still contain helminth eggs, and enable a 
comparison to be made between the nemabiomes before and after treatment.  FECs 




were performed on these faecal samples by counting multiple slides to reduce the 
multiplication factor used to either 4.6 (standard resistance testing protocol) or 6.25 
(four FECPAK
G1
 slides) This is important as when performing Faecal Egg Count 
Reduction Tests (FECRTs) a higher sensitivity test results in improved accuracy 
(Levecke et al., 2011). 
In order to determine the nemabiome of the horses that provided the samples in the 
resistance testing section (Section 4.3.1) genetic sequencing of the samples collected 
both pre- and post-treatment, would be performed to determine the species 
composition. In order to identify the species of parasite contained in the faecal the 
samples, DNA would be extracted and then a section amplified using Polymerase 
Chain Reaction (PCR). This would provide a number of sequences unique to 
individual nematode species which could then be compared to a database of known 
sequences, and the proportions of each species identified calculated. The samples 
would also be tested to determine if Single Nucleotide Polymorphisms (SNPs) were 
present that correlated with BZ resistance. 
 
4.2 CHAPTER AIMS 
 Monitor anthelmintic resistance to different anthelmintic classes in several 
yards across the UK 
 Collect pre- and post-treatment faecal samples where anthelmintic resistance 
is identified 
 Identify primers from the literature that could be used to identify 
cyathostomin species and identify SNPs associated with BZ resistance 




 Optimise DNA extraction procedure from faecal samples 
 Investigate the possibility of extracting helminth DNA from FECPAKG2 
preparations 
 Extract helminth DNA from the faecal samples and amplify using PCR 
 Sequence the helminth DNA using a MinION benchtop sequencer 
(https://nanoporetech.com/) and track changes in the nemabiome in response 
to anthelmintic treatment 
4.3 MATERIALS AND METHODS 
 Nematode Resistance monitoring pre and post anthelmintic treatment 4.3.1
In total, fifty faecal samples were taken from horses across two yards in West Wales 
during the summer of 2016, 25 per yard. From each sample from the first yard, two 
G1 preparations were made, according to the standard FECPAK
G1
 testing protocol 
described in Section 7.1 “Standard FECPAK G1 protocol”. Three slides were 
counted from the first preparation, and one slide counted from the second 
preparation. The samples were processed using the FECPAK
G1
 method in order that 
the data could be used as part of the validation of the FECPAK
G2
 system. From the 
second yard, samples from each horse were prepared using the resistance testing 
protocol developed during the optimisation phase and described in Section 7.2 of the 
appendix, giving a sensitivity of 4.6 epg. 
All horses with a pre-treatment FEC of 200 epg or over (the suggested treatment 
threshold in Coles (2009)) were treated with Ivermectin paste as per the 
manufacturer’s instructions, owner-administered, and post-treatment samples 




collected on day 14 after treatment. Post treatment samples were all tested using the 
standard resistance testing protocol (section 7.2 of the appendix). 
During the summer of 2017, faecal samples were taken from 67 horses in three yards 
in the UK. The yards used were the two yards from the 2016 study of Ivermectin 
resistance, plus one yard in North East England. Pre-treatment samples were tested 
using the resistance testing protocol described in section 7.2 of the appendix.  
All horses with a pre-treatment FEC of 200 epg or over were treated with liquid 
Fenbendazole (Panacur 10% suspension) at a rate of 1 ml per 13 kg bodyweight per 
manufacturer’s instructions. Anthelmintic was owner-administered, in feed. Post 
treatment samples were collected on day 14 after treatment, and tested using the 
same resistance testing protocol. 
 Molecular genetics  4.3.2
 Primer selection: rDNA  4.3.3
In order to determine which nematode species were present within faecal samples, a 
portion of the small sub-unit of the ribosomal gene (see Figure 4-2) would be 
amplified using PCR. This gene is highly conserved among nematodes, and as the 
MinION is a powerful sequencer, it was decided to amplify the largest possible 
segment of this gene. The aim of this section of work was to select primers that had a 
forward primer as close to the 5’ end of the 18S region, and reverse primers that 
were as close to the 3’ end of the 28S region as possible. 
 





Figure 4-2  Schematic diagram of ribosomal gene of eukaryotic  DNA from (Hillis and Dixon, 1991) 
NTS = Non-Transcribed Spacer; ETS = External Transcribed Spacer; ITS = Internal Transcribed 
Spacer; 18S, 5.8S and 28S = genes 
 
From the literature, a number of papers were selected which used PCR to amplify the 
a portion of the rDNA gene from nematodes (Table 4-1) 




Table 4-1 Primers to amplify rDNA taken from the literature 




located in the 3' portion of 18S, the small 
ribosomal subunit gene, approximately 
190 bp from its junction with ITS1, the 
first internally transcribed spacer. 
5'-
GTAGGTGAACCTGCAGATGGA
T-3' located in the 5' portion of 28 S, 
the large ribosomal subunit gene, 
approximately 80 bp from the 
junction with ITS2, the second 
internal transcribed spacer 
Between both spacers is the 5.8 S ribosomal gene that 
is generally around 155 bp in length 
Peachey et 
al., (2017) 






Gives the region of the ribosomal DNA cistron 
including the 3’end of the 18S gene, ITS1, 5.8S, ITS2 
and the 5’ end of the 28S gene 





5’-GGGCGGTATCTGATCGCC-3’ The primers amplify an internal fragment of the 18S, 
approximately 900 bp in length (the full-length gene is 
approximately 1700 bp): the forward primer binds at a 
site around 100 bp inward from the 5′end of the gene, 
and the reverse primer at around 700 bp inward from 
the 3′ end. This gives nematode specific 18S DNA and 
avoids contamination from fungi. 
Mitchell   et 
al., (2019) 
Avramenko 
et al.,( 2015) 
’-ACGTCTGGTTCAGGGTTGTT-3’ 5’-TTAGTTTCTTTTCCTCCGCT-
3’ 
Gives ITS2 region. Taken from Gasser et al (1993). 
This gives a segment 250 bp long, and was used by 
Mitchell to speciate cyathostomins in equine faecal 
samples 




 DNA Extraction QiAgen kit 4.3.4
4.3.4.1 DNA Extraction QiAgen kit with beads  
DNA extraction from equine faeces was performed with a QiAmp DNA stool kit 
(QiAgen.com). The standard protocol was modified to include a bead disruption 
step. A sample of 350 mg of frozen faeces were added to a 2 ml micro-centrifuge 
tube, along with 1.6 ml Buffer ASL and four 1mm Thistle zirconia / silica beads 
(ThistleScientific.co.uk). The tube was vortexed horizontally for two minutes, then 
incubated at 95°C for five minutes, inverting halfway through to ensure even 
heating. The manufacturer’s recommended protocol was then followed. 
The DNA extraction was repeated using a Tissue Lyser (QiAgen, Hilden, Germany). 
This time, 250 mg of frozen faeces were placed in a 2 ml tube, along with one 1.5 
mm glass bead, and 2 ml of buffer ASL. The samples were bead-beated in a Tissue 
Lyser (QiAgen, Hilden, Germany) at 50 beats per second, for three minutes. Two ml 
of the lysate was transferred into a new 2 ml tube, and the protocol continued as 
before. 
4.3.4.2 DNA Extraction QiAgen kit without beads  
Faecal DNA was also extracted using the QiAmp standard mini-stool kit protocol 
without the addition of beads. The protocol followed was identical to that in the first 
part of section 4.3.4.1 with the exception that in the initial step, 260 mg frozen faeces 
and 2 ml of Buffer ASL were added to the 2 ml micro-centrifuge tube, with no 
Thistle beads. 
4.3.4.3 DNA Extraction QiAgen kit freeze drying 
In order to discover whether a greater amount of starting material could be used for 
the DNA extraction, freeze drying prior to DNA extraction was also assessed. In 




brief, 5 g of faeces was freeze-dried for four days, which reduced the mass of each 
sample to around 1.5 g each (range 0.9 g to 2.9 g). This freeze dried material was 
then compared to the frozen samples with and without beads using the QiAmp 
standard mini-stool kit following the manufacturer’s instructions with minor 
modifications as stated in sections 4.3.4.1 and 4.3.4.2 . 
4.3.4.4 DNA extraction from Ascarid tissue and Panagrellus redivivus using QiAgen kit 
 In order to obtain DNA to use as a positive control, an adult female Ascarid was 
obtained from a colleague, and DNA extracted using a QiAmp Blood and Tissue kit 
(h ttps://www.qiagen.com/us/). Fourteen mg of Ascarid tissue was chopped and 
placed in a 1.5 ml Eppendorf and the protocol followed as per the manufacturer’s 
instructions. 
In addition, DNA was extracted from Panagrellus redivivus, a free living nematode 
which is maintained in-house at Aberystwyth University. A mix-stage active culture 
of P. redivivus on autoclaved porridge oats (Papadopoulos et al., 1989) was sourced 
from stocks ,  and distilled water was gently floated onto the culture surface in order 
to decant via pipette nematodes into a 1.5 ml Eppendorf. The nematodes were 
subsequently allowed to settle under gravity, and the supernatant drawn off in order 
to remove  any residual floating porridge sediment and live nematode presence  
confirmed by low power light microscopy. DNA extraction was performed using a 
QiAmp blood and tissue kit (https://www.qiagen.com/us/) following the 
manufacturer’s standard protocol. 
 




 DNA Extraction:  CTAB (Cetyl Trimethylammonium Bromide) method  4.3.5
Following the difficulties experienced in optimising DNA isolation using QiAgen 
kits, extraction of DNA from equine faecal samples using the CTAB method was 
attempted. The CTAB protocol itself was adapted from Dellaporta et al. (1983), Yu 
and Morrison (2004) and William et al. (2012). 
In brief, lysis buffer was prepared containing 50 mM EDTA pH 8, 500 mM Tris 
HCL pH8 and 500 mM NaCl. This was autoclaved at 121ºC for 15 minutes, and 4% 
(w/v) SDS was added while it was still warm, and stirred until it dissolved. The 
CTAB/NaCl was prepared, containing 700 m NaCl and 10% (w/v) CTAB, and 
autoclaved. 
Initially, a comparison between freeze-dried and frozen faecal sample was 
completed, following earlier experimental work using freeze-dried samples. This 
work had discovered that freeze-drying merely reduced the weight but not the 
volume of the sample, and therefore did not permit a greater quantity of sample to be 
processed, but as the CTAB protocol stipulated freeze-dried material, this was 
revisited.  
Two 2 ml tubes were prepared, with equal volumes of sample which equated to 50 
mg of freeze-dried sample or 200 mg frozen sample. The CTAB method was 
followed as described in Section 7.3 of the Appendix. 
In common with the findings from Section 4.3.4.2 (DNA Extraction QiAgen kit 
without beads ), it was decided that there was no benefit in freeze-drying the samples 
before DNA was extracted, and so approximately 200 mg of frozen sample was used 
for each extraction, and the CTAB protocol followed as above. Ten samples were 




prepared simultaneously each time, and the work was repeated until DNA had been 
extracted from all the samples. 
 DNA Extraction from FECPAKG2 Cassette preparations  4.3.6
A 1.5 ml aliquot of a FECPAK
G2
 preparation that had been processed for faecal egg 
counting and stored at -20°C was used for DNA extraction. When counted, the faecal 
preparation had shown 17 eggs in 0.5 ml, so the sample potentially contained 
approximately 51 nematode eggs. In order to separate the eggs from the saline 
solution, a number of wash steps were performed. The sample was diluted with 10 
ml distilled water, and centrifuged for 5 minutes at 276 × g and 5 minutes at 1500 × 
g, the supernatant discarded and the pellet re-suspended in 1 ml distilled water. This 
solution was transferred into a 1.5 ml micro-centrifuge tube and centrifuged at 
22,000 × g for 5 minutes, the supernatant discarded and the pellet re-suspended in 
200 µl distilled water. The protocol for the DNeasy Blood and Tissue kit 
(https://www.qiagen.com/us/) was then followed according to the manufacturer’s 
instructions. 
Extracted DNA was quantified using a Nanodrop 1000 spectrophotometer 
(http://www.thermofisher.com). 
In addition, 500 µl of a FECPAK
G2
 Cassette preparation was used, that had been 
stored at -20°C. From the egg counting data, this sample potentially contained 
between 9 and 34 eggs. The sample was warmed to room temperature, and the 
protocol above followed, omitting wash steps. The DNA was again quantified using 
a NanoDrop 1000 spectrophotometer (http://www.thermofisher.com). 




The DNA extraction from the unwashed sample was also unsuccessful, so it was 
decided to experiment with different preparation methods at the faecal sample stage, 
to see if the salt was potentially causing an issue with the extraction, or if washing 
the sample was losing the eggs, or the eggs were deteriorating due to low 
temperature storage. In order to do this, a fresh faecal sample was obtained 
(FECPAK
G2
 slide count FEC quantified this sample at 184 epg) and was prepared 
using the 20 ml FECPAK
G2
 protocol described in Appendix 1 “Standard Resistance 
testing protocol”. A second sedimentor was prepared, but instead of diluting the 
sediment with 80 ml saline, 80 ml water was used. Three 1 ml aliquots were taken, 
one from the regular protocol, and two from the water-diluted sedimentor. One of 
these water-diluted aliquots was centrifuged at 22,000 × g for three minutes and the 
supernatant discarded. The DNeasy protocol above was followed on all three 
aliquots.  
Following the success of the CTAB DNA extraction method on the faecal samples, 
this method was also attempted on the FECPAK
G2
 cassette preparations. 
Two 1 ml aliquots of FECPAK
G2
 cassette preparation were selected, which had been 
stored at minus 20ºC. The samples had FECs of 478 epg and 874 epg, meaning that 
the samples would be expected to contain 21 and 38 eggs respectively. 
The standard CTAB DNA extraction protocol was performed (see Section 7.3 of the 
appendix), with the exception that in step four the tubes were centrifuged for three 
minutes at 500 × g and one minute at 900 × g, to ensure that all eggs were recovered.  




 PCR optimisation rDNA  4.3.7
In order to determine the species of nematodes in the faecal samples, optimisation of 
primers and PCR conditions for amplifying a segment of the ribosomal gene was 
required.  Primers were selected from the literature, as described in section 4.3.3 
Primer selection: rDNA. 
All primers identified in the literature were initially tested. This was performed using 
a sample of DNA extracted using the QiAmp kit without bead disruption with a 
positive control of Biomphalaria glabrata DNA (donated by Dr K. Geyer). For PCR, 
25 µl reactions were performed using MyTaqRed DNA polymerase (Bioline, UK) 
according to the manufacturer’s instructions with 10 µM forward and reverse 
primers and approximately 100 ng of template DNA. 
PCR conditions were: initial denaturation at 95ºC for 1 minute, denaturation at 95ºC 
for 15 seconds, annealing at 55ºC for 15 seconds, extension at 72ºC for 10 
seconds and final extension at 72ºC for 5 minutes, with 35 cycles performed.  
A second DNA sample was tested which had been extracted using the QiAgen kit 
vortexed for 2 minutes with 4 × 1mm Thistle beads. Primers tested were ‘Floyd’, 
‘Marek’ and ‘Peachey’. As the DNA was of a lower concentration it was first 
concentrated using a speed vac (Concentrator plus, Eppendorf UK) for 20 minutes. 
PCR conditions were slightly altered, reducing the annealing temperature to 53 ºC to 
see if this would strengthen the band produced by the Peachey primers and my 
extracted DNA sample. The number of cycles was increased to 40 to maximise the 
amount of DNA amplified. 




The ‘Floyd’, ‘Marek’ and ‘Peachey’ primers were tested again, in attempt to find 
better positive controls, which were ascarid DNA and Schistosomule DNA. As the 
product from the ‘Peachey’ primers was only 99 bp it was considered to be too 
small, and so the primers from ‘Floyd’, ‘Marek’ and ‘Powers’ were again tested 
using ascarid, Schistosomule and P, redivivus DNA with the PCR annealing 
temperature increased to 56ºC. 
All PCR products were imaged on a 1% agarose gel at 100 V using SYBR safe DNA 
gel stain (https://www.thermofisher.com, to check that a band of the expected size 
was generated. 
 PCR of DNA extracted using QiAgen kit 4.3.8
The aim of this work was to amplify a region of nematode DNA from the faecal 
samples, using the extraction conditions and the primer set that were considered to 
perform the best. Once the ‘Floyd’ primers had been selected as the most promising 
ones to use, and a dozen faecal samples processed using the optimal method of 
extraction (frozen samples, without a bead disruption step), the samples were tested 
using PCR. PCR conditions were as before using the ‘Floyd’ primers. 
PCR products were imaged on a 1% agarose gel at 100 V, to check that a band of the 
expected size was generated.  
 PCR of DNA extracted using CTAB method 4.3.9
The ‘Floyd’ primers were selected, as these were the most promising to produce a 
long fragment of the rDNA gene, and were tested on ten of the DNA samples 
extracted using the CTAB method using the PCR conditions previously optimised. 
The PCR from the above experiment failed to amplify anything from the ten samples 




extracted using the CTAB method, so the experiment was repeated using only 
approximately 20 ng of template.  
As there had been success for a couple of the samples using 20 ng of template, it was 
decided to try the primers used in Mitchell et al. (2019), also Avramenko et al. 
(2015) which had been taken from Gasser et al.(1993), using 20 ng of template 
DNA. These primers gave a smaller expected product size of 250 bp, but had 
successfully been used to identify cyathostomin species in Mitchell et al. (2019). 
PCR annealing temperature was reduced to 55ºC. 
PCR products were imaged on a 1% agarose gel at 100 V, to check that a band of the 
expected size was generated. 
 Primer selection:  β tubulin isotype 1  4.3.10
Literature was examined for primers which would amplify either the entire β tubulin 
gene, or those SNPs associated with BZ resistance in cyathostomins. The results are 
shown in Table 4-2. 
It was decided to use the primers from Hodgkinson et al. (2008), as they amplify the 
whole of the β tublin isotype 1 coding sequence, and also to assess the primers from 
(Ishii et al. (2017) in the event that the ‘Hodgkinson’ primers were unsuccessful. The 
third set of primers, from Coles et al. (2006) and Pape et al. (2003) were not used, as 
they were designed to amplify separately susceptible and resistant  tubulin isotypes, 
given this would not be necessary when PCR products would be sequenced using the 
MinION.  




Table 4-2 Primers to amplify all or part of the β tubulin gene in GI nematodes taken from the literature. 
Paper Forward primer Reverse primer Notes 
Coles et al., (2006) 5’-
GGTTGAAAATACAGACGA
GACTTT-3’ (susceptible allele) 
5’-
GGTTGAAATACAGACGAG
ACTTA-3’ (resistant allele) 
5’-
AGCAGAGAGGGGAGCAAAG
CCAGG-3’ (same for both 
alleles) 
 
Pape et al., (2003) 5’-
GGTTGAAAATACAGACGA
GACTTT-3’ (susceptible allele) 
5’-
GGTTGAAATACAGACGAG
ACTTA-3’ (resistant allele) 
5’-
AGCAGAGAGGGGAGCAAAG
CCAGG-3’ (same for both 
alleles) 
Cn24FS (first forward primer) is able to detect the base 
associated with phenylalanine in codon 200, whereas 
Cn25FR (second forward primer) detects tyrosine at this 
position. Thereby only the final base at the 3’ end of each 
forward primer, corresponding to the middle base of 
amino acid 200, confers the specificity. 
 








These amplify isotype 1 of the β tubulin gene. They 
amplify the full length gene. The one listed here as the 
reverse primer was called the “nematode splice leader”  
 






These amplify codon 167 and give a fragment 120 bp in 
length 




 PCR optimisation beta tubulin  4.3.11
The β tubulin gene is the drug target for the benzimidazole class of drugs (Lacey, 
1989). Sequencing this gene would enable identification of mutations in the gene 
that might either be existing known mutations, or potential novel ones. 
The first primer set to be tested were those from Hodgkinson et al.(2008), which 
amplify the full length gene of isotype 1 of the β tubulin gene. Once again, the 
diluted CTAB DNA was used as the sample template (20 ng per reaction) and P. 
redivivus DNA used for the positive control. For PCR, 25 µl reactions were 
performed using MyTaqRed DNA polymerase (Bioline, UK) according to the 
manufacturer’s instructions with 10 µM forward and reverse primers and 
approximately 20 ng of template DNA. 
PCR conditions were as for the rDNA work, with an annealing temperature of 63ºC. 
In the paper that the primers were taken from (Hodgkinson et al., 2008), RNA was 
extracted from adult worms and used to make cDNA. The PCR amplified the whole 
of isotype 1 of the beta tubulin gene, and made a product of 1437 bp. Because in this 
project, gDNA was being used, the product would possibly be even larger than 1437 
bp, and so it was decided to revisit the PCR conditions to give a longer extension 
time, to facilitate the amplification of a large product. It was also decided to use 
increase the quantity of template DNA to 80 ng. PCR conditions – changed as per 
Hodgkinson et al. (2008) to initial denaturation at 94ºC for 1 minute, denaturation 
at 94ºC for 1 minute, annealing at 63ºC for 1 minute, extension at 72ºC for 1 
minute and final extension at 72ºC for 10 minutes, with 35 cycles. 




As the above experiment still did not amplify anything, the experiment was repeated 
twice more. The first repeat had the extension time increased to two minutes per 
cycle, and the second time it was increased to three minutes per cycle.  
Having failed to amplify the whole beta tubulin gene, it was decided to try the 
primers from Ishii et al.(2017) which amplify only codon 167, one of the two codons 
associated with BZ resistance in cyathostomins (von Samson-Himmelstjerna et al., 
2007a). As these primers would give a smaller product they had been considered 
inferior to the ‘Hodgkinson’ primers, but would possibly be easier to amplify. For 
PCR, 25 µl reactions were performed using MyTaqRed DNA polymerase (Bioline, 
UK) according to the manufacturer’s instructions with 10 µM forward and reverse 
primers and approximately 20 ng of template DNA and PCR conditions of: initial 
denaturation  at 95ºC for 1 minute, denaturation at 95ºC for 15 seconds, annealing 
at 53ºC for 15 seconds, extension at 72ºC for 10 seconds and final extension at 
72ºC for 5 minutes, with 40 cycles. 
All PCR products were imaged on a 1% agarose gel at 100 V, to check that a band of 
the expected size was generated. 
 Cloning and sequencing nematode DNA  4.3.12
In order to check that the PCR was correctly amplifying nematode DNA, prior to 
preparing and sequencing PCR products using the MinION 
(https://nanoporetech.com/), PCR products were inserted into the PGemTeasy 
sequencing vector (Promega, UK) and cloned using Escherichia coli. Each 
bacterium would then likely contain a single rDNA insert (rather than the mixed 
population amplified from the faecal DNA samples), which could be sequenced 
using Sanger sequencing to determine the species from which it came. 




4.3.12.1 Cloning and sequencing, High Fidelity PCR 
Hi fidelity PCR was performed using MyFi 2x mix polymerase (Bioline UK) with 25 
µl reactions according to the manufacturer’s instructions with 10 µM forward and 
reverse primers and using approximately 20 ng of template DNA. PCR conditions 
were as in section 4.3.3 Primer selection: rDNA with an annealing temperature of 
55ºC and 25 cycles used to maximise accuracy. 
For this experiment, two positive controls (P. redivivus and Baylisascaris 
schroederi) were used, and two negative controls (no DNA template, and DNA from 
a faecal sample with a zero FEC).  
Ten µl of each PCR product along with 2.5 µl of loading dye were run on a 1% 
agarose gel at 100 V, to check that a band of the expected size was generated. The 
two amplicons selected for transformation into E. coli were Widget pre and Major 
pre.  
4.3.12.2  PCR product purification, ligation and cloning 
PCR products from the selected samples were purified using an Invitrogen Pure Link 
Quick Gel Extraction and PCR Purification Combo kit 
(https://www.thermofisher.com) to remove primers, dNTPs, enzymes, short-failed 
PCR products and salts from the PCR products following the manufacturer’s 
instructions.  
The purified PCR products were then ligated into the PGEM-T Easy vector 
(www.promega.co.uk) according to the manufacturer’s instructions using 3 µl of the 
purified PCR products.  




The vector was then inserted into  Alpha select Bronze Efficiency E. coli cells 
(https://www.bioline.com/uk/), which contain a lacZ marker that provides α-
complementation of the ß-galactosidase gene for blue/white colour screening, 
enabling visual confirmation that the plasmid has been successfully inserted in the 
colony selected for sequencing. Transformation was performed as per the 
manufacturers’ guidelines with heat shock at 42°C for 30 secs before ice for 2 mins. 
Transformed cells were revived with SOC media (www.sigmaaldrich.com) and the 
tubes placed into the shaking incubator at 37ºC 200 rpm for ninety minutes. 
Transformed E. coli was then plated out on IAX plates (containing 3.5% w/v LB 
premix (Miller brand, www.fishersci.co.uk) and 0.1% X-GAL in DMF (5-Bromo-4-
Choro-3-Indolyl-β-D-Galactoside, Melford Laboratories Ltd, Ipswich), 0.1% IPTG 
(Isopropyl-β-D-thiogalactopyranoside, www.fishersci.co.uk ) and 0.1% Ampicillin 
(www.fishersci.co.uk )). 
Following overnight incubation at 37ºC, the plates were examined for the presence 
of white colonies, which signified successful uptake of the plasmid.  Transformed 
colonies were picked and screened using a colony PCR approach. Briefly, eight 1 ml 
tubes were labelled per sample, and 50 µl Nuclease-free water added to each one. 
For each tube, a white colony was selected, labelled on the petri dish, then scraped 
off with a 10 µl pipette tip and pipetted into the tube, pipetting up and down to mix. 
From each tube, 10 µl was transferred into a labelled PCR tube, the tubes centrifuged 
briefly and then boiled at 95ºC for 6 minutes. The remainder of the solution was 
retained at four degrees for use in the next step, growing on and sequencing. 




PCR was performed as follows, with 5 µl of each colony solution using the 
Avramenko / Mitchell primers and MyTaq Red polymerase. PCR conditions as 
previously with an annealing temperature of 55ºC and 40 cycles. 
PCR products were visualised using gel electrophoresis on a 1% agarose gel run at 
100 V as described previously, which showed that all the colonies had produced 
bands of the expected sizes.  
4.3.12.3 Colony growth, plasmid extraction and sequencing 
Colonies of interest were selected to be grown on for purification and sequencing. 
Colonies were grown overnight in round bottomed polypropylene tubes containing 7 
ml of LB broth with 0.1% ampicillin. Remaining 40 µl colony solutions from colony 
PCR were added to the LB broth/ampicillin and the caps closed to halfway to allow 
gas exchange to take place. Cultures were incubated overnight at 37°C, shaking at 
200 rpm. 
Post overnight culture, if required, glycerol stocks were prepared. Stocks were 
prepared by mixing 100% glycerol with the grown-on colony liquid at a 1:1 ratio in a 
small, screw-topped tube and storing at -80°C. 
Plasmids were purified using an Isolate II Plasmid mini-kit (www.bioline.com) 
according to the manufacturer’s guidelines using 1.5 ml of each overnight culture.  
Each plasmid sample was eluted in 30 µl of nuclease free H2O.  
Plasmid DNA was again quantified using a NanoDrop 1000 spectrophotometer 
(www.thermofisher.com). 
Plasmid DNA samples selected for sequencing were diluted to give 200 – 250 ng 
DNA in 5 µl total volume, prepared in 0.2 ml PCR tubes.  




Plasmid DNA samples were prepared with either an M13 forward primer 
(Invitrogen, www.thermofisher.com) or an M13 reverse primer. Plasmid DNA was 
sequenced in house at Gogerddan campus, Aberystwyth University, using Sanger 
sequencing. The remaining plasmid DNA was stored at -20ºC until required. 
Sequence data from Sanger sequencing were initially analysed in BioEdit (Hall, 
1999)  removing plasmid DNA overhangs.  The trimmed sequence was then 
analysed using a BLASTn against the National Center for Biotechnology 
Information (NCBI) database without limiting for any species using the default 
parameters. 
 Barcoding samples to enable multiplex analysis on MinION  4.3.13
In order to sequence multiple samples through the MinION (Oxford Nanopore 
Technologies, Oxford, UK), it was necessary to label each sample with a barcode. 
This would permit all of the samples to be sequenced simultaneously, with a separate 
output from the basecalling for each sample that could be used to determine the 
species present.  
A spreadsheet of barcodes was obtained from Dr Arwyn Edwards, Aberystwyth 
University. Each barcode comprised a leader sequence of 15 bases, which was 
conserved across all the barcodes, a unique 24 base barcode, and then the primer 
sequence itself. The barcodes would be used to provide a unique forward primer 
sequence for each sample, with the same reverse primer sequence used for all the 
samples. This would yield amplicons from each sample with a barcode “tag” 
enabling the samples to be discerned from each other when base-called using the 
MinION (https://nanoporetech.com/). Barcode sequences can be seen in Section 7.5 
in the Appendix. 




4.3.13.1 Barcode primer testing 
Initially, three barcoded forward primers were purchased (www.sigmaaldrich.com), 
in order to determine whether it would be possible to produce the barcoded PCR 
products directly from the faecal DNA samples, or whether it would be necessary to 
perform a nested PCR with the second PCR cycle using barcoded primers. After the 
initial PCR confirmation, a further 26 barcodes were purchased giving a unique 
primer for each faecal DNA sample. 
The ‘Avramenko’ primers were used for this section of work, because they had been 
successful in amplifying the ITS-2 region of the rDNA gene which would be 
sufficient to determine which species were present in the samples (Section 4.3.9). 
Two sets of PCR were performed simultaneously, using the protocol and PCR 
conditions from 4.3.9 albeit with only 35 cycles. The first set in each case used DNA 
from the faecal samples as the templates, and the second set used ITS-2 amplicons as 
the templates. Two negative controls were used for these experiments, one which 
had no template, and one which had a DNA template from a sample (Vinur) with a 
zero FEC. 
4.3.13.2 First nested PCR 
Having determined that the barcodes were best used as the second stage of a nested 
PCR, a template had to be produced from each sample, containing the ITS-2 
amplicon. The protocol and PCR conditions from section 7.4 of the Appendix were 
used, with 35 cycles. 
Repeat PCR was performed on those samples that did not show strong bands in the 
first attempt (5, 10, 13, 15, 16, 25 and 26) followed by a second repeat if required.  





4.3.13.3 Second nested PCR: adding barcodes  
In order to produce sufficient of the barcoded amplicons for MinION sequencing, 
three PCR runs for each sample were performed, using the individual barcoded 
primers as detailed in Section 7.5 of the Appendix. PCR conditions were as before, 
with repeat PCR runs as required. 
 
 MinION sequencing  4.3.14
Following faecal DNA sample barcoding, all samples were prepared for sequencing 
using the Oxford Nanopore Technologies Ltd MinION device; a small bench-top 
DNA sequencer (Figure 4-3). 
 
Figure 4-3 Oxford Nanopore Technologies MinION sequencer, which provides benchtop sequencing 
in the laboratory of multiple samples simultaneously. The device is requires a connection to a PC and 
will be utilised for helminth sequencing for the first time. 
 




Barcoded DNA samples were cleaned and purified followed by the addition of 
adapters  to feed the strands of DNA through the pores in the MinION 
(https://nanoporetech.com/) to allow sequencing to be performed. 
4.3.14.1 MinION sample preparation: clean-up  
All the barcoded PCR products to be sequenced were defrosted at room temperature, 
and mixed together. A QiAgen gel clean-up kit (www.QiAgen.com ) was used 
according to the manufacturer’s instructions using 1.5 volumes of buffer QG 
(yellow) and omitting the isopropanol and initial incubation step. 
Eluted DNA was measured on a Qubit (www.ThermoFisher.com ) to ensure that 
each tube contained a DNA concentration of over 600 ng/µl. One of the three 
replicate samples was frozen at -20ºC as a back-up. The remaining two tubes were 
pooled for further clean-up.  
4.3.14.2 MinION sample preparation: bead clean-up  
A further clean-up step was performed using magnetic beads 
(https://www.beckmancoulter.com/). Two hundred µl of magnetic beads were added 
to the sample (this relatively large quantity of beads was used because the amplicons 
were short) and mixed by pipetting up and down. The tube was incubated at room 
temperature for eight minutes, agitating it from time to time to keep the contents 
mixed and then placed into a magnetic rack (Magnetic Separatron 
http://samandtomindustrys.science ) so that the beads which had the DNA adhered to 
them, moved to the side of the tube against the magnet. The supernatant was 
removed using a pipette, and the beads washed with 80% ethanol. The tube was 
rotated on the rack so that the beads detached from the side of the tube, and then 
were re-attracted to the magnet. This step was repeated twice more, to give the DNA 




coated beads a good wash. The ethanol was removed by pipetting, then the sample 
was briefly centrifuged and returned to the rack where any remaining ethanol was 
again removed. Thirty µl of 9 mM Tris pH 8 with 50 mM NaCl was added, and 
pipetted up and down to mix and incubated at room temperature for ten minutes. An 
aliquot of 1 µl was removed and checked on the Qubit Fluorometer to ensure that the 
DNA concentration had not reduced. 
4.3.14.3 MinION sample preparation: Library preparation  
The adapters which would feed the DNA strands through the nanopore in the 
MinION sequencing device were added using a LSK-108 library preparation kit 
(Oxford Nanopore Technologies Ltd) as per the manufacturer’s instructions. 
4.3.14.4 Preparation and loading of the MinION  
Two labelled Lo-bind Eppendorfs were used for the library and for the MinION 
priming mixture. The priming mix contained 576 µl RBF (from the LSK-108 kit) 
well mixed before drawing off and 624 µl Nuclease-free water, and the library 
contained 35 µl RBF (again well mixed), 2.5 µl Nuclease-free water, 14 µl of the 
DNA preparation from step 4.3.14.3, making sure no beads were included and 25.5 
µl of library loading beads (Oxford Nanopore Technologies Ltd). 
The quality of the library was finally checked using Qubit and provided a reading of 
22 ng/µl with a total volume of 75 µl giving 1.65 µg of DNA. A Flow Cell check 
was performed using the MinKNOW software (The MinION device software) which 
revealed 1,188 single pores functioning (469, 380, 253 and 8 in the four groups 
respectively). Each group contains 512 pores, and the Flow Cell check process 
examines each pore for blockages which would impede sequencing.  




The flow cell was primed by loading 200 µl of the priming mix into the priming port 
(Figure 4-4) and leaving for ten minutes allowing the flow cell to prime. The DNA 
library was then loaded onto the flow cell by pipetting the entire 1.65 µg of library 
into the spot-on port (Figure 4-4). The loaded MinION was connected to a laptop 
and left overnight to sequence, controlled by MinKNOW software 
(https://nanoporetech.com/). 
 
Figure 4-4 Oxford Nanoporetech MinION sequencer inside view, showing priming port and spot-on 
port used for loading DNA library samples; in this case nematode ITS-2 amplified products from 
equine DNA faecal extractions.  
 
 Data analysis  4.3.15
Having produced raw data reads from the MinION sequencing process, conversion 
into a list of the helminth species present in each sample, along with the proportions 
of each species DNA that was present in each sample, was required. 




4.3.15.1 Data analysis: conversion of MinION output to DNA sequences  
The raw output from the MinION produced FAST5 files. These data were run 
through the software program Albacore (Oxford Nanopore Technologies Ltd) which 
would provide a base-call; taking the electrical output from the MinION and 
converting it to and A, C, G or T, providing Albacore output files in FASTQ format. 
Albacore was set with a quality score cut off at greater than 7, separating reads into 
pass / fails. 
The passing base-called reads from the were then analysed through PoreChop 
(https://github.com/rrwick/Porechop) which identifies and removes each barcode, 
and bins each FASTQ file into separate folders specific for each barcode. The 
min_split_read_size was set at 400, splitting reads with a central barcode and 
discarding fragments of less than 400 bp. 
Following PoreChop analysis, data were analysed with CutAdapt 
(https://cutadapt.readthedocs.io/en/stable/) (Martin, 2011) which enables the primers 
to be removed and reads to be filtered through a quality control process. CutAdapt 
results in the data converted to FASTA format which was then analysed via 
BLASTn against the NCBI database to identify from which species each sequence 
was derived. In total, ten different parameter runs were assessed on CutAdapt. 
1. Remove forward and reverse primers (if found) and trim to 250 bases. 
2. Remove forward and reverse primers (if found) and discard if length < 100 
bases. 
3. As run 2 but discard if both primers not found. 
4. As run 3 but discard if the quality scores is < 15. 




5. Remove forward and reverse primers (if found) and discard if length < 220 
bases. 
6. Remove forward and reverse primers (if found) and discard if length < 500 
bases. (To quality control the data set to see if every sequence was 
discarded). 
7. Remove forward and reverse primers (if found), trim sequence to 250 bases 
and discard if < 220 bases. 
8. Remove forward and reverse primers (if found), trim sequence to 400 bases 
and discard if < 220 bases. (Given the predicted amplicon was predicted to be 
approximately 400 bp long). 
9. As run 8 but discard if < 350 bases. 
10. Remove forward and reverse primers (if found) and discard if > 500 or < 350 
bases. 
NB In runs where trimming occurred, bases were trimmed equally from the 5’ 
and the 3’ ends, to remove low quality parts of the read. 
4.3.15.2 Data analysis: BLASTn searches to identify species  
Outputs from CutAdapt were compared against the NCBI database 
(https://www.ncbi.nlm.nih.gov/) using a BLASTn analysis. Initially, an output was 
produced that reported the top sequence identity, but it became apparent that this 
often produced good matches but over only a short sequence length, which 
consequently had a high e-value (a high potential for the match to be coincidental). 
Owing to this, it was decided to report only sequences with a certain percentage 
identical match, and three sensitivities were chosen – 97%, 95% and 90%. From 
these results, any with an alignment length of less than 35 bases (10% of the 




sequence length as per Avramenko et al. (2015)) were discarded, as were any with e-
values which were greater than 0.001. The remaining sequences were sorted and 
summarised by species. 
Using the 90% sensitivity, it became apparent that most of the expected matches (i.e. 
cyathostomin species) had good long alignment lengths of 300 – 350 bases. 
Therefore, discarding alignment lengths under 100 bases to further increase accuracy 
was trialled on two barcode runs (barcode 3 and barcode 8). 
4.3.15.3 Data analysis: sequence proportion comparison  
The species identified from each sample were quantified, and the proportions of each 
calculated. Given that the total number of sequences produced in each sample was 
more a factor of the success of the DNA extraction all calculations were performed 
on relative proportions of each nematode species. In total, six principal species were 
identified along with those species which constituted less than 5% of the total 
sequences in any sample which were collected together and termed “Minor species” 
for the rest of the data analysis.  
4.3.15.4 Data analysis: effect of treatment on each principal species 
A fourth root transformation and Bray Curtis similarity analysis was performed on 
the sequence proportions, and visualised using an MDS plot. Scatter plots were 
produced for each species, plotting post-treatment sequence proportions from each 
horse against pre-treatment sequence proportion. Trend lines were added, to go 
through the origin, illustrating the percentage increase or decrease following 
treatment, and R
2
 values added to indicate how strongly this relationship was 
explained by the data. P values were produced using the “Regression” feature of the 




data analysis plug-in for Microsoft Excel, to demonstrate whether any relationship 
between pre- and post-treatment sequence proportion of a species was significant. 
The analysis was repeated plotting change in sequence proportion against 
anthelmintic treatment efficacy (the proportion that the FEC reduced in each sample 
two weeks after treatment). P values were produced in the same manner. These 
calculations were repeated twice, once using the actual change in sequence 
proportion, and once using the percentage change in sequence proportion. This was 
done in order to take into account the differing levels of each species – for example, 
a change in sequence proportion from 5% to 10% would be more relevant than a 
change from 60% to 65% even though the actual change would still be 5. This 
avoided over-stating the importance of those species that were not highly 
represented. 
Initially, it had been hoped that a comparison could be made between the species 
found at the three different locations. However, due to the low levels of parasitic 
infections identified, there were insufficient samples tested at two of the locations for 
the results to be meaningful. Contingency tables were produced to investigate 
whether the pre- or post-treatment samples were significantly different from each 
other in the three locations, and also whether they were significantly different from 
each other across all the samples. The principal species were used as the row 
variables, with the pre- or post-treatment sequence proportions as column variables. 
Pie charts were also produced to demonstrate the proportions of sequences found in 
each of the locations. 
To assess if there was a relationship between FEC and the diversity of species 
identified within each sample, the Shannon index of species diversity was calculated 




using the actual number of sequences observed in each sample. Actual sequence 
numbers were used in this instance in order not to filter out those species where the 
sequences made up less than 1% of the total. When comparing Shannon indices, the 
size of the population is not relevant, so in this case sequence numbers rather than 
proportions could be used with no detriment. The Shannon index for each sample 
was calculated using the formula: 




Where, in the equation above, 𝑝i is the proportion of sequences in the ith species. P 
values were calculated using the Regression function of the data analysis plug-in for 
Microsoft Excel, to demonstrate if there was a significant correlation between FEC 
and Shannon index for either pre- or post-anthelmintic treatment samples, or 
between the Shannon index of the pre- and the post-treatment samples.  





 Resistance testing  4.4.1
In order to assess anthelmintic effects on the equine nemabiome it was important to 
determine if there was any nematode resistance present to the anthelmintic 
compounds tested and therefore faecal samples containing nematode eggs from 
resistant populations (from the post-treatment samples) and mixed populations (from 
the pre-treatment samples) were collected for genetic sequencing.  
Overall, the mean reduction in strongyle nematode FEC fourteen days after treatment 
with Ivermectin was 100% ± 1%. Infection levels of those horses that were treated 
ranged from 221 epg to 1987 epg (Mean overall of treated horses 587 epg, yard one 
mean 607 epg, and yard two mean 560 epg). When analysed via location, thirteen of 
the samples on yard 1 had pre-treatment FECs of below 200 epg, and therefore were 
not treated. Two of the horses from the study were moved before post-treatment 
samples could be collected. The mean reduction post-treatment of the remaining ten 
horses was 100%. It was interesting to note the presence of Parascaris equorum 
nematode eggs in one of the post-treatment samples. In yard two, sixteen of the 
samples had pre-treatment FECs of below 200 epg, and of the nine treated horses, 
the mean reduction in FEC was 99%.  
When treating with Fenbendazole, across all yards, fifty two of the equine faecal 
samples tested had pre-treatment FECs of less than 200 epg, and thus were excluded 
from further testing, due to being under the selected treatment threshold (Coles, 
2009) . Of the fifteen horses that were treated, no samples provided evidence that 
Fenbendazole was effective at removing the worm burden. Post-treatment FEC 




reductions ranged from 0% to 74% with a mean reduction of 38% ± 23% (Figure 
4-5). Of interest, was the identification of one horse sample (Jigsaw) that had a pre-
treatment P. equorum FEC of 327 epg that was reduced to zero post-treatment. 
 
Figure 4-5 Reduction in equine strongyle nematode FEC 14 days post treatment with Fenbendazole. 
Blue bars are pre-treatment FECs and red bars represent post-treatment FECs. The numbers given 
above each bar provide the actual epg for ease of comparison. 
 
All pre- and post-treatment samples were retained for future DNA nemabiome 
analysis. 




 Molecular genetics  4.4.2
Genetic sequencing of DNA extracted and amplified from equine faecal samples, 
collected both pre- and post-treatment, was attempted to determine the nematode 
species composition constituting the equine nemabiome.  
 Primer selection: rDNA  4.4.3
In order to determine which species were present, a portion of the ribosomal gene 
would be amplified using PCR. This gene is highly conserved among nematodes, 
and as the MinION is a powerful sequencer, amplification of the largest possible 
segment of this gene was hoped for. 
Primers selected from the literature for rDNA sequencing are provided in Table 4-3. 




Table 4-3 Small sub-unit rDNA primers selected from the literature for nemabiome amplification assessment. 




















ITS1 5.8s ITS2 
155bp plus ITS1 
and 2 total 425bp 
Wide range of 
nematodes 
57º 




5′ TAATGAGCCGTTCGCAGT 3’ 18s 99bp Various, 









5’-GGGCGGTATCTGATCGCC-3’ Fragment of 18s 









Mitchell et al. 
(2019) and 
Andersen et al. 
(2013) 






it on horses) 
55º 




 DNA Extraction: QiAgen kit  4.4.4
The first priority in the DNA extraction process was to assess extraction methods, 
and the first method tested was a commercial kit. 
Using the QiAmp DNA stool kit, but with the addition of a bead disruption step, the 
final amount of DNA produced from a representative test sample was measured on a 
NanoDrop spectrophotometer (https://www.thermofisher.com/uk/en/home.html), 
was 7.8 ng/µl with 260/280  and 260/230 ratios of 1.74 and 0.71 respectively. The 
DNA was examined on a 1% Agarose gel run at 100 V, to confirm quality (Figure 
4-6 a) and demonstrated high molecular weight DNA. 
Using the QiAmp DNA stool kit as per manufacturer’s instructions, with no bead 
disruption step, the final amount of DNA produced from the test sample when 
analysed on a NanoDrop spectrophotometer was 31.0 ng/µl with 260/280 and 
260/230 ratios of 1.71 and 1.52 respectively. The DNA was visualised on a 1% 
Agarose gel run at 100 V, to confirm quality (Figure 4-6b). It can be seen that this 
DNA produced more of a band at the top than that produced with the bead disruption 
step (Figure 4-6a), showing a greater proportion of high molecular weight DNA. 
 
 





Figure 4-6 Equine faecal DNA extraction using QiAgen kit analysed on a 1% agarose gel. a) With 
bead disruption step. Lane 1shows 1kb ladder (Bioline) DNA can be observed at the top of lanes 2 
and 3. b) Without bead disruption step. Lane 1shows 1kb ladder (Bioline) DNA can be observed at 
the top of lanes 2, 3 and 4. 
 
4.4.4.1 DNA Extraction: QiAgen kit freeze drying  
In order to discover whether a greater amount of starting material could be used for 
the DNA extraction, it was decided to try freeze drying some samples. Klettur pre-
treatment sample was chosen for this experiment which had a FEC of 478 epg. The 
quantity of DNA extracted is presented in Table 4-4 below, which shows that using 
freeze dried faecal material and along with a bead disruption step produced a greater 
amount of DNA which was of greater quality than the other methods. 
 
 




Table 4-4 Quantity of DNA extracted from freeze-dried and frozen equine faecal samples as measured 
on a NanoDrop spectrophotometer, extracted with the QiAgen QiAmp stool kit either with or without 
a bead disruption step. Both 260/280 and 260/230 ratios are given as an indicator of DNA purity. 
Method 
 
DNA ng/µl 260/280 260/230 
1. Frozen 6.9 1.21 0.80 
2. Freeze 
dried 
5.7 1.41 0.85 
3. Frozen with 
beads 




10.1 1.76 0.68 
 
Two replicates of DNA extraction were performed using the QiAgen stool kit and a 
bead-beating step using a Tissue Lyser (QiAgen, Hilden, Germany). This yielded 
DNA of 5.8 ng/µ (260/280 ratio 1.58 and 260/230 ratio 0.57) and 11.9 ng/µ (260/280 
ratio 1.83 and 260/230 ratio 0.73) when measured on the NanoDrop. 
A summary of the NanoDrop readings from all the DNA samples which were 
extracted using the QiAmp DNA Stool kit with additional modifications is provided 
in Table 4-5. Only one of the DNA extraction samples, the first extraction on Gertie 
pre, gave a reasonable quantity and quality of DNA using this extraction method. 
  




Table 4-5 Summary of quantities of DNA extracted from faecal samples using QiAgen QiAmp DNA 
Stool kit and with modified protocols. All DNA quantities and ratios were measured on a NanoDrop 
spectrophotometer. 
Sample and protocol ng/ul 260/280 260/230 
Without beads    
Major pre 7.8 1.74 0.71 
Gertie pre 31.0 1.71 1.52 
Klettur pre  6.9 1.21 0.80 
Widget pre 7.9 1.41 0.38 
Widget post 3.9 2.10 0.50 
Klettur pre 4.0 1.49 0.30 
Klettur post 4.6 1.62 0.31 
Seren pre 2.7 1.28 -0.55 
Seren post 4.0 1.35 -3.18 
Major pre 2.8 1.30 -0.94 
Major post 3.5 1.51 5.09 
Gertie pre 8.1 1.50 0.69 
Gertie post 7.6 2.57 0.46 
Akela pre 12.0 2.03 0.62 
Akela post 4.3 1.97 0.80 
Freeze dried without beads    
Klettur pre  5.7 1.41 0.85 
With beads    
Klettur pre  5.9 1.70 0.33 
Freeze dried with beads    
Klettur pre  10.1 1.76 0.68 
Tissue Lyser    
Topaz pre  5.8 1.58 0.57 
Topaz post  11.9 1.83 0.73 
 
 DNA Extraction: CTAB method 4.4.5
Given the low quantity of extracted DNA using the commercial QiAgen extraction 
kit, an alternative method was assessed. The chosen method followed was that used 
by Mitchell et al. (2019)  which had been adapted from Yu and Morrison (2004), 
Dellaporta et al. (1983) and William et al. (2012). 




4.4.5.1 DNA Extraction: CTAB method, comparison between freeze-dried and frozen 
sample  
In order to assess the use of freeze dried and fresh frozen faeces a single replicate of 
a CTAB DNA extraction was performed on an equal volume of a freeze-dried and a 
frozen aliquot of the same faecal sample. The freeze-dried sample yielded 481 ng/µl 
DNA (260/280 ratio of 1.44 and 260/230 ratio of 1.20) whereas the frozen sample 
yielded almost 6-fold more concentrated DNA at 2,802 ng/µl (260/280 ratio of 1.86 
and 260/230 ratio of 1.62) when measured on a NanoDrop spectrophotometer.  
Given the greater quantity of DNA extracted via the CTAB method, DNA was then 
extracted from all samples using an aliquot of approximately 200 mg from each of 
the frozen faecal samples. The DNA was quantified using the NanoDrop as before, 
providing DNA levels of greater than 315.2 ng/ µl (Table 4-6). 
  




Table 4-6 Summary of quantity of DNA extracted from equine faecal samples using CTAB method, 
measured on a NanoDrop spectrophotometer and Qubit Fluorometer. Mean NanoDrop 1052 ng/µl 





260/280 260/230 Qubit 
ng/µl 
Widget pre 1211.8 2.05 2.18 176 
Widget post 2802.0 1.86 1.62 195 
Klettur pre 970.8 1.90 1.61 125 
Klettur post 647.9 1.82 1.38 76.2 
Seren pre 394.6 1.97 2.01 70.8 
Seren post 945.1 1.94 1.69 113 
Jigsaw pre 629.3 1.91 1.55 89 
Jigsaw post 921.3 2.04 2.13 112 
Major pre 315.2 1.91 1.70 32 
Major post 447.5 1.90 1.77 69.2 
Gertie pre 540.4 1.87 1.75 102 
Gertie post 814.1 1.97 1.73 102 
Hope pre 1106.1 1.80 1.39 106 
Hope post 1549.4 1.89 1.63 150 
Billee pre 1662.6 2.02 2.07 152 
Billee post 484.7 1.83 1.59 54.4 
Duke pre 2303.6 2.00 2.08 290 
Duke post 1692.9 2.04 1.99 154 
Sox pre 1141.9 1.98 1.84 110 
Sox post 1723.2 1.83 1.56 216 
Topaz pre 590.1 1.90 1.84 47.2 
Topaz post 537.9 1.95 1.95 65.6 
Mary pre 1070.8 1.93 1.67 118 
Mary post 1185.9 2.07 2.37 121 
Yoyo pre 906.7 1.69 1.14 36.4 
Yoyo post 754.1 1.78 1.27 67.8 
 




DNA was manually inspected using gel electrophoresis on a 1% Agarose gel run at 
100 V, to visualise the extracted DNA. (Figure 4-7), showing good quality DNA. 
 
 
Figure 4-7 Assessing the quality of DNA extracted from equine faecal samples using the CTAB 
method. 1: Widget pre, 2:. Widget post, 3: Klettur pre, 4: Klettur post, 5:. Seren pre, 6:. Seren post, 7: 
Jigsaw pre, 8: Jigsaw post, 9: Major pre, 10: Major post, 11: Gertie pre, 12: Gertie post, 13: Hope pre, 
14: Hope post, 15: Billee pre, 16: Billee post, 17: Duke pre, 18: Duke post, 19: Sox pre, 20: Sox post, 
21: Topaz pre, 22: Topaz post, 23: Mary pre, 24: Mary post, 25: Yoyo pre, 26: Yoyo post. Pre denotes 
before anthelmintic treatment and post signifies samples 14 days after anthelmintic treatment. Ladder 
(1 kb Hyperladder, Bioline) on the left hand lanes. Stars indicate DNA bands, brackets indicate RNA. 
 
It can be observed that both DNA (indicated by stars) and RNA (indicated by 
brackets) are present in DNA extraction samples (Figure 4-7). No RNAse treatment 
was used, as RNA would not interfere with the DNA sequencing. Given the 




NanoDrop spectrophotometer quantification measures both DNA and RNA, all DNA 
extractions were also quantified using a Qubit 2.0 Fluorometer 
(www.thermofisher.com) which quantifies only DNA (Figure 4-6). 
As expected, the Qubit readings for the DNA concentrations were lower than those 
obtained from the NanoDrop spectrophotometer which also included RNA.  
 
 DNA Extraction from FECPAKG2 Cassette preparations 4.4.6
In order to link nematode FECs, via the FECPAK
G2
 to molecular species 
determination, this section of work aimed to determine if the samples prepared for 
imaging using the cassette and Micro-I could be used for downstream DNA analysis. 
This would potentially enable an efficient workflow to detect and quantify a parasitic 
infection, and then also determine the species present.  
4.4.6.1 DNA extraction from FECPAKG2 Cassette preparations  
Firstly, the QiAgen QiAmp stool kit was used to extract DNA from the FECPAK
G2
 
cassette preparations. Initial NanoDrop results from the first attempt was based upon 
a sample that was centrifuged and washed prior to the extraction and provided 
extremely low DNA levels of 0.8 ng/µl (260/280 ratio of 1.81 and 260/230 ratio of -
0.43) likely indicating that the DNA extraction may not have been successful. Given 
the DNeasy protocol suggests washing the sample in phosphate buffered saline it 
seemed likely that saline would not inhibit the extraction. Therefore, DNA extraction 
was repeated without washing the eggs from the saline to avoid potential egg loss 
during these wash steps. 




Following extraction of the FECPAK
G2 
cassette prepared sample which was not 
washed a concentration of DNA at 2 ng/µl (260/280 ratio of 6.34 and 260/230 of 
0.32) was achieved.   As these two samples had been stored at -20ºC it was decided 
to repeat the extraction using a fresh faecal sample prepared using the FECPAK
G2
 
method, and this sample was also prepared using water instead of saline, to 
determine if the saline was interfering with the DNA extraction process. A 
centrifugation step was also added to the final replicate. 
NanoDrop results from the samples prepared from a fresh faecal preparation were as 
follows: 
Sample 1 (saline) 3.5 ng/µl 260/280 1.26 260/230 0.57 
Sample 2 (water) 2.3 ng/µl 260/280 1.01 260/230 0.86 
Sample 3 (centrifuged) 4.2 ng/µl 260/280 1.26 260/230 0.58 
The DNA extraction was also attempted from the FECPAK
G2
 cassette preparations 
using the CTAB method. Despite the previous success of the CTAB method the 
NanoDrop results for the on the FECPAK
G2
 Cassette samples was again significantly 
low.  Of the two replicates assessed, only one gave a positive DNA concentration at 
0.3 ng/µl (Klettur: 260/280 ratio of 0.39 and 260/230 ratio of 0.14).  The second 
replicate produced a concentration at -0.4 ng/µl (Widget: 260/280 ratio of 0.92 and 
260/230 ratio of -0.29).  
 PCR optimisation: rDNA  4.4.7
Following successful DNA extraction either from the Qiagen kit or the CTAB 
method, PCR primers and PCR conditions were assessed for amplifying a segment 




of the small sub-unit ribosomal gene, to enable the species of helminths contained in 
the samples to be determined. 
4.4.7.1 PCR optimisation: rDNA initial selection  
Initially, the primers were tested on a B. glabrata DNA sample as a potential 
positive control in addition to DNA extracted from an equine faecal sample which 
had yielded the greatest concentration of DNA when extracted using the QiAgen kit.  
 
Following PCR amplification, all products were analysed on a 1% w/v Agarose gel 
(Figure 4-8a). Of significant interest was a weak product that was observed using the 
‘Peachey’ primers and the equine DNA extraction, although this was larger than the 
anticipated 99 bp size at approximately 200 bp. In addition, strong banding at the 
expected size for both the ‘Marek’ and ‘Floyd’ primer sets were also observed, but 
only to the positive control (Figure 4-8b). 
  





Figure 4-8 PCR primer optimisation for equine faecal analysis a) PCR products from initial rDNA 
primer comparison, with the contrast adjusted to visualise weak bands and b) with the original 
contrast settings. (Lanes: 0: 1 kb ladder, 1: Marek control, 2: Marek sample, 3: Powers control, 4: 
Powers sample, 5: Peachey control, 6: Peachey sample, 7: Floyd control, 8: Floyd sample, 9: 
Avramenko control, 10: Avramenko sample, 11: Negative control)  




A second replicate was also performed using the DNA extracted from a different 
equine faecal sample with 11.4 ng/µl. Only the ‘Floyd’, ‘Marek’ and ‘Peachey’ 
primers were assessed in this replicate given they had produced PCR products on the 
previous attempt. 
As before PCR products were imaged using gel electrophoresis. However, no 
products were visible other than for the positive control for which a band of 
approximately 1,000 bp was observed (Figure 4-9a & Figure 4-9b). 





Figure 4-9a) PCR primer optimisation for equine faecal analysis a) PCR products from second rDNA 
primer comparison, with the contrast adjusted to visualise weak bands and b) with the original 
contrast settings. (Lanes: 0: 1 kb ladder, 1: Floyd control, 2: Floyd sample, 3: Floyd negative control, 
4: Marek sample, 5: Marek negative control, 6: Peachey sample, 7: Peachey negative control). 
  




4.4.7.2 PCR optimisation: rDNA using helminth DNA 
Given the success of certain primers amplifying snail DNA, they were optimised for 
nematodes using Ascarid DNA. As previously the ‘Floyd’, ‘Marek’ and ‘Peachey’ 
primers were assessed. Following PCR product analysis on a 1% Agarose gel, only a 
product was amplified for the snail DNA control at approximately 1,000 bp, and not 
for the Ascarid DNA with any primer set (Figure 4-10). 
  





Figure 4-10 PCR primer optimisation for equine faecal analysis using Ascarid DNA. (Lanes: 0: 1 kb 
ladder, 1: Floyd control, 2: Floyd Ascarid, 3: Floyd negative control, 4: Marek Ascarid negative 
control, 5: Marek negative control, 6: Peachey Ascarid, 7: Peachey negative control). 
 
As the quality of the Ascarid DNA was unknown, a sample of DNA from somules of 
the parasitic flatworm Schistosoma mansoni was used to test the primers to see if a 
product could be obtained from alternative helminth DNA. 
The PCR products were imaged on a 1% w/v Agarose gel run at 100 V with the 
‘Marek’ and ‘Floyd’ primer sets providing strong products with the schistosomule 
DNA. However, the ‘Marek’ product was smaller than when amplified on snail DNA 
(Figure 4-11). There were also additional products observed following amplification 




with the ‘Peachey’ primer set, although these were all larger than the 99 bp expected 
product size and only weak bands. 
 
Figure 4-11 PCR products assessing rDNA primers used with schistosomule and Ascaris DNA 
(Lanes: 0: 1 kb Hyperladder, 1: Floyd control, 2: Floyd schistosomule, 3: Floyd Ascaris, 4: Floyd 
negative control, 5: Marek schistosomule, 6: Marek Ascaris, 7: Marek negative control, 8: Peachey 
schistosomule, 9: Peachey Ascaris, 10: Peachey negative control). 
 
With no amplification observed for the Ascarid DNA, fresh DNA was extracted 
from a female Ascarid worm and used for all further experiments. As there was a 
doubt on the quality of the worm itself, a commercially produced chemically 
preserved sample, DNA was also extracted from Panagrellus redivivus, a free-living 
nematode, as a further attempt to see if a nematode control could be acquired. 
All three primer sets produced bands with both the Schistosomule DNA and the P. 
redivivus DNA but once again the Ascarid DNA failed to produce a band with any of 
the primer sets tested (Figure 4-12). The ‘Floyd’ primers produced the strongest 




products with the nematode, P. redivivus DNA and thus chosen as the primers to use 
for further work. 
 
Figure 4-12 PCR products assessing rDNA primers used with schistosomule and Ascaris and P. 
redivivus DNA (Lanes: 0: 1 kb Hyperladder, 1: Floyd schistosomule, 2: Floyd negative control, 3: 
Floyd P. redivivus 4: Floyd Ascarid, 5: Marek schistosomule, 6: Marek negative control, 7: Marek 
Panagrellus, 8: Marek Ascarid, 9: Powers schistosomule, 10: Powers negative control, 11: Powers P. 
redivivus, 12: Powers Ascarid) 
 
 PCR of DNA extracted using QiAgen kit  4.4.8
Following selection of suitable PCR primers the aim of this work was to amplify a 
region of parasite DNA from the DNA extractions on faecal samples, using the 
extraction conditions and the primer set that were considered to perform the best. 
The ‘Floyd’ primers had been selected as the most promising ones to use, and 12 
faecal samples were processed using the optimal method of extraction using the 
QiAgen kit (frozen samples, without a bead disruption step), then the samples were 
tested using PCR. 




The PCR products were imaged using gel electrophoresis (Figure 4-13) and 
demonstrated a variety of amplified products all of which were of different bp sizes 
when compared to the positive control DNA.  
 
Figure 4-13 PCR products assessed using ‘Floyd’rDNA primers and DNA extracted using QiAgen kit 
(Lanes: 0: 1 kb Hyperladder 1: Positive control (P. redivivus), 2: Negative control, 3: Widget pre, 4: 
Widget post, 5: Klettur pre, 6: Klettur post, 7: Seren pre, 8: Seren post, 9: Major pre, 10: Major post, 
11: Gertie pre, 12: Gertie post, 13: Akela pre, 14: Akela post). Product of expected size produced 
from positive control, highlighted by red arrow. 
 
 PCR of DNA extracted using CTAB method   4.4.9
Following the limited success of PCR amplification with the ‘Floyd’ primer set on 
DNA extracted with the QiAgen kit, amplification was assessed using the CTAB 
extracted samples. In total, ten faecal samples were processed using the CTAB 
method of extraction and analysed using PCR. The amplification was unsuccessful, 
as was a second replicate with the template DNA reduced to 20 ng (data not shown). 




As the ‘Floyd’ primer set had been unsuccessful at amplifying the DNA extracted 
from the faecal samples, it was decided to try one of the other primer sets. Using 20 
ng of template DNA in each reaction and using the ‘Avramenko’ primer set that had 
successfully been used to speciate cyathostomins in Mitchell et al. (2019) a good 
PCR product was observed for every sample of DNA extracted from a faecal sample 
using the CTAB method (Figure 4-14). The products produced for the samples were 
at approximately 400 bp, whereas for the control it is 200 bp. The expected size of 
the product when amplifying cyathostomin DNA was 400 bp, as seen in Mitchell et 
al.(2019). It was interesting to note that two bands were observed in samples 7 and 8 
(Major pre and Major post). 
 
Figure 4-14 PCR products assessed using ‘Avramenko’ITS-2 primers and DNA extracted using 
CTAB (Lanes: 0: 1 kb Hyperladder 1: Positive control, 2: Negative control, 3: Widget pre, 4: Widget 
post, 5: Klettur pre, 6: Klettur post, 7: Major pre, 8: Major post, 9: Gertie pre, 10: Gertie post, 11: 
Seren pre, 12: Seren post).   
 




 Cloning and sequencing to confirm nematode DNA  4.4.10
The aim of this work was to check that the PCR was correctly amplifying nematode 
DNA, prior to preparing and sequencing it using the MinION. This was achieved by 
inserting the PCR amplicons into a vector and cloning using E. coli.  
4.4.10.1 Cloning and sequencing: High Fidelity PCR  
PCR was repeated using the optimised rDNA PCR conditions but using a high 
fidelity polymerase; MyFi 2 × mix polymerase (Bioline.com) to provide amplicons 
that could be inserted into a sequencing vector. PCR products were imaged using gel 
electrophoresis on a 1% w/v Agarose gel run at 100 V (Figure 4-15). A sample of 
DNA from another nematode was available, Baylisascaris schroederi and so this 
was included as a second positive control in addition to a second negative control of 
DNA from an equine faecal sample with a zero FEC. 
 





Figure 4-15 PCR products assessed using ‘Avramenko’ITS-2 primers and high fidelity polymerase 
(Lanes: 0: 1 kb Hyperladder 1: Positive control (P. redivivus), 2: Positive control (B. schroederi), 3: 
Negative control, 4: Negative control Vinur zero FEC, 5: Widget pre, 6: Widget post, 7: Klettur pre, 
8: Klettur post, 9: Major pre, 10: Major post)  




The DNA samples extracted from Major (both pre and post; Figure 4-15 lanes 9 and 
10) again showed a double band. All DNA extracted from the equine faecal samples 
amplified a product. Neither of the positive controls amplified anything likely due to 
low template DNA added (1 µl to be consistent with the faecal sample DNA; 
previously 4 µl of control DNA had been used). 
Prior to vector insertion, selected amplicons were quantified using a NanoDrop 
spectrophotometer, with Widget pre giving 5.8 ng/µl (260/280 ratio of 1.87 and 
260/230 ratio of 0.93) and Major pre showing 4.2 ng/µl (260/280 ratio of 2.15 and 
260/230 ratio of 0.20).  
 
4.4.10.2 Cloning and sequencing: Colony PCR product confirmation  
PCR products from the overnight colonies transformed with PGEM Teasy 
containing the amplified PCR products were imaged using gel electrophoresis on a 
1% w/v Agarose gel run at 100 V, to check that bands of the expected size were 
produced (Figure 4-16). It can be observed that all the Widget colonies (Lanes 1-8) 
were products of the same bp size, and that some of the Major colonies (Lanes 9-16) 
had cloned up the larger and the smaller of the two products that had been in the 
original PCR product. 





Figure 4-16 PCR products assessed from colony PCR using ‘Avramenko’ ITS-2 primers. (Lanes: 0: 1 
kb Hyperladder, N: negative control, V: negative FEC control, P: positive control (P. redivivus), B: 
positive control (B. schroederi), 1-8: Widget samples, 9 – 16: Major samples) 
 
Following colony PCR confirmation selected plasmids representing each product 
size were purified and quantified using the NanoDrop (Table 4-7). In total, between 
200 and 250 ng of DNA was submitted for sequencing for each sample. 
 
 




Table 4-7 NanoDrop quantification of Plasmid purifications prior to Sanger sequencing. Both 260/280 
and 260/230 ratios are included for an indication of purity. 
Sample DNA ng / µl 260/280 260/230 
6 (Widget) 48.2 1.68 1.41 
11 (Major, small 
band) 
310.7 1.84 2.25 
12 Major, larger 
band) 
89.6 1.81 2.12 
 
4.4.10.3 Cloning and sequencing: colony growth and sequencing 
The results of the Sanger sequencing were BLASTed using BLASTn against the 
National Center for Biotechnology Information (NCBI) database. Both forward and 
reverse samples for sample 11 (Major smaller band) and 12 (Major larger band) 
successfully sequenced, with the sample 11 giving a 98% sequence identity to the 
cyathostomin Coronocyclus coronatus  and sample 12 giving a 100% sequence 
identity to another cyathostomin Cylicostephanus goldi. Unfortunately, sample 6 did 
not sequence successfully, with the forward sequence returning an error and the 
reverse sequence returning only a couple of bases. 
 Barcoding samples to enable multiplex analysis on MinION 4.4.11
In order to sequence multiple samples through the MinION (Oxford Nanopore 
Technologies, Oxford, UK), it was necessary to label each sample with a barcode. 
This would permit all of the samples to be sequenced simultaneously, with a separate 
output from the base calling for each sample that could be used to determine the 
species present in. Therefore, the aim of this work was to create a library of 
amplicons from each faecal sample, each labelled with a unique barcode. 




4.4.11.1 Barcoding samples: barcode primer testing 
Initially, three of the barcodes were tested, both directly with the DNA from faecal 
samples, and as a nested PCR on the PCR amplicons from these samples. Barcode 
one produced products from both DNA samples and PCR products (Figure 4-17a), 
whereas barcode 15 only produced products when used as nested PCR (Figure 
4-17b). Barcode 35 also produced good products from the PCR products, and faint 
bands from the DNA samples (Figure 4-17c). However, there was some 
contamination in the negative control for barcode 35. Nested PCR was therefore 
chosen as the optimal method. 





Figure 4-17 PCR products assessed using barcoded ITS-2 primers. (Lanes: L: 1 kb Hyperladder, P: 
Positive control (Schistosomule), N: Negative control, 0: Zero FEC negative control, 1 – 6: DNA 
from faecal samples used as template (Widget pre, Widget post, Klettur pre, Klettur post, Major pre, 
Major post), 7 – 12: PCR products used as template (Widget pre, Widget post, Yoyo pre, Yoyo post, 
Jigsaw pre, Jigsaw post)) a) Barcode 1, b) Barcode 15, c) Barcode 35 
 
 




4.4.11.2 Barcoding samples: first nest of PCR  
Amplicons of the ITS-2 rDNA region were produced from each DNA sample and 
run on a 1% w/v Agarose gel at 100 V (Figure 4-18) showing good bands for the 
majority of the faecal DNA samples. Five samples (13, 15, 16, 25 and 26) showed 
only faint products so a repeat PCR was performed on these samples (Figure 4-19). 
Samples 5 and 10 continued to be weaker than the other samples and so were also 
repeated. No band was observed for the positive control, possibly due to degradation 
of the template DNA. Given the PCR had worked for the other samples this was not 
considered important. No bands were observed for either the negative control or the 
zero FEC sample. 
  





Figure 4-18 PCR products assessed using ‘Avramenko’ ITS-2 primers on all CTAB extracted faecal 
DNA samples (Lanes: L: 1kb Hyperladder P: Positive control (P. redivivus); N: Negative control (no 
template); 0: Negative control (zero FEC template); 1: Widget pre; 2: Widget post; 3: Klettur pre; 4: 
Klettur post; 5: Major pre; 6: Major post; 7: Gertie pre; 8: Gertie post; 9: Seren pre; 10: Seren post; 
11:Jigsaw pre; 12: Jigsaw post; 13: Hope pre; 14: Hope post; 15: Billee pre; 16: Billee post; 17: Duke 
pre; 18: Duke post; 19: Sox pre; 20: Sox post; 21: Topaz pre; 22: Topaz post; 23: Mary pre; 24: Mary 
post; 25: Yoyo pre; 26: Yoyo post.) Samples producing double bands highlighted with arrows. 





Figure 4-19 PCR products assessed using ‘Avramenko’ ITS-2 primers on CTAB extracted faecal 
DNA samples which had previously produced poor results. (Lanes: L: 1 kb Hyperladder, P: Positive 
control (P. redivivus); N: Negative control (no template); 5: Major pre; 10: Seren post; 13: Hope pre; 
15: Billee pre; 16: Billee post; 25: Yoyo pre; 26: Yoyo post.) 
 
Samples 5 (Major pre) and 10 (Seren post) produced good bands and the PCR 
products were retained to provide the templates for the barcoding. Those PCR 
products which did not produce a band were discarded. As the positive control still 
did not make a band, it was decided to try S. mansoni DNA as the positive control 
for the next attempt, and to use a different well in the PCR machine. 
Figure 4-20 shows the third attempt at amplifying the final samples, with strong 
bands visible in samples 13 (Hope pre), 15 (Billee pre) and 26 (Yoyo post). Weak 
bands were visible in both versions of sample 16 (Billee post), suggesting that the 




initial DNA extraction was the cause of the problem, not the dilution thereof. Sample 
25 (Yoyo pre) still did not amplify well, and was discarded from future analysis. 
Samples 13a, 15a, 16a, 25a and 26a were all discarded due to possible contamination 
issues, having been included merely as a check to determine if there would be a 
difference in their performance. 
 
 
Figure 4-20 PCR products assessed using ‘Avramenko’ ITS-2 primers on CTAB extracted faecal 
DNA samples which had previously produced poor results, second repeat.  (Lanes: L: 1 kb 
Hyperladder, P: Positive control (S. mansoni); N: Negative control (no template); 13: Hope pre; 15: 
Billee pre; 16: Billee post; 25: Yoyo pre; 26: Yoyo post, 13a – 26a same samples from a different 
DNA dilution.) 
 
A final attempt a making the best possible template for the second nest of PCR to 
add the barcodes was performed for the poorest samples, and the products imaged 
using gel electrophoresis. The results were still fairly poor, and products were weak 
(Figure 4-21). Amplicons from 25a and 25b were pooled for the second nest. 





Figure 4-21 PCR products assessed using ‘Avramenko’ ITS-2 primers on CTAB extracted faecal 
DNA samples which had previously produced poor results, final repeat.  (Lanes: L: 1 kb Hyperladder, 
P: positive control, N: negative control, 25a and 25b: Yoyo pre, 25c: Yoyo pre using 2 µl template)  
 
4.4.11.3 Barcoding samples: second nest of PCR (adding barcodes)  
Three replicates of the second nest of PCR were produced for each barcode, in order 
to provide sufficient product for sequencing using the MinION. Barcoded amplicons 
of the ITS-2 rDNA region were produced from each DNA sample and run on three 
1% w/v Agarose gels at 100 V. Figure 4-22 is a representative example. 
 





Figure 4-22 PCR products assessed using barcoded ITS-2 primers on CTAB extracted faecal DNA 
samples (Lanes: L: 1 kb Hyperladder, P: positive control, N: negative control, 1a, 1b, 1c: Widget pre, 
2a, 2b, 2c: Widget post, 3a, 3b, 3c: Klettur pre, 4a, 4b, 4c: Klettur post, 5a, 5b, 5c: Major pre, 6a, 6b, 




The second nest of PCR to add the barcodes was repeated for samples 13, 15, 16, 19, 
25 and 26, and the results imaged on a gel (Figure 4-23). Four of the samples 
produced a better result on this second attempt (13, 15, 25 and 26), sample 16 was 
worse, and sample 19 was questionable. 
 





Figure 4-23 PCR products assessed using barcoded ITS-2 primers on CTAB extracted faecal DNA 
samples, repeat for samples with weak products (Lanes: L: 1 kb Hyperladder, P: positive control, N: 
negative control, 13a, 13b, 13c: Hope pre, 15a, 15b, 15c: Billee pre, 16a, 16b, 16c: Billee post, 19a, 
19b, 19c: Sox pre, 25a, 25b, 25c: Yoyo pre, 26a, 26b, 26c: Yoyo post) 
 
 MinION sequencing of the equine nemabiomes 4.4.12
The aim of this section of work was to prepare the amplicons and sequence them 
using the Oxford Nanopore Technologies Ltd MinION device. The MinION 
sequences DNA by passing a single strand of DNA through a tiny pore in a 
membrane, and detecting the changes in electrical current that occur as each base 




passes through. The sequencing was successful, and the results are discussed in 
section 4.4.13 Data analysis. 
 Data analysis 4.4.13
4.4.13.1 Data analysis: conversion of MinION output to DNA sequences 
The raw output from the MinION produced 395,104 total reads, presented in FAST5 
files. These data were run through Albacore (Oxford Nanopore Technologies Ltd) 
for base-calls with output files in FASTQ format. After base-calling, a total of 
280,298 reads passed quality scores with 106,021 sequences failing quality scoring 
and 11,785 (< 3%) skipped (not processed concurrently due to lack of computer 
processing power). 
The base-called reads from the pass folder were then run through PoreChop to 
identify and remove each barcode whilst binning each barcode into separate folders. 
The min_split_read_size was set to 400, meaning that if a read was found with a 
barcode in the centre, it would be split and fragments of less than 400 bp would be 
discarded. In total 173,011 reads were identified to a barcode and reads that weren’t 
identified to a barcode totalled 66,775 (discarded 40,512). All barcodes were 
identified apart from barcode 16 (Table 4-8). 
  




Table 4-8 PoreChop results sequencing ITS-2 amplicons produced from equine faecal samples, 
showing number of MinION reads identified to each barcoded sample by the PoreChop software. 
Barcodes 27 and 28 are zebra samples, to be discussed in Chapter 5. 
Bar  code reads Bar  code reads 
1 10,690 15 1,253 
2 6,870 17 3,912 
3 2,463 18 2,872 
4 3,222 19 1,254 
5 3,046 20 4,524 
6 8,052 21 13,436 
7 9,119 22 20,405 
8 8,167 23 10,573 
9 22,407 24 3,310 
10 2,754 25 547 
11 9,737 26 1,712 
12 3,243 27 1,110 
13 2,040 28 1,226 
14 15,067   
    
Total 173,011   
      
No 
barcode 
66,775   
      
Grand 
total 
239,786   
 
Sequences were analysed through CutAdapt to enable primers removal, filtered 
through a quality control and converted to FASTA format which could be BLASTed 
against the NCBI database to identify which species the sequences came from. In 
total, ten different runs were tried (section 4.3.15.1). 
The results of the 10 different CutAdapt runs are shown in Table 4-9. 
  




Table 4-9 CutAdapt results sequencing ITS-2 amplicons produced from equine faecal samples giving 
the total number of DNA sequences remaining for each barcode after different quality control filters 
Barcodes 27 and 28 are zebra samples, to be discussed in Chapter 5. 
Bar 
code 




Run 5 Run 6 Run 7 Run 8 Run 9 Run 10 
1 10,690 9,776 116 88 9,594 1,474 9,594 9,594 9,236 7,766 
2 6,870 6,287 38 28 6,105 973 6,105 6,105 5,680 4,710 
3 2,463 2,179 23 21 2,110 319 2,110 2,110 1,932 1,617 
4 3,222 2,847 20 13 2,770 483 2,770 2,770 2,586 2,103 
5 3,046 2,698 28 21 2,609 454 2,609 2,609 2,198 1,745 
6 8,052 7,318 85 60 7,083 1,298 7,083 7,083 5,186 3,893 
7 9,119 8,461 97 78 8,330 1,147 8,330 8,330 7,906 6,769 
8 8,167 7,553 77 55 7,395 1,090 7,395 7,395 7,056 5,972 
9 22,407 20,985 212 155 20,702 2,745 20,702 20,702 19,765 17,031 
10 2,754 2,419 25 19 2,331 388 2,331 2,331 2,176 1,792 
11 9,737 9,017 94 67 8,812 1,415 8,812 8,812 7,890 6,482 
12 3,243 2,879 31 22 2,766 499 2,766 2,766 2,392 1,895 
13 2,040 1,807 12 9 1,733 307 1,733 1,733 1,605 1,298 
14 15,067 13,886 141 92 13,625 2,054 13,625 13,625 13,039 10,993 
15 1,253 1,054 5 3 982 243 982 982 840 597 
17 3,912 3,543 38 25 3,440 543 3,440 3,440 3,152 2,613 
18 2,872 2,546 26 16 2,479 424 2,479 2,479 2,315 1,894 
19 1,254 1,084 10 4 1,027 183 1,027 1,027 937 755 
20 4,524 4,154 33 26 4,068 636 4,068 4,068 3,818 3,185 
21 13,436 12,433 114 93 12,230 1,926 12,230 12,230 11,296 9,376 
22 20,405 18,889 241 183 18,576 2,536 18,576 18,576 17,379 14,858 
23 10,573 9,789 111 86 9,618 1,338 9,618 9,618 9,152 7,818 
24 3,310 3,008 33 24 2,934 439 2,934 2,934 2,756 2,318 
25 547 476 6 4 465 80 465 465 392 315 
26 1,712 1,532 7 5 1,433 277 1,433 1,433 1,184 907 
27 1,110 947 9 5 886 166 886 886 801 636 
28 1,226 1,061 12 9 1,030 197 1,030 1,030 957 761 


















Run ten removed both primers where they were found and kept only reads between 
350 and 500 bases long. Run ten was judged to offer the greatest chance of 
discarding chimeric sequences and partial sequences, and returning only those 




sequences that were a true amplification of the selected portion of the ITS-2 section 
of the rDNA gene. 
4.4.13.2 Data analysis: BLASTn searches to identify species  
The data from CutAdapt run 10 were compared against the NCBI database using a 
BLASTn search. It was decided to report only sequences with a certain percentage 
identical match, and three sensitivities were chosen – 97%, 95% and 90%. From 
these results, any with an alignment length of less than 35 bases (10% of the 
sequence length as per (Avramenko et al., 2015)) were discarded, as were any with 
e-values of 0.001 or greater. In order to compare the three sensitivities, a test barcode 
(barcode one) was used. Initially, 7,766 sequences were BLASTed against the 
database. At 97% identity over a length of 35 bases, only 41 sequences came up with 
a match. At 95% identity, 141 sequences were matched, and at 90% identity 2,608 
came up with a match. It was decided to use the results of the 90% BLAST for 
further analysis.  
Using the 90% sensitivity, it became apparent that most of the expected matches (i.e. 
cyathostomin species) had good, long alignment lengths of 300 – 350 bases. Given 
this, experimentation with discarding alignment lengths of under 100 bases to further 
increase accuracy was trialled on two barcodes (barcode 3 and barcode 8) (Table 
4-10 and Table 4-11). 
  




Table 4-10 Number of DNA sequence matches and proportion of sequences matched at >35 and >100 
bases for barcode 3, BLASTn search of MinION data at 90% identity. Left two columns are actual 
number of sequences matched to each species, right two columns are % proportions of the total for 
each barcode that match to each species. Discard length is minimum length of sequence matched. 
Random species are those species which are not intestinal parasites of equines. 
Species 
Discard length 
Barcode 3 - 
35 






Random species 34   7  
Coronocyclus coronatus 7 7  1 2 
Coronocyclus labratus 1 1  0 0 
Cyathostoma verrucosum 14   3  
Cyathostomum catinatum 135 135  27 30 
Cyathostomum pateratum 22 21  4 5 
Cylicocyclus ashworthi 2 3  0 1 
Cylicocyclus auriculatus 1 1  0 0 
Cylicocyclus nassatus 174 174  35 39 
Cylicostephanus calicatus 3 1  1 0 
Cylicostephanus goldi 70 68  14 15 
Cylicostephanus 
longibursatus 
32 31  6 7 
Cylicostephanus minutus 1 1  0 0 
Strongylus vulgaris 1   0  
 497 443  100 100 
 
  




Table 4-11 Number of DNA sequence matches and proportion of sequences matched at >35 and >100 
bases for barcode 8 BLASTn search of MinION data at 90% identity. Left two columns are actual 
number of sequences matched to each species, right two columns are % proportions of the total for 
each barcode that match to each species. Discard length is minimum length of sequence matched. 
Random species are those species which are not intestinal parasites of equines. 
 
In total, for all barcodes, 35,209 sequences were matched at 90% identity over at 
least 100 bases, and 22 species of cyathostomin were identified, along with one large 
strongyle species namely Craterostomum acuticaudatum. There were only 23 
Species 
Discard length 
Barcode 8 - 
35 






Random species 80 1  4 0 
Coronocyclus coronatus 12 5  1 0 
Cyathostoma verrucosum 53   3  
Cyathostomum catinatum 100 99  5 5 
Cyathostomum pateratum 30 30  1 2 
Cylicocyclus auriculatus 1 1  0 0 
Cylicocyclus 
brevicapsulatus  
2   0  
Cylicocyclus elongatus 1   0  
Cylicocyclus insigne 3 1  0 0 
Cylicocyclus leptostomus 2 1  0 0 
Cylicocyclus nassatus 52 51  3 3 
Cylicocyclus radiatus 4 3  0 0 
Cylicostephanus calicatus 3 3  0 0 
Cylicostephanus goldi 144 144  7 8 
Cylicostephanus 
longibursatus 
1551 1545  76 82 
Cylicostephanus minutus 9 4  0 0 
Cylicostephanus poculatus 6 2  0 0 
Strongylus vulgaris 1   0  
 2054 1890  100 100 




matches which were not nematode parasites of horses, and these were three 
Ancylostoma species (hookworm parasites of dogs, cats and humans), two Uncinaria 
species (hookworm parasites of bears and sea lions) and three strongyle species that 
are parasites of marsupials. These may in fact have been novel equine species for 
which the ITS-2 sequence has not yet been characterised in the NCBI database. 
These 23 matches have been termed “Random species”. The proportions of species 
identified in each barcode are depicted in Figure 4-24. 
 
Figure 4-24 Parasite species identified from each barcoded equine faecal DNA sample by BLASTn 
search of NCBI database. 




4.4.13.3 Data analysis: sequence proportion comparison 
The species identified from each sample were quantified, and the proportions of each 
calculated. As the actual number of sequences produced in each sample was more a 
factor of the success of the DNA extraction than a reflection on the number of 
parasites present, from this point onward all calculations were performed on % 
proportions. Six principal species were identified namely Coronocyclus coronatus, 
Cyathostomum catinatum, Cyathostomum pateratum, Cylicocyclus nassatus, 
Cylicostephanus goldi, and Cylicostephanus longibursatus. Species which 
constituted less than 5% of the total of any sample were termed “Minor species” and 
were collected together for the purposes of data analysis. Box and whisker plots were 
produced to illustrate the species breakdown of sequences identified overall (Figure 
4-25a), from pre-treatment samples (Figure 4-25b) and from post-treatment samples 
(Figure 4-25c). No major change in the overall species composition is noticeable 
from these plots. 





Figure 4-25 Box and whisker plot of helminth ITS-2 rDNA sequences identified from equine faecal 
samples a) total of all samples, b) samples from before BZ anthelmintic treatment, c) samples 
following BZ anthelmintic treatment. 
 
 




Overall, the change in sequence proportion after BZ anthelmintic treatment 
demonstrated the greatest change in Cylicostephanus longibursatus which increased 
following treatment, and Cylicocyclus nassatus which reduced (Figure 4-26). 
However, this was not consistent over all the nemabiomes tested as can be observed 
in Figure 4-27 which demonstrates that all the principal species both increased and 
decreased in different populations following anthelmintic treatment. 
 
 
Figure 4-26 Overall change in sequence percentage of each helminth species identified from ITS-2 
sequencing on faecal DNA samples following BZ anthelmintic treatment, data from all horses 
combined. Error bars show standard deviation. 





Figure 4-27 Individual change in sequence percentage of each helminth species identified from ITS-2 
sequencing on faecal DNA samples following BZ anthelmintic, data from each horse shown 
separately, along with percentage anthelmintic efficacy 
 
A fourth root transformation and Bray Curtis similarity analysis was performed on 
the sequence proportions, and visualised using an MDS plot; a two dimensional 
representation of the three dimensional change in sequence proportions (Figure 
4-28). The calculated stress value of 0.11 demonstrates that the plot is a fair 
representation of the multi-dimensional data. The distances between each set of pre- 
and post-treatment points are similar (e.g. between points one and two, three and 
four etc.) which means that composition of sequences have changed by a similar 
amount, even though it is not always in the same direction. The analysis 
demonstrated that there was no significant difference at a community level between 




pre- and post-treatment samples (p = 0.79), i.e. at a population level, BZ 
anthelmintic treatment had no effect on the community of parasites. 





Figure 4-28 Non-metric MDS plot of diversity of pre- and post- BZ anthelmintic treatment sequence diversity in equine faecal samples, showing no significant difference at a 
community level between pre- and post-treatment samples. Representative pairs of samples (before and after BZ anthelmintic treatment on a single horse) have been linked 
with lines to illustrate. 





4.4.13.4 Data analysis: effect of treatment on each principal species 
Scatter plots were produced for each species, plotting post-treatment sequence 
proportions from each horse against pre-treatment sequence proportion. Trend lines 
were plotted, through the origin, to illustrate the percentage increase or decrease 
following treatment, and R
2
 values added to indicate how strongly the relationship 
was explained by the data (Figure 4-29) with the data summarised in Table 4-12. 
. 
  





Figure 4-29 Scatter plots presenting the relationship between pre- and post-treatment DNA sequence 
proportions of each major helminth species present. Trend lines set through the origin. a) 
Coronocyclus coronatus, b) Cyathostomum catinatum, c) Cyathostomum pateratum, d) Cylicocyclus 
nassatus, e) Cylicostephanus goldi, f) Cylicostephanus longibursatus  
  




Table 4-12 Summary of treatment effect on the proportions of sequences from the six principal 
species across all horse nemabiomes (listed order of prevalence), showing the percentage remaining 
after anthelmintic treatment (compared to the pre-treatment proportions), goodness of fit showing 
how consistent the change in proportion is for each species, and P values produced by Excel 






















39 38 96% 73% 0.0004 
Cylicocyclus 
nassatus 
26 21 67% 44% 0.0083 
Cylicostephanus 
longibursatus 
14 23 148% 19% 0.1140 
Cylicostephanus 
goldi 





5 4 80% 60% 0.0028 
Coronocyclus 
coronatus 
2 2 113% 63% 0.0020 
 
Individual sample sequence proportions are shown in Figure 4-30. 






Figure 4-30 Proportions of ITS-2 DNA sequences found in equine faecal samples pre- and post- BZ 
anthelmintic treatment, for each individual horse. Blue bars show pre-treatment proportions, red bars 
show post-treatment proportions. a) Coronocyclus coronatus, b) Cyathostomum catinatum, c) 









4.4.13.5 Data analysis: change in sequence proportion in relation to anthelmintic treatment 
efficacy  
The change in sequence proportion was compared with the BZ anthelmintic 
treatment efficacy for the four species which showed a significant correlation 
between pre- and post-treatment levels. No significant correlation was observed 
between the change in prevalence of the DNA sequences for a species and the 
overall reduction in FEC after treatment in any case (Table 4-13), although there was 
a tendency towards significance for the percentage sequence change in the most 
numerous species, C. catinatum.  
Table 4-13 Correlation between change in sequence proportion after treatment and drug efficacy for 
the four consistently resistant species – actual change in sequence proportions compared, and 
percentage change in sequence proportions. P values produced by Excel Regression data analysis 
function to show if this relationship is significant. 
 




Cyathostomum catinatum 0.40 0.08 
Coronocyclus coronatus 0.80 0.57 
Cyathostomum pateratum 0.40 0.86 
Cylicocyclus nassatus 0.98 0.10 
 
4.4.13.6 Data analysis: differences between yards  
Initially, it was hoped that a comparison could be made between the populations of 
helminth species observed at the three different sampling locations. However, due to 
the low levels of parasitic infections identified, there were insufficient samples tested 
at two of the locations for the results to be reproducible. Contingency tables were 
produced to investigate whether the pre- or post-treatment samples were significantly 




different from each other in the three locations, and also whether they were 
significantly different from each other across all the samples (Table 4-14).  




Table 4-14 Summary of contingency tables to show significant difference in DNA sequence 
proportions of the helminth species between samples in each yard. The principal species were used as 
the row variables, with the pre- or post-treatment sequence proportions as column variables. 
Yard Pre-treatment p value Post-treatment p value 
1 0.73 0.16 
2 1.00 0.98 
3 0.00 0.00 
Overall 0.00 0.00 
 
Overall, both pre- and post-treatment samples were significantly different from each 
other. Samples from yard 1 (n = 2) were not significantly different from each other 
either before or after treatment, neither were samples from yard 2 (n = 3). Samples 
from yard 3 (n = 7) were significantly different both before and after treatment. 
Sequence diversity proportions for each sample are shown in Figure 4-31.  





Figure 4-31 Proportions of ITS-2 DNA sequences from each helminth species in pre- and post- BZ 
anthelmintic treatment equine faecal samples a) Yard 1, b) Yard 2, c) Yard 3 
 
4.4.13.7 Data analysis: species diversity and egg counts 
The aim of this section of work was to see if there was a relationship between faecal 
egg counts and the diversity of species identified in the samples. This was performed 
by calculating Shannon indices for the pre- and post-treatment DNA sequences in 
each sample. The mean Shannon index for pre-treatment samples was 1.309 ± 0.321 
and for post-treatment samples 1.343 ± 0.314. There was no significant correlation 




between either pre- or post-treatment FEC and Shannon index, or between pre-
treatment Shannon index and post-treatment Shannon index (p < 0.05) (Table 4-15).  
Table 4-15 Shannon index of species diversity of DNA sequences in pre-treatment and post-treatment 
faecal samples compared to FECs. Overall there was no significant correlation between either pre- 
and post-treatment Shannon indices, or between pre-treatment or post-treatment Shannon index and 











Widget 874 1.359 368 1.456 
Klettur 478 1.502 179 1.219 
Hope 307 1.465 414 0.958 
Duke 216 1.243 115 1.245 
Sox 294 1.544 235 1.222 
Major 354 1.663 317 1.782 
Gertie 446 1.223 405 0.747 
Seren 511 0.573 212 1.527 
Jigsaw 368 1.381 147 1.573 
Topaz 1058 1.478 672 1.595 
Mary 690 0.788 179 1.095 
Yoyo 271 1.490 207 1.698 
     
Mean 489 1.309 288 1.343 
SD 260 0.321 158 0.314 
     
p value (FEC vs Shannon index) 0.597  0.950  
     
p value (pre Shannon vs post Shannon) 0.531    
 
 Primer design: beta tubulin  4.4.14
The second part of the molecular genetics analysis involved looking for SNPs 
associated with BZ resistance, in case any new ones could be discovered.  
Primers selected from the literature for further investigation are provided in Table 
4-16.




Table 4-16 Primers selected from the literature to amplify βtubulin gene in DNA extracted from equine faecal samples 





et al. (2008) 
5’-
AACGCAATCAATGTGTATTTCGC-




Isotype 1 of 
beta tubulin 


















 PCR optimisation: β tubulin  4.4.15
With success in amplifying nematode DNA with rDNA primers an attempt was 
made to amplify the beta tubulin isotype 1 gene. This would enable the identification 
of polymorphisms in this gene that might either be existing known mutations, or 
potential novel ones. 
4.4.15.1 PCR optimisation: beta tubulin Hodgkinson primers 
The first primer set to be tested were those from Hodgkinson et al.(2008), which 
amplify the full length gene of isotype 1 of the beta tubulin gene. Hodgkinson had 
used these primers on cDNA made from RNA. The PCR products were imaged 
using gel electrophoresis however no bands were visible other than for the positive 
control (Data not shown). 
As no bands were visible, the primer set was re-examined, but using different PCR 
conditions, as laid out in Hodgkinson et al (2008). The major difference was a longer 
extension time, to allow a larger product to be created. The PCR products were 
imaged using gel electrophoresis but again no bands were observed for any of the 
samples (Data not shown).  The experiment was repeated again with an addition of 
increasing to a two minute extension time and finally a three minute extension time. 
In all cases no PCR products were amplified from the DNA from faecal samples 
even with a three minute extension time, and thus the primer set were discarded at 
this point (Data not shown). 
 
4.4.15.2 PCR optimisation: beta tubulin Ishii primers  
The second primer set to be trialled was that from Ishii et al. (2017), which amplifies 
codon 167 of the beta tubulin gene, one of the codons associated with BZ resistance 




in cyathostomins (von Samson-Himmelstjerna et al., 2007a). The PCR products 
were imaged using gel electrophoresis (Figure 4-32). As the expected product was 
small, approximately 120 bp, a low molecular weight ladder was also loaded onto 
the gel in addition to the regular 1 kb ladder used throughout the work thus far. No 
strong products were produced by this PCR, and multiple products were produced 
for both the positive control and several of the faecal DNA samples. 
 
Figure 4-32 PCR products assessed from ‘Ishii’ β tubulin primers and DNA extracted from equine 
faecal samples both pre- and post- BZ anthelmintic treatment. (Lanes: L1: Low molecular weight 
ladder, L2 1kb Hyperladder, 1: Positive control (P. redivivus), 2: Negative control, 3: Widget pre, 4: 
Widget post, 5: Klettur pre, 6: Klettur post, 7: Major pre, 8: Major post) Multiple products highlighted 
with red arrows. 
  





 Resistance testing  4.5.1
This section of the work aimed to determine if there were populations of nematode 
parasites in any of the yards tested that were resistant to a class of anthelmintic. If 
resistant nematode populations were discovered, samples would be retained so that 
genetic analysis could be performed on both the pre-treatment and post-treatment 
samples to determine shifting equine nemabiomes. 
For the yards tested, Ivermectin was observed to be fully effective 14 days after 
treatment. This was in accordance with the results found by Relf et al. (2014) and 
similar to Tzelos et al. (2017) where Ivermectin was effective in 17 out of 18 
locations in the UK. The employed experimental design in the current work followed 
the current resistance testing guidelines published by (Coles et al., 2006). As with all 
anthelmintics, Ivermectin resistance will first be indicated by a reduced egg 
reappearance period (ERP) (Kaplan and Nielsen, 2010) and there is an indication 
that future resistance monitoring guidelines will recommend a post-treatment FEC at 
28 days after treatment with Ivermectin (Coles, Pers. comm). Of concern was that an 
ERP after treatment with another ML, Moxidectin, showed a shortened ERP in seven 
out of eight premises tested in the UK (Tzelos et al., 2017).  Interestingly, in the 
current work eggs from P. equorum were observed post-treatment, suggesting 
reduced efficacy of Ivermectin against this parasite as reported previously (Beasley 
et al., 2015; Bishop et al., 2014; Boersema et al., 2002; Hearn and Peregrine, 2003; 
Lind and Christensson, 2009; Lyons et al., 2006; Lyons et al., 2008; Näreaho et al., 
2011; Slocombe et al., 2007; Veronesi et al., 2010; Veronesi et al., 2009). However, 




and perhaps unfortunately, insufficient data were available for a significant 
conclusion to be drawn about P. equorum resistance in this study. 
In all yards tested, Fenbendazole was found to have a reduced efficacy against 
cyathostomin egg shedding. The best post-treatment FEC reduction was 74% of the 
pre-treatment level, and post-treatment FEC in one horse increased. Therefore, in all 
animals the FECRT displayed resistance as defined by the WAAVP (Coles et al., 
1992). This is unsurprising, since widespread reports of BZ resistance in 
cyathostomins has led to it being contra-indicated as a means of control (Matthews, 
2014). Despite this noted cyathostomin resistance, the one horse infected pre-
treatment with P. equorum (at a level of 327 epg) showed a 100% reduction after 
treatment with Fenbendazole. Although there were not a statistically significant 
number of P. equorum infections to test, it does suggest that Fenbendazole (Panacur) 
still has a place in the anthelmintic arsenal. In addition, despite the well documented 
reduction in efficacy of BZ against adult cyathostomins, it has been observed that BZ 
has a 71.2% efficacy against encysted LL3/L4 larvae when administered at 10 mg/kg 
for five consecutive days, which was not significantly different from Moxidectin at 
85.2% (Reinemeyer et al., 2015). 
 Molecular genetics  4.5.2
All pre- and post- anthelmintic treatment samples were retained from this study for 
further molecular analysis in an aim to determine the nemabiome of the horses post 
BZ treatment. This would be done by next generation genetic sequencing of the 
samples collected both pre- and post-treatment, to determine the species 
composition. The samples would also be tested to determine if Single Nucleotide 
Polymorphisms (SNPs) were present that correlated with BZ resistance. 




 Primer selection: rDNA 4.5.3
In order to determine which species were present, a section of the small sub-unit 
ribosomal gene would be amplified using PCR. This gene is highly conserved among 
nematodes, and as the MinION is a powerful sequencer, it was decided to amplify 
the largest possible segment of this gene. Initial research suggested that the primers 
from Floyd et al. (2005) would be the best to use as they produced an amplicon of 
approximately 900 base pairs. However, the primers which worked the best, those 
that provided strong PCR products from faecal DNA extractions, were those from 
Avramenko et al. (2015) which had successfully been used in similar work by 
Mitchell et al. (2019). These produced amplicons of approximately 400 base pairs. 
 DNA Extraction 4.5.4
In order to determine which species were present in the pre- and post-treatment 
samples, and also to determine which SNPs were present in those species which had 
survived treatment with anthelmintics, it was necessary to extract the helminth DNA 
from the eggs contained in the equine faecal samples.  
The DNA produced using the QiAmp DNA stool kit standard protocol yielded a 
higher quantity of DNA than that produced using the kit with an added bead beating 
step, when the test extractions were performed. It was therefore decided to not to 
incorporate a bead beating step when extracting the DNA from the faecal samples, 
for sequencing using the MinION. It is likely that the strongyle eggs in the faecal 
samples are more delicate and easier to lyse than alternative helminth species such as 
Fasciola eggs where bead beating is often incorporated (Dr Rhys Jones Pers. 
Comm.). Fragile nematode eggs is in agreement with earlier work, which 
demonstrated that Trichuris eggs were the only species examined that required 




mechanical lysis, while strongyle eggs can be effectively lysed by a combination of 
freezing and heating (Demeler et al., 2013). 
Once the DNA extracted using the QiAgen kit was used as a PCR template, it 
became apparent that it did not contain a sufficient quantity of parasite DNA for the 
next step of the project, and thus a different DNA extraction method was explored. 
Following the difficulties experienced trying to extract DNA using the QiAgen kit, 
an alternative method was assessed. Specifically, a CTAB method was adopted and 
the protocol chosen based upon and adapted from Dellaporta et al. (1983), Yu and 
Morrison (2004) and William et al. (2012). Initially, a comparison between freeze-
dried and plain frozen sample was made, following earlier experimental work using 
freeze-dried samples. In this work it was discovered that freeze-drying merely 
reduced the weight but not the volume of the sample, and therefore did not permit a 
greater quantity of sample to be processed. However, the CTAB protocol stipulated 
freeze-dried material, so this was revisited. In fact, a far greater quantity of DNA 
was recovered directly from the frozen faecal sample than from the same sample that 
had first been freeze-dried. Thus, the freeze-drying step was omitted from future 
analysis. 
Relatively good quantities of overall DNA were extracted using the CTAB  method, 
although at this stage it was not known how much of this DNA was parasite DNA, 
microbial DNA, host horse DNA from sloughed off intestinal cells, or DNA from the 
grass that had been eaten (Tortora and Anagnostakos, 1987). A faecal sample from a 
horse with repeated zero FEC results was also used for DNA extraction, and this also 
yielded a high concentration of DNA, suggesting, as expected, that there was a large 
quantity of non-parasite DNA present in the samples. This zero-FEC DNA sample 




would be used as an additional negative control during the PCR steps which were 
designed to separate out nematode DNA from the other DNA present in the samples. 
 DNA Extraction from Micro-I preparations  4.5.5
It was decided to determine if the samples prepared for imaging using the 
FECPAK
G2
 Cassette could be used for downstream DNA analysis. This would 
potentially enable an efficient workflow to detect and quantify a parasitic infection, 
and also determine the species present.  
Initially, an attempt was made to remove the saline from the FECPAK
G2
 Cassette 
preparation. This was done by diluting the sample with water so that the eggs no 
longer floated, and then centrifuging the sample to collect the eggs. The NanoDrop 
results from the sample that was washed before extraction provided extremely low 
DNA levels possibly indicating that the DNA extraction had not been successful. It 
was possible that the eggs had been lost at the wash steps. Given that in the DNeasy 
protocol, one of the options when using cells was to re-suspend them in phosphate 
buffered saline (PBS), salt concentration was considered unlikely to disrupt the DNA 
extraction procedure and it was decided to repeat the experiment without washing 
the eggs from the saline to minimise egg loss. Despite this removal of wash steps, 
extremely low levels of DNA were again extracted.  
To investigate if the salt was actually causing an issue with the extraction, or if 
washing the sample was losing the eggs, a fresh faecal sample was obtained (average 
infection level, FECPAK
G2 
slide count FEC showed 184 epg), and two FECPAK
G2
 
Cassette preparations made. One preparation re-suspended the sediment from the 
sedimentation step in saline in the normal matter, and one re-suspended the sediment 
in water. An aliquot of the water-diluted sample was centrifuged to concentrate the 




eggs, to see if this would improve the DNA extraction. As with previous results 
DNA extraction quantities and purity remained very poor. Thus, it was concluded 
that extracting DNA directly from the FECPAK
G2 
cassette preparation was unlikely 
to be successful with this approach.  
As it was later discovered that the QiAgen kit yielded far poorer results in both 
quantity and quality for equine faecal extractions than the CTAB method of DNA 
extraction, it was decided to re-visit the question of whether DNA could be extracted 
directly from the FECPAK
G2 
Cassette preparation. As the salt was found not to affect 
the extraction of DNA, the CTAB protocol was followed using the solution as 
prepared for the FECPAK
G2 
Cassette but without a wash step. The outcome the two 
extractions performed were problematic and this DNA isolation pipeline was 
abandoned. One possible reason for the DNA isolation failure was the fact that the 
protocol to prepare the faecal samples for imaging in the FECPAK
G2
 Cassette 
involves diluting 23-fold the quantity of DNA available. Therefore, the numbers of 
eggs and hence the quantities of DNA extracted were low and not considered 
sufficient for the downstream application of nemabiome determination in this 
research, future work may allow sequencing of  DNA extracted from the helminth 
eggs that were initially visualised using the FECPAK
G2
 Micro-I and determining the 
species of those eggs. 
 PCR optimisation: rDNA   4.5.6
In order to enable the species of nematodes contained in the samples to be 
determined, it was first necessary to optimise primers and PCR conditions for 
amplifying a segment of the small sub-unit ribosomal gene. Initial primer selection 
work demonstrated a strong product with the initial positive control (DNA from B. 




glabrata, a snail) for both the primers taken from Marek et al. (2010) and Floyd et 
al. (2005). A weak band with the DNA from the faecal samples was shown with the 
primers taken from Peachey et al. (2017), so this was also selected for further 
investigation, although the product was very small at only 99 bp. 
Initial work testing the primers against positive control DNA suggested that the 
‘Floyd’ primers would be optimal,  however, once PCR amplification of the final 
DNA from faecal samples was initiated, it the ‘Floyd’ primers failed to perform as 
well as expected, and so the decision was made to switch primers and use the ones 
which had been successful in similar work performed by Mitchell et al. (2019), 
which had been taken from Avramenko et al. (2015). These produced a smaller 
product than the ‘Floyd’ primers (400 bp instead of 900 bp) but proved to be more 
successful in producing amplicons from the DNA extracted from equine faecal 
samples. 
 PCR of DNA extracted from equine faecal samples  4.5.7
Once the ‘Floyd’ primers had been selected as the most promising ones to use, and 
faecal samples processed using the optimal method of extraction (frozen samples, 
without a bead disruption step), the samples were tested using PCR. These primers 
gave a band of approximately 900 bp from the positive control, which was DNA 
from Panagrellus redivivus. However, the PCR failed to produce any similar sized 
bands from any of the DNA extracted from faecal samples using the QiAgen kit. It 
was at this point that the decision was made to try an alternate method of DNA 
extraction – the CTAB method. 
Initially, the ‘Floyd’ primers were again used, with 100 ng of template DNA. The 
PCR failed to amplify any products from all samples tested. One potential reason 




could have been that too much template was used. If an excess of template DNA is 
included in a PCR reaction, there is the possibility that there will be insufficient 
primers to ensure that both the forward and reverse primers bind to the same strand 
of DNA. If this happens in the initial cycle of PCR, then there will not be any of the 
correct size of product to amplify in the further cycles, and the PCR will fail. In 
order to determine if this had been the problem, it was decided to repeat the PCR, but 
using only approximately 20 ng of template. 
Using 20 ng of template and the ‘Floyd’ primer set PCR products were observed, so 
it was decided to try the primers used in Mitchell et al.(2019) and Avramenko et 
al.(2015) which had been taken from Gasser et al. (1993) on the diluted DNA 
samples. These primers gave a smaller expected product size, but had successfully 
been used to speciate cyathostomins in Mitchell et al. (2019) where they gave a 
product of approximately 400 bp. This product size differs from the size expected in 
other nematodes (250 bp when used on cattle nematodes in Avramenko et al.(2015), 
and interestingly the product produced in the positive control of P. redivivus was 
only 200 bp. These primers produced a band for every one of the samples tested, and 
thus it was decided to select these primers for future production of amplicons for 
sequencing and species identification. It was interesting that in one of the samples, 
two bands of slightly different sizes were produced, and speculation was that these 
were from different nematode species. 
Prior to preparing and sequencing the amplified DNA from the equine faecal 
samples using the MinION, it was necessary to check that the PCR was correctly 
amplifying nematode DNA. This was achieved by inserting the amplicons into a 




vector and cloning using Escherichia. coli (E. coli) which confirmed the 
amplification of cyathostomin DNA.  
 Barcoding and sequencing via MinION  4.5.8
In order to sequence multiple samples through the MinION (Oxford Nanopore 
Technologies, Oxford, UK) each sample was labelled with a unique barcode. In 
doing so, all of the faecal DNA samples could be sequenced simultaneously, with a 
separate output from the basecalling for each sample that could be used to determine 
the species present. Twenty six unique barcoded primers were used to label forward 
primers previously used in nemabiome analysis (Avramenko et al., 2015), (Mitchell   
et al., 2019) and the ITS-2 rDNA amplicons from the 13 paired pre- and post-
treatment equine faecal samples were subjected to a second nest of PCR to label 
them with these barcodes. The MinION sequencing run was successful, and the data 
produced are discussed in section 4.5.9 Data analysis. 
 Data analysis  4.5.9
The data were passed through several quality control filters. Firstly they were base-
called, and output which couldn’t be identified to a base discarded. Secondly, the 
data were de-multiplexed and the reads separated into a folder for each barcode.  The 
next stage was to remove the barcode primers, and discard DNA sequences that were 
either shorter or longer than the expected length. Several different filters were 
applied, in order to produce the highest quality data possible whilst still retaining 
sufficient sequences to produce meaningful results. 
Run one was not set to discard any sequences; it only trimmed them to 250 bases. 
Run two discarded fragments under 100 bases, and did not discard many, suggesting 
that the majority of the sequences were longer than 100 bases. Runs three and four 




discarded sequences if both primers were not located and actually discarded almost 
all of the data suggesting that both the entire primer sequences were not often present 
likely  as a consequence of the barcodes being trimmed previously. Therefore, filters 
3 and 4 were not used in subsequent runs. Run five discarded sequences less than 
220 bases, and like filter 1 hardly discarded any sequences giving further evidence 
that the majority of sequences were longer than 220 bases. The suggestion of long 
sequence reads was encouraging, as short fragments would not be as accurate for 
determining from which species they came (Wommack et al., 2008). Run six 
discarded sequences under 500 bases long, and was included to see if it would 
discard everything. In fact, over 23,000 sequences remained, meaning that some of 
the sequences were longer than expected. These sequences could possibly be 
chimeric sequences generated during the PCR (Corsaro and Venditti, 2018), and so it 
was decided to discard any reads longer than 500 bases. Run seven was set to trim 
the reads to 250 bases (the length of the amplicon expected as reported in 
Avramenko et al. (2015) and discard any reads shorter than 220 bases, and run eight 
was set to trim the reads at 400 bases, the length that the amplicon appeared to be 
following agarose electrophoresis in this study, and discard any reads shorter than 
220 bases. These two runs discarded the same number of reads, along with run 5, as 
was expected. Run nine was the same as run eight, but discarded fragments less than 
350 bases long. This didn’t discard a huge amount more, meaning that most of the 
reads were at least 350 bases long – again encouraging, when the expected length 
was around 400 bases. The final run, run ten, removed both primers where they were 
found (and also anything before the forward primer or after the reverse primer), and 
kept only reads between 350 and 500 bases long. It was decided that filtering process 
10 had the greatest chance of discarding chimeric sequences and partial sequences, 




and returning only those sequences that were a true amplification of the selected 
portion of the small sub-unit rDNA gene. Filters were applied using CutAdapt 
(Martin, 2011) as in other nanopore sequencing research, such as Wei et al.(2018a; 
2018b). 
4.5.9.1 Data analysis: BLASTn searches to determine nemabiome  
The data from CutAdapt run 10 were compared against the NCBI database 
(https://www.ncbi.nlm.nih.gov/) using a BLASTn search. It was decided to report 
only sequences with a certain percentage identical match, and three sensitivities were 
chosen – 97%, 95% and 90% similar to Mitchell et al. (2019). From these results, 
any with an alignment length of less than 35 bases (10% of the sequence length as 
per Avramenko et al. (2015)) were discarded, as were any with e-values of 0.001 or 
greater as per Wommack et al. (2008). It was decided to use the results from the 90% 
identity BLAST as per Avramenko et al. (2017) for two reasons. Firstly, very few 
matches were made at more than 90% identity, but more importantly, sequences 
from the higher identity were only short lengths (less than 100 bases), and it was 
thought more accurate to have a lower identity match over a good long sequence 
than a good match over a very short sequence. 
In total, 35,209 sequences were matched at 90% identity over at least 100 bases, and 
22 species of cyathostomins were identified, along with one large strongyle species, 
C. acuticaudatum which interestingly was present in only a post anthelmintic 
treatment sample. There were only 23 matches which were not nematode parasites of 
horses, and these were three Ancylostoma species (hookworm parasites of dogs, cats 
and humans), two Uncinaria species (hookworm parasites of bears and sea lions) 
and three strongyle species that are parasites of marsupials. This gave an error rate of 




0.06%, or less than one sequence per sample as in Avramenko et al. (2017), which 
was considered to be very low. There is no evidence in the literature that hookworm 
infections are found in horses, so likely these 23 matches were equine parasite 
species which do not yet have their ITS-2 rDNA sequence characterised in the NCBI 
database, and the BLAST reported the closest match. Three species of cyathostomins 
(Coronocyclus labiatus, Cyathostomum labratum and Tridentoinfundibulum gobi) 
were present in only pre-treatment samples, although their occurrence was low. 
Their absence from post-treatment samples suggests that BZ anthelmintics may still 
be effective against these species and this may explain why they did not occur more 
frequently. 
4.5.9.2 Nemabiome sequence proportion comparison  
Six principal species were identified in equine nemabiomes pre and post BZ 
anthelmintic treatment; namely Coronocyclus coronatus, Cyathostomum catinatum, 
Cyathostomum pateratum, Cylicocyclus nassatus, Cylicostephanus goldi, and 
Cylicostephanus longibursatus. These identifications support the five principal 
species observed in (Traversa et al. (2009) with the addition of C. coronatus. 
Furthermore, all six species feature in the eleven principal species identified in 
horses from the Ukraine (Kuzmina and Kharchenko, 2008). However, only three 
species match the most abundant six species observed by Lind et al. (2003) which 
were C. nassatus, C. catinatum and  C. longibursatus. These data suggest a relatively 
consistent equine nemabiome, given that there are at least 83 species of intestinal 
helminth parasites that infect horses (Lichtenfels et al., 2008a). Species which made 
up less than 5% of the total of any sample were termed “Minor species” and were 
collected together for the purposes of data analysis.  




Overall change in sequence proportion post BZ anthelmintic treatment demonstrated 
the greatest variability in C. longibursatus, which increased following BZ 
anthelmintic treatment, and C. nassatus which reduced in abundance. However, this 
was not consistent over all the equid nemabiomes examined as all the principal 
species variously increased and decreased in different populations following BZ 
treatment. Data analysis demonstrated that there was no significant difference at a 
community level between pre- and post-BZ treatment samples (p = 0.79).  Thus, at a 
population level, BZ anthelmintic treatment had no effect on the community of 
parasites. 
As there had been no significant effect of treatment observed when the horse was 
used as the experimental unit, it was decided to investigate the data from the point of 
view of each principal helminth species identified in the nemabiomes. This would 
determine if there was a relationship between the species and the effect of treatment. 
Using the scatter plots produced, a significant correlation between pre- and post-
treatment proportions was observed in four out of the six principal species (p < 
0.05). The species which made up the greatest proportion of pre-treatment 
sequences, C. catinatum (39% of pre-treatment sequences) demonstrated limited 
response to BZ treatment, with 96% of sequences still remaining (goodness of fit 
73% p = 0.0004), suggesting that this species was consistently BZ resistant across all 
the horses tested. The second highest proportion of sequences was C. nassatus, at 
26% of pre-treatment sequences. This species demonstrated reduced BZ resistance 
(67% sequences remaining after treatment) and was also less consistent (goodness of 
fit 44%) yet still of significance (p = 0.0083). C. pateratum and C. coronatus were 
demonstrated consistently high levels of BZ resistance (80% remaining, goodness of 




fit 60%, p = 0.0028 and 113% remaining, goodness of fit 63%, p = 0.002 
respectively). However, these species represented only 5% and 2% of pre-treatment 
sequences. The remaining two species, C. longibursatus and C. goldi, did not exhibit 
consistent responses to BZ treatment with a goodness of fit of 19% (p = 0.1140) and 
-18% (p = 0.3876) respectively. These two species constituted 14% and 13% of pre-
treatment sequences. Importantly, these data illustrate that BZ resistance is not 
global across all cyathostomin species. 
It was interesting that the two species with an inconsistent response to treatment 
were both from the same genus, and also that they are found mostly in the dorsal 
colon – the most cranial (closest to the mouth) site that cyathostomins occupy 
(Morariu et al., 2016). The species least well controlled by the administration of the 
Fenbendazole anthelmintic, C. coronatus, is located in the caecum which is the most 
caudal site occupied by cyathostomins (Morariu et al., 2016). This fits in with the 
fact that BZ treatment is administered orally, and that Fenbendazole is poorly 
absorbed systemically (McKellar et al., 2002) so its effect is mostly directly from the 
gut. The other three species consistently demonstrating levels of BZ resistance – C. 
catinatum (96% remaining after treatment), C. nassatus (67% remaining after 
treatment) and C. pateratum (80% remaining after treatment) - all principally occupy 
the ventral colon (Morariu et al., 2016).To summarise, the location in the equine 
gastro-intestinal tract related to the response to BZ anthelmintic treatment with those 
cyathostomin species residing at the start of the tract being more well controlled than 
species residing further along. This is an important finding, as administration of sub-
lethal concentrations of anthelmintics is known to lead to anthelmintic resistance 
(Sangster, 2001). 




4.5.9.3 Change in nemabiome proportions in relation to BZ treatment efficacy  
For those principal species which demonstrated consistent resistance to BZ 
anthelmintic treatment, no significant correlation between the total efficacy of BZ 
anthelmintic (i.e. the reduction in FEC following treatment for each horse) and the 
change in sequence proportion of the nemabiome principal species was observed. 
This was true whether the actual change in sequence proportion was used, or the 
percentage change. The two values were calculated in order to take into account the 
differing levels of each species – a change in sequence proportion from 5% to 10% 
would be more relevant than a change from 60% to 65% even though the actual 
change would still be 5%. This avoided over-stating the importance of those species 
that were not highly represented. This suggests that the reduction in FEC following 
anthelmintic treatment is not equal over all strongyle species, but varies with each 
horse owing to the significant differences in their nemabiomes. 
4.5.9.4 Nemabiome differences between locations  
Overall, both pre- and post-BZ anthelmintic treatment samples were significantly 
different from each other. Samples from yard 1 were not significantly different from 
each other either before (p = 0.73) or after treatment (p = 0.16), neither were samples 
from yard 2 (p = 1.00 before treatment, 0.98 after treatment). Samples from yard 3 
were significantly different both before (p < 0.001) and after treatment (p < 0.001). It 
is not known whether this was due to the small number of samples (yard 1 n = 2, 
yard 2  n = 3, yard 3 n = 7) or because yard 3 was a rescue yard and therefore had a 
more transient population of horses than the other two yards.  




4.5.9.5 Nemabiome species diversity and egg counts  
It was decided to examine the data to determine if there was a relationship between 
faecal egg count and the diversity of species found in the samples. Species diversity 
was measured using a Shannon index. The mean Shannon index of both pre- and 
post-treatment samples was around 1.3, which is substantially lower than that 
observed previously in equids (Kuzmina and Kharchenko, 2008) and (Lind et al., 
2003). Kuzmina and Kharchenko (2008) reported Shannon indices of around 2.5 to 3 
with (Lind et al., 2003) reporting indices of around 2. However, (Kuzmina and 
Kharchenko, 2008; Young et al., 1999) hypothesised that species diversity decreased 
in locations where regular anthelmintic treatments were applied, so a decade of 
anthelmintic treatment might have caused a reduction in the baseline species 
diversity. This reduced diversity is supported by the lower mean Shannon index of 
1.8 found later by  Sallé  et al. (2018), and although that was still higher than 
observed in this study, the data had been collected in 2011 and 2012 so still follows 
the trend. 
When linking diversity to FEC, no significant correlation (p > 0.05) was in fact 
observed between either Shannon index and FEC, or between the pre- and post-
treatment Shannon indices for each sample.  With this being the first study of its 
type, no similar studies were identified in the literature for a comparison to be made. 
 β Tubulin work 4.5.10
It had been hoped to identify the SNPs associated with BZ resistance, in case any 
new ones could be discovered. In order to do this, it was necessary to amplify the 
beta tubulin gene, which is the anthelmintic target for the BZ class of compounds 




(Lacey, 1989, 1990). This would likely enable identification of mutations in the gene 
that might either be existing known mutations, or potential novel ones.  
 Firstly it was necessary to optimise primers that would amplify the β tubulin gene. It 
was decided to use the primers from Hodgkinson et al. (2008) as they amplify the 
whole of the β tublin gene, whilst also to try the primers from Ishii et al.(2017). A 
third set of primers, from Coles et al.(2006) and Pape et al. (2003) were not used, as 
they were designed to amplify separately the susceptible and resistant isotypes, and 
this would not be necessary when the products would be sequenced using the 
MinION.  
The first of the two potential primer sets identified in section 4.3.7 to be tested were 
those taken from Hodgkinson et al. (2008). These had been used to amplify isotype 1 
of the full length β tubulin gene in cyathostomins. Initially, the PCR was 
unsuccessful, so the extension time was lengthened. In the original paper, RNA was 
extracted from adult worms and used to make cDNA for the template. In the current 
research, gDNA was used as the PCR template; therefore the expected amplified 
product may have been longer than the 1437 bp in the original paper, due to non-
coding intronic regions also being present. A longer extension time would therefore 
allow for a longer product to be produced, so extension time was increased from 10 
seconds to one minute, which was the length of time used in Hodgkinson et al., 
(2008). However, this approach was still unsuccessful, as were two and three minute 
extension times. 
Having failed to amplify the entire β tubulin gene, it was decided to try the primers 
from Ishii et al. (2017), which amplify a region encompassing codon 167, one of the 
two codons associated with BZ resistance in cyathostomins (Lacey, 1989). As this 




primer set would produce a smaller product it was considered inferior to the 
‘Hodgkinson’ primers in relation to future nanopore sequencing, but would possibly 
be easier to amplify. The PCR produced some unclear products at around 50 bp and, 
since the expected product was around 250 bp, it was considered that this had not 
been successful.  
As the literature dealt only with DNA extracted from helminth samples themselves 
and not from faecal samples, at this point it was decided that the available time 
would be better spent attempting to determine the nemabiome by sequencing the 
ITS-2 rDNA amplicons and analysing the results obtained from this work, and so the 
β tubulin work was put aside. It is possible that new primers could be designed for 
amplifying cyathostomin β tubulin genes from gDNA in the future; however this is 
hampered by the lack of quality genome data available. To date, only three equine 
parasite genomes are available in WormBase 
(https://parasite.wormbase.org/species.html) (C. goldi, P. equorum and S. vulgaris) 
and all three have very poor coverage. Time constraints did not permit further 
exploration of this avenue. 
4.6 CONCLUSION 
The work successfully determined the equine nemabiome from DNA extracted from 
faecal samples. Twenty two species of cyathostomin were identified, along with one 
large strongyle species namely Craterostomum acuticaudatum which was present in 
one sample, interestingly only after anthelmintic treatment. Six principal species 
were identified namely Coronocyclus coronatus, Cyathostomum catinatum, 
Cyathostomum pateratum, Cylicocyclus nassatus, Cylicostephanus goldi, and 
Cylicostephanus longibursatus. Three species were absent from all post-treatment 




samples (Coronocyclus labiatus, Cyathostomum labratum and Tridentoinfundibulum 
gobi), although their overall occurrence was low. Their absence from post-treatment 
samples suggests that BZ anthelmintics may still be effective against these species 
and this may explain why they did not occur more frequently.  
Initial comparison of the sequence proportions of the pre- and post-treatment 
samples showed that nemabiome populations responded very differently to BZ 
treatment. Two different effects were in operation: in some species, such as 
Cyathostomum catinatum and Coronocyclus coronatus, there was a high and 
consistent level of drug resistance, whereas in others BZ treatment had a more 
variable effect. As the most numerous species found both before and after treatment 
was C. catinatum, this partially explained the lack of difference between pre- and 
post-treatment samples.  Failure of BZ treatment became greater in species which 
tend to occupy niches further along the digestive tract. The two species which did 
not show a consistent response to BZ tend to reside in the dorsal colon, the most 
cranial part of the tract occupied by cyathostomins. The species which was least well 
controlled by the administration of Fenbendazole, C. coronatus, tends to reside in the 
caecum, which is the most caudal part of the tract occupied by cyathostomins. This 
fits in with the fact that drug treatment is administered orally, and that Fenbendazole 
is poorly absorbed systemically (McKellar et al., 2002) thus its effect is mostly 
directly from the gut. 
No significant correlation (p > 0.05) was in fact found between either Shannon index 
of species diversity and FEC, or between the pre- and post-treatment Shannon 
indices for each sample. This suggests that treatment did not affect the diversity of 
species present, and the fact that the most abundant species, C. catinatum, was 




poorly controlled by drug treatment goes a long way to explaining this. It also 
suggests that species diversity was not correlated with overall parasite egg shedding 
either. These data followed the general downward trend in nemabiome diversity over 
time observed in other studies. 
In the four species which showed a consistent response to BZ treatment, there was 
no correlation between the change in species proportion and the overall reduction in 
FEC for that animal. This suggests that the reduction in FEC following anthelmintic 
treatment is not equal over all strongyle species, but varies with each horse owing to 
the significant differences in their nemabiomes. Prior determination of the 
nemabiome could therefore inform the likelihood of BZ treatment success in 
advance of administration, and reserve its use for animals whose parasite burden is 
composed of mainly susceptible species. Further work using different anthelmintic 
classes has the potential to build a valuable knowledge base which would allow 
targeted treatment with the most appropriate anthelmintic, and help delay the 
development of anthelmintic resistance. 
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5 APPLICATION OF FECPAKG2 AND NEMABIOME 
SEQUENCING TO EXOTIC EQUIDS 
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Conservation of exotic equids by captive breeding can be essential, such as in the 
case of the Przewalski's horse (Equus przewalskii) which became extinct in the wild 
in the 1960s and has survived only as a consequence of a captive breeding 
programme (Souris et al., 2007). Research has identified that exotic equids such as 
E. przewalskii and zebra species harbour intestinal helminth parasites of similar 
species to domestic equines (Epe et al., 2009). Therefore, regular monitoring, such 
as the use of FECs, is a useful tool for helminth control in exotic equid species when 
in a captive environment, and may be the only intervention required for helminth 
control (Epe et al., 2009). 
Free ranging wild zebra have typically higher worm burdens than do managed 
animals and in the absence of anthelmintic treatment are still commonly infected 
with large strongyles, which are now rare in domestic horse populations (Wambwa 
et al., 2004). Commonly observed in both ranched and free ranging zebra is the 
nematode Crossocephalus viviparous from the family Atractidae which does not 
appear to infect horses despite their sharing of the same habitat (Krecek et al., 1995) 
and is often found in high infection levels (Wambwa et al., 2004). The majority of 
cyathostomin species infect all equids. However, there are some species particular to 
one host such as Cylicocyclus triramosus which is only known to infect zebra 
(Kharchenko et al., 1997). Investigation using scanning electron microscopy has 
revealed that the ascarid species infecting both wild and captive zebra is the same 
one that infects the domesticated horse, namely P. equorum (Ansel et al., 1974). 
Thus, the monitoring and understanding of parasitic helminth infections is a crucial 
part of exotic equid species conservation. 
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Following the successful optimisation and validation of the FECPAK
G2
 for use in 
equine samples (Chapters 2 and 3) and the use of the MinION to sequence 
nemabiomes from DNA extracted from equine faecal samples (Chapter 4), these 
methods were trialled on faecal samples from Chapman’s zebra. Therefore, the aim 
of this work was to investigate the applicability of the FECPAK
G2
 and Nanopore 
sequencing as a method of understanding and monitoring parasitic helminth 
infections in exotic equids. 
5.2 CHAPTER AIMS 
 Explore FECPAKG2 and MinION sequencing suitability for exotic equids 
 Examine nemabiome of zebra and compare to the equine nemabiomes 
sequenced 
5.3 MATERIALS AND METHODS 
 Sample Collection and FECs 5.3.1
During the spring of 2018, samples were collected from a small herd of Chapman’s 
zebra, Equus quagga chapmani, residing at Folly Farm Zoo and Adventure Park in 
Pembrokeshire, Wales UK. Individual samples were collected from three zebra, and 
a pooled sample was taken from two zebra (mare and foal) who were housed 
together. The samples were processed using the standard FECPAK
G2
 slide resistance 
testing protocol, described previously for equids (Section 7.2 of the Appendix). 
Following treatment with a BZ anthelmintic (Panacur [Intervet UK Ltd]; 
Fenbendazole active ingredient) administered in the feed, further samples from two 
of the zebra were obtained on day 14 after treatment, and processed using the same 
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method. In addition, the pre-treatment samples were imaged using the FECPAK
G2
 
Micro-I using the optimised and validated equid protocol. 
 DNA extraction 5.3.2
DNA was extracted from two of the individual zebra pre-treatment samples which 
had observable infections from the positive identification of eggs during FECs for 
both strongyles and Parascaris equorum. DNA was extracted using the protocol 
described previously in Section 4.3.5 “DNA Extraction:  CTAB (Cetyl 
Trimethylammonium Bromide) method” optimised for equine samples. 
 PCR amplification of zebra nemabiome ITS-2sequences 5.3.3
Amplicons were produced using the same method as in Section 4.3.9 “PCR of DNA 
extracted using CTAB method”. Forward and reverse primers were taken from 
Avramenko et al. (2015). For PCR amplification, 25 µl reactions were performed 
using MyFi 2× DNA polymerase (Bioline, UK) according to the manufacturer’s 
instructions with 10 µM forward and reverse primers and approximately 20 ng of 
zebra faecal DNA. A negative control was prepared using 1 µl Nuclease-free water, 
and a positive control using 20 ng equine faecal DNA. PCR conditions were: initial 
denaturation at 95ºC for 1 minute, denaturation at 95ºC for 15 seconds, annealing at 
55ºC for 15 seconds, extension at 72ºC for 10 seconds and final extension at 72ºC for 
5 minutes, with 35 cycles performed. PCR was repeated where necessary to provide 
sufficient template DNA for barcoding. 
 Barcoding zebra faecal DNA samples 5.3.4
Having determined in Chapter 4 (Section 4.3.13) that the barcodes to identify the 
individual nemabiome samples during the MinION sequencing process were best 
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used as the second stage of a nested PCR, a template was produced from each zebra 
sample, labelling each sample of amplified nematode ITS-2 rDNA produced from 
the zebra faecal samples. Two of the samples were selected for this work, those from 
Kanzi and Ayah, as they showed the highest FECs from the individual zebra faecal 
samples.  In order to produce a sufficient quantity of the barcoded amplicons for 
MinION sequencing, three PCR runs for each sample were performed, using the 
individual barcoded primers number 27 (Kanzi) and 28 (Ayah) (refer to section 7.5 
of the Appendix for barcodes). PCR conditions were as stated before in Section 5.3.3 
“PCR amplification of zebra nemabiome ITS-2sequences”, with repeat PCR runs as 
required. 
 MinION nemabiome sequencing 5.3.5
The barcoded zebra nemabiome amplified DNA samples were sequenced using the 
MinION desktop sequencer simultaneously with the horse samples as described 
previously in Chapter 4 (Section 4.3.14 MinION sequencing). Sequence quality 
control and sequence identification was performed on the resulting data as described 
in Chapter 4 (Section 4.3.15 Data analysis). 
5.4 RESULTS 
Given the success of FECPAK
G2
 development and MinION nemabiome sequencing 
of equine faecal samples, this chapter aimed to determine if anthelmintic resistance 
in the parasite nemabiome in a small population of zebra was present and to what 
extent their resident nemabiome differed from those in the domestic horse. Thus, 
zebra samples were monitored for their response to BZ anthelmintic treatment whilst 
the faecal samples were retained for future DNA analysis. 
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 Sample Collection and FECs  5.4.1
Three out of the four samples demonstrated evidence of infection with both 
strongyles and P. equorum species (Table 5-1) with the highest epg recorded for 
strongyles at 189 epg.  The highest recorded epg for P. equorum was the sample of 
‘Ayah’ at 170 epg. For the two post-treatment zebra samples that were available, 
treatment with Fenbendazole (Panacur) gave a 100% reduction in the faecal egg 
counts (Table 5-1).  
Table 5-1 Faecal egg counts (epg) using the FECPAK
G2
 slide on zebra samples. Pre- and Post-
treatment FECs were performed using a BZ based anthelmintic. 









Kanzi 28 83 0 0 
Ayah 14 179 0 0 
Nutmeg 18 0 - - 
Penny and 
Dayo 
189 5 - - 
 
The pre-treatment samples were also imaged using the FECPAK
G2
 Micro-I which 
successfully visualised both strongyle and P. equorum eggs (Table 5-2).  
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Table 5-2 Mean of faecal egg counts (epg) using the FECPAK
G2
 slide (n=5) and FECPAK
G2
 cassette 
(n=2) on zebra faecal samples 









Kanzi 28 83 0 0 
Ayah 14 179 0 52 
Nutmeg 18 0 13 0 
Penny and 
Dayo 
189 5 169 13 
 
 DNA extraction 5.4.2
DNA extracted from zebra faecal samples was imaged using gel electrophoresis on a 
1% w/v Agarose gel run at 100 V to visualise the DNA.  In total, 2 µl of zebra faecal 
DNA was loaded into each lane along with 0.5 µl 5 × loading dye (Bioline.com) 
(Figure 5-1). 
It can be observed from Figure 5-1 that both DNA and RNA were present in the 
zebra faecal samples. Quantification of the DNA extracted from the zebra faecal 
samples using a NanoDrop spectrophotometer yielded nucleotide concentrations of 
1164.9 ng/µl for Kanzi and 1471.9 ng/µl for Ayah. When quantified using a Qubit 
2.0 Fluorometer, DNA concentrations of 200 ng/µl for Kanzi and 298 ng/µl for Ayah 
were obtained. 
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Figure 5-1 Zebra faecal DNA extraction using CTAB method analysed on a 1% agarose gel. The red 
arrow highlights high molecular weight DNA extracted, with the area beneath showing that RNA is 
also present. 
 
 PCR amplification of zebra nemabiome ITS-2 sequences 5.4.3
Nematode ITS-2 amplicons were produced from the DNA that had been extracted 
from two of the zebra pre-treatment faecal samples using the same method as in 
Chapter 4 (Section 4.3.9 PCR of DNA extracted using CTAB method). The PCR 
products were imaged using gel electrophoresis on a 1% w/v Agarose gel run at 100 
V (Figure 5-2). A product of around 400 bp was produced from the DNA from the 
zebra faecal samples similar to that observed in the domestic equine samples, 
demonstrated by the positive control in Figure 5-2 which is an equine faecal DNA 
sample. In addition, a slightly smaller product was produced in the ‘Kanzi’ zebra 
sample, as had been observed in earlier work on equine faecal DNA samples. 
However, there were also several weaker products of smaller sizes produced from 
both zebra faecal DNA samples that had not been observed in the equine samples. 
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Figure 5-2 ITS-2 Amplicons from Zebra faecal DNA samples produced with MiFi 2× analysed on a 
1% agarose gel. Lanes: L: 1kb Hyperladder, P:  positive control (equine), N: negative control, 1: 
Kanzi, 2: Ayah) 
 
 Barcoding zebra faecal DNA samples 5.4.4
To produce the first nest of PCR prior to barcode labelling, the two zebra samples 
were amplified using the final PCR protocol (section 7.4 in the Appendix), and the 
products run on a 1% w/v Agarose gel. Initially, it did not appear that this process 
had been successful (Figure 5-3a). However, when the contrast was adjusted, faint 
bands could be observed Figure 5-3b). 
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Figure 5-3 18S Amplicons from Zebra faecal DNA samples produced with MyFi 2× Mix analysed on 
a 1% agarose gel. Lanes: L: 1kb Hyperladder, P:  positive control (equine), N: negative control, 1: 
Kanzi, 2: Ayah) a) with original contrast settings, b) with contrast adjusted to visualise products. 
Despite low levels of PCR products, barcodes were added in a second nest of PCR as 
with the equine samples. Repeat PCR was performed, however products were again 
very weak (Data not shown).  
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 MinION nemabiome sequencing 5.4.5
It was decided to take the zebra samples forward for nemabiome sequencing despite 
the low levels of PCR products generated, and the samples were sequenced using the 
MinION. The DNA sequences produced from the zebra faecal samples were 
subjected to the same DNA sequence quality control and identification procedures as 
used for the horse samples in Chapter 4 (Section 4.3.15 Data analysis). Following 
data analysis, the DNA sequences in the zebra samples representing the nemabiome 
could be grouped into five principal species, which coincided with the five most 
numerous species observed in the horse samples, namely C. catinatum, C. 
pateratum, C. nassatus, C. goldi and C. longibursatus (Figure 5-4). Interestingly, no 
DNA sequences were identified for P. equorum in common with the one horse 
sample that had shown a positive P. equorum egg count. Both zebra nemabiomes 
were similar to each other, with the exception of the proportions of C. goldi and C. 
longibursatus, which differed between the two samples. 
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Figure 5-4 Proportions of DNA sequences identified by MinION sequencing in zebra pre-treatment 
faecal DNA samples a) Kanzi, b) Ayah. Five major cyathostomin sequences were identified, ‘Minor 
species’ represent species with less than 5% of DNA sequences in both nemabiomes. 
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Understanding and monitoring parasite infections in captive zebra is an important 
part of their husbandry, as management factors such as crowding, transfer of animals 
and stress due to factors such as weaning can precipitate temporary severe helminth 
infection (Epe et al., 2009). As many exotic equid species are endangered, it is 
especially important to avoid the development of anthelmintic resistance in order to 
safeguard captive populations. In exotic equids, non-invasive methods of monitoring 
levels of helminth infection and anthelmintic resistance are preferable; therefore the 
optimised FECPAK
G2
 and nemabiome sequencing techniques were expanded from 
domestic equines to alternative equid species. 
When utilising FECs, three out of the four zebra faecal samples demonstrated 
evidence of P. equorum infection despite these samples being collected from adult 
animals. In domestic horses, immunity to P. equorum usually develops during the 
first eighteen months of life (Laugier et al., 2012). However, a Kenyan study 
observed that 30% of adult Burchell’s zebra, Equus burchelli antiquorum examined, 
both ranched and free ranging, harboured P. equorum infections (Wambwa et al., 
2004) suggesting that zebra do not develop immunity to P. equorum in the same 
manner as horses. This theory has also been suggested in relation to Grant’s zebra, 
Equus quagga boehmi, with the author postulating that this might be a result of the 
zebra having not evolved alongside P. equorum, or that they are less resistant to it 
than are domestic equids (Scullion, 1982). A similar incidence of P. equorum 
infection (35%) to the Kenyan study was observed in a study of wild Grevy’s zebra, 
Equus grevyi (Muoria et al., 2005). In addition to P. equorum, the Kenyan study also 
identified Strongylus infections in 90% of the subjects, but cyathostomins in only 5% 
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(Wambwa et al., 2004). A study of Chapman’s zebra found a similar prevalence of 
P. equorum infection of 39%, and strongyle infection of 89% in German captive 
animals (Epe et al., 2009). The zebra in the current study showed a higher 
prevalence of P. equorum infection than found in the literature in either captive or 
wild animals, although the number of animals monitored was small. 
The post-treatment FECs on zebra samples demonstrated excellent success with a 
BZ based anthelmintic with a 100% reduction in both strongyle and P. equorum egg 
counts. The P. equorum result confirmed the findings from the horse samples tested 
previously (Chapter 4). In the current work, horse samples demonstrated widespread 
resistance to Fenbendazole in the population of strongyles yet this was not 
demonstrated in the zebra FECRTs. However, the work is not directly comparable as 
in the horse study, animals were only included in the equine study if the level of 
strongyle egg shedding before BZ treatment was at least 200 epg, and pre-treatment 
FECs in the zebra samples were much lower (28 epg and 14 epg in the two cases 
where paired pre- and post-treatment samples were available). 
Performance of the FECPAK
G2
 Micro-I system was similar with zebra samples as 
with horse samples. The samples were imaged using the cassette only twice, 
compared to five times when using the FECPAK
G2
 slide, which gave a higher 
“lowest detection limit” when using the FECPAK
G2
 cassette and meant that the 
FECs of two of the samples fell below this limit and strongyle infections were thus 
not detected in those samples when using the cassette. P. equorum counts were 
highly variable between replicates of each sample when counting using the slide (e.g. 
FECs ranged from 23 epg to 161 epg in one sample, and 92 epg to 299 epg in 
another), meaning that the one time a P. equorum infection went unidentified when 
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 cassette was likely due to a similar variability. It has been 
demonstrated that there is no linear relationship between FEC and worm burden for 
P. equorum in horses (Nielsen et al., 2010), and thus strategic treatment against these 
parasites in horses is recommended (Rendle et al., 2019) with a positive FEC used as 
evidence of infection status rather than as a quantification of infection level. For 
zebra, regular FECs would therefore monitor the P. equorum infection status, and 
with replicate cassettes taking only seconds to prepare, greater accuracy at detecting 
helminth infections in zoo situations could easily be achieved. The FECPAK
G2
 
system therefore represents a potentially useful tool for use with exotic equids. 
Following FECRT analysis, DNA extractions were performed for application to 
nemabiome sequencing as demonstrated for the domestic equid. Initial success was 
demonstrated through PCR amplification of helminth DNA from the zebra faecal 
samples. Both of the faecal samples tested had low levels of strongyle infection (28 
epg and 14 epg). However, both zebra had a reasonable level of P. equorum egg 
shedding at 83 epg and 179 epg respectively. Thus, it was hoped that subsequent 
sequencing might produce notable differences in nemabiome populations including 
the strongyle species present compared to the horse samples. However, with the 
increased presence of P. equorum infections in adult animals,  unusual given 
domestic horses likely develop immunity by the age of twelve to eighteen months 
(Reinemeyer, 2009), it was hoped that sequencing data may provide evidence of P. 
equorum infection. 
The strongyle species observed in the zebra nemabiome were, in fact, comprised of 
the same principal species as the domestic horse samples sequenced previously, 
albeit 5 principal species instead of 6. The missing principal species from the zebra 
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samples was that of Coronocyclus coronatus which was almost absent in the zebra 
faecal samples and thus was no longer classified as a principal species. However, 
this was the least numerous of the principal species in the equine samples at 2% of 
the total sequences, making its lower occurrence in the zebra samples likely due to 
the low overall strongyle FEC levels. Comparing the results of the zebra nemabiome 
DNA sequencing with the pre-treatment horse samples, the proportion of C. 
catinatum was approximately equal in proportions at around 50% along with the 
combined proportions of the two Cylicostephanus species at approximately a third of 
all sequences. However, in the zebra nemabiome there was a higher proportion of C. 
pateratum (15% as opposed to 4 – 10% in the three horse yards) and a much lower 
proportion of C. nassatus (5 – 7% as opposed to 13, 22 and 32% in the horse yards). 
Given that C. pateratum showed high levels of BZ resistance in the equine study, 
and C. nassatus was much better controlled, these differences could well be 
explained by Folly Farm’s anthelmintic programme. The zebra in this study were 
regularly treated with BZ anthelmintics due to their method of administration being 
via feeding, an important advantage over syringe administered anthelmintics when 
dealing with essentially wild equid species (Lia et al., 2010). 
Compared to each other, the two zebra nemabiomes were very similar apart from the 
proportions of C. goldi and C. longibursatus identified. From the work on equine 
samples in Chapter 4 it was discovered that these two cyathostomin species 
exhibited an inconsistent response to BZ anthelmintic treatment, so repeated BZ use 
on the host zebra may have influenced this nemabiome difference. Access to faecal 
DNA samples from a greater number of zebra would be necessary for further 
exploration of the similarities between nemabiomes in this host species. 
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In common with the only identification of P. equorum within the horse samples was 
the absence of P. equorum DNA sequences within the nemabiome. One likely reason 
for this absence is that P. equorum eggs are protected by a tough shell unlike 
strongyle species (Kazacos and Turek, 1983), which may not have been successfully 
disrupted during the DNA extraction process. As yet, no research has been 
documented attempting to extract DNA from P. equorum eggs. Alternative research 
has looked at DNA extracted from P. equorum adults themselves (Janssen et al., 
2013; Tydén et al., 2013) or, where eggs were used, by performing a larval culture 
and then extracting the DNA from the larvae produced (Tydén et al., 2014). The 
inability of P. equorum DNA to be extracted during the current work, to incorporate 
P. equorum into the nemabiome analysis, was disappointing from a view point of 
completeness.  However, as the eggs of P. equorum are readily identified visually 
during the FEC process, incorporation into DNA sequencing analysis for potential 
diagnostics is of limited interest. Although a larval hatch assay would allow more 
complete sequencing of the nemabiome, the process is far more time consuming and 
labour intensive than faecal DNA extraction, therefore a combination FEC and faecal 
DNA sequencing approach is potentially far more scalable for routine use.  
 
5.6 CONCLUSION 
The work performed for this chapter demonstrates that both the FECPAK
G2
 and 
MinION nemabiome sequencing were effective for zebra. It also illustrated that the 
cyathostomin nemabiome sequencing method was effective even at low FEC levels. 
These methods therefore represent useful tools to improve the health of captive 
zebra, and could also be used to monitor that of zebra in the wild. 
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The zebra in this study harboured the same species of cyathostomin as had been 
found in the equine samples. However, there was a greater proportion in the zebra 
samples of those cyathostomin species that had shown the greatest resistance to BZ 
treatment in the equine study. This suggests that the history of repeated BZ 
administration in the zebra used in the study may have influenced the host 
nemabiomes towards those species least responsive to BZ treatment. Therefore, 
monitoring of the change in zebra nemabiomes over time, together with FEC 
monitoring, would give an early warning if treatment with an alternative 
anthelmintic would be advisable to prevent problematic levels of helminth infections 
occurring.  




6 FINAL DISCUSSION 




6.1 DEVELOPMENT AND VALIDATION OF THE FECPAKG2 FOR 
EQUIDS, AND MONITORING OF ANTHELMINTIC RESISTANCE 
The work in Chapters 2, 3 and 5 demonstrated that the FECPAK
G2
 could be applied 
to the equid sector, both domestic equines and exotic species, with some 
modification of the initial preparation of the faecal samples compared to ruminant 
samples. The FECPAK
G2
 therefore offers a user-friendly method of monitoring 
helminth infections in these host species. Sustainable control of equine helminths 
requires monitoring of egg shedding via FECs (Matthews, 2014) yet studies 
demonstrate that the majority of horse owners do not utilise FECs at all, or do not 
perform them with the recommended frequency (Slater, 2017). Furthermore, the 
potential for a more sensitive test with a lower detection limit exists given the 
challenges discovered during this work associated with the optics of the FECPAK
G2
 
Micro-I. Therefore, planned improvements to the imaging system will no doubt lead 
to a user friendly and sensitive diagnostic. Availability of such diagnostics may 
improve the current situation, wherein even Veterinary practices often recommend 
anthelmintic treatment without prior diagnosis of infection (Sallé and Cabaret, 2015), 
and would be of great benefit if the Danish system, whereby equine anthelmintics are 
obtainable only in cases where clinical diagnosis of infection is present (Nielsen et 
al., 2014b), was emulated in other countries. 
Additionally, the opportunity exists for further development of the FECPAK
G2
 for 
additional uses. Further optimisation work similar to that undertaken in Chapter 2 
offers the potential for expansion into other species where GI parasites are also 
problematic, both domestic and exotic. In the absence of FEC testing, 




recommendation is for anthelmintic treatment to be administered monthly to dogs 
under some management regimes (ESCCAP, 2017), offering the potential for 
substantial reductions in anthelmintics if FECs were routinely used.  
Development of the FECPAK
G2
 for other exotic species offers the potential for 
monitoring and control of helminth parasites in zoos and wildlife parks, where 
widespread infection of GI helminths is often detected (Goossens et al., 2005; Lim et 
al., 2008). Further work could thus support the conservation of many endangered 
species. Furthermore, potential exists for the development of the FECPAK
G2 
for the 
detection of additional parasite species in addition to nematodes. Ongoing work to 
adapt the cassette system to sediment eggs rather than float them offers the potential 
for diagnosis of fluke infections (Reigate, unpublished data), although there remain 
some parasite species for which FEC is not a suitable diagnosis, such as 
Anoplocephala perfoliata (Meana et al., 1998). 
Significant anthelmintic resistance was detected against BZs in the equine 
cyathostomin populations monitored, although BZs still appeared to be effective 
against P. equorum in both the domestic equines and zebra tested. Strongyle FECs in 
the zebra were much lower than in the equine samples, and were effectively 
controlled by BZ in the host zebra monitored. A larger population of zebra to study 
would inform if the apparent efficacy of BZ was due to the low FEC levels, or vice 
versa. Continued and expanded monitoring could inform the treatment decision 
support offered by Techion Ltd. when the FEC results are returned. The availability 
of large amounts of equine FEC data, which will be collected if the FECPAK
G2
 
system becomes widely utilised, offers the potential for early warning if a particular 
anthelmintic compound starts showing reduced efficacy. Feeding this information 




back into future research will likely improve the quality of the decision support, and 
may offer some scope to investigate the efficacy of different treatment thresholds, as 
the current recommendation of treatment at 200 epg (Coles, 2009) is still only 
arbitrary. Of course, research into decision support would be needed for additional 
host species, especially exotics where little research currently exists. 
 
6.2 OPPORTUNITIES WITH NEMABIOME SEQUENCING 
Gastro-intestinal helminths live in complex communities within the host (Lello et al., 
2004) and little research has been done studying these communities within equine 
hosts (Mitchell et al., 2019). The work performed in Chapter 4 optimised a DNA 
extraction and PCR protocol which allowed strongyle DNA to be extracted from 
eggs within equine faecal samples, which could then be used for amplification of the 
ITS-2 region followed by sequencing using a MinION benchtop sequencing device 
in order to determine the equine ‘nemabiome’ pre and post anthelmintic exposure. 
When performed on the zebra faecal samples in Chapter 5 it demonstrated that this 
approach remained successful even at low egg shedding levels, with their consequent 
low levels of DNA. This finding offers promise that DNA extracted directly from the 
FECPAK
G2
 cassette preparations could be successfully sequenced, in order that 
nematode eggs could be both visualised and identified to species level. Nanopore 
sequencing of microbial populations has been carried out entirely off-grid and in 
remote locations (Edwards et al., 2018; Gowers et al., 2019) suggesting that 
nemabiome sequencing could also likely be used in remote areas to support wild or 
semi-managed populations of exotic equids and potentially other species. 




Importantly, differential diagnosis of large or small strongyle infections is possible 
using faecal DNA extraction and nemabiome sequencing. There is some evidence 
that S. vulgaris is re-emerging due to TST essential to reduce anthelmintic resistance 
in cyathostomins (Nielsen et al., 2012). As S. vulgaris is more pathogenic than small 
strongyle species (Pihl et al., 2017) a simple, non-invasive test to monitor for the 
presence of S. vulgaris is an important weapon in the fight against equid GI 
nematodes.  
The nemabiome investigation in Chapter 4 demonstrated that BZ resistance is not 
uniform across cyathostomin species, but likely varies depending on their preferred 
site in the GI tract. Those species which reside most caudally in the GI tract were 
least well controlled by the administration of BZ anthelmintics, whereas those 
species with a predilection for more cranial areas of the GI tract did not exhibit 
consistent resistance to treatment. Species diversity was not affected by a single BZ 
treatment, but the species diversity of nemabiomes in the current study followed a 
general trend towards decreasing diversity over time. This reduction was further 
confirmed investigating zebra nemabiomes (Chapter 5) which exhibited the same 
principal species as those found in the equine study, but with the proportions skewed 
towards those more resistant to BZ treatment, possibly as a result of their history of 
repeated BZ exposure and limited rotational grazing opportunities. 
The variable overall FEC reduction following BZ treatment observed in the current 
equine study appeared to be caused by the differing host nemabiomes, and 
consequently nemabiome sequencing prior to treatment offers crucial information as 
to whether BZ treatment is likely to be successful, in advance of its administration. 
Therefore, continuation of the current nemabiome methodology could support and 




potentially determine the susceptibility of cyathostomin species to alternative classes 
of anthelmintic.  Given the level of non-BZ anthelmintic resistance (Peregrine et al., 
2014; Tzelos et al., 2017) such an approach could lead to a tailored treatment 
approach in a manner akin to that currently employed with targeted antibiotic 
treatment (Viceconte et al., 2017). Any information acquired prior to anthelmintic 
usage to select an appropriate anthelmintic would potentially further delay the 
development of anthelmintic resistance by avoiding exposing helminth species to 
anthelmintic compounds that do not adequately control them. 
Expanding the current equine nemabiome monitoring process across the UK would 
potentially inform whether resistant cyathostomin species are evenly distributed 
across the country or, more likely, if there are clusters in different locations 
representing differing BZ resistance phenotypes (Hodgkinson et al., 2008; Ishii et 
al., 2017). In doing so, nemabiome monitoring could offer the potential of 
preserving populations of equines where BZ anthelmintics, and potentially also other 
anthelmintic classes, are still effective by avoiding introducing those cyathostomin 
species least responsive to treatment (Leathwick et al., 2019).  In addition, studying 
populations of alternative equid host species such as donkeys and mules (and a 
greater number of zebra) would also be interesting to determine if the nemabiomes 
differ with different host species, or if the changes are more highly correlated with 
management practices and their geographical location. Moreover, the addition of 
nemabiome data to existing modelling techniques such as those used by Sauermann 
et al. (2019) would enhance our understanding of resistant cyathostomin 
epidemiology. 




Further adaptation of molecular techniques and Nanopore sequencing offers the 
potential to detect mutations in SNPs associated with BZ resistance in cyathostomins 
(Hodgkinson et al., 2008), and monitoring populations of parasites in this way would 
track the spread of BZ resistant alleles. This need not be limited to equine parasites, 
and could be expanded to other anthelmintic classes and other host species where 
anthelmintic resistance is documented (James et al., 2009) especially those where 
more complete helminth genomes are available for reference. 
6.3 POTENTIAL OF NEXT GENERATION SEQUENCING AND 
METAGENOMICS 
The potential exists to monitor the nemabiomes of numerous host animals, but the 
power of this approach is not limited to merely monitoring helminth populations. A 
combination of the two techniques discussed above offers the potential to identify 
SNPs associated with anthelmintic resistance and combine this information with the 
change in nemabiome following anthelmintic treatment. More complete and 
improved quality genomes exist for nematode parasites of sheep and cattle 
(https://parasite.wormbase.org/species.html), which would likely make this approach 
more immediately successful in host species other than equines. 
Metagenomic analysis, which can assemble genomes from mixed samples of DNA 
using sophisticated bioinformatics tools, offers the future possibility of discovering 
more about the structure and function of genes in mixed populations of helminths, in 
addition to exploring the nemabiomes themselves (Roumpeka et al., 2017). This 
technique has already been used on DNA from faecal samples, albeit hitherto only 
for microbial populations (Alneberg et al., 2014). As metagenomics techniques are 




further developed for eukaryotes, the potential to analyse cyathostomin DNA using 
the whole-genome-shotgun techniques could be applied to pre- and post- 
anthelmintic treatment faecal DNA samples, and therefore offer an insight into the 
mode of IVM resistance which is currently poorly understood (Laing et al., 2017). 
This approach could additionally add to our library of cyathostomin genomes, which 
are woefully under-represented in current databases. 
6.4 LIMITATIONS OF THE WORK CONDUCTED 
Validation of the more sensitive FECPAK
G2
 protocol was hampered by the problems 
with the image stacking software, however once this issue is rectified it should be 
possible to repeat the validation work for the 25 ml slurry protocol. In addition, other 
egg recovery methods could be investigated, potentially validating the system for use 
with a much lower multiplication factor and hence lower limit of detection. 
An omission when monitoring the nemabiome changes was the monitoring the 
nemabiome of a horse or horses as a negative control, determining the extent of 
change in the nemabiome over a two week period without an anthelmintic being 
administered. This would have been an interesting comparison to the changes seen in 
the nemabiomes after BZ administration. 
6.5 FURTHER DEVELOPMENT OF THE WORK 
As mentioned in section 6.4, monitoring the changes in nemabiomes over time of 
horses without anthelmintic treatment would be interesting. A longitudinal study, 
sampling and sequencing every two weeks could track potential changes in the 
species present. In addition, the study could be repeated to monitor the nemabiomes 
of horses treated with other anthelmintics, although the samples would need to be 




taken at a greater interval than two weeks post treatment, to allow re-infection to 
occur. This work would inform if certain species are showing a reduced egg 
reappearance period (ERP) which is a precursor to resistance developing (Shea Porr 
et al., 2017). 
A larger study of nemabiome monitoring could detect whether there are geographical 
differences in the helminth species present, as the current study had too few samples 
from each area studied. This would not necessarily need to be horses with a FEC of 
over 200 epg as treatment would not be needed for pure nemabiome monitoring, 
which would ameliorate the lack of samples due to low FECs that hampered this 
study. 
6.6 RECOMMENDATIONS FOR COMMERCIAL USE 
An immediate commercial application for the work in this study is the use of the 
now validated FECPAK
G2
 system as a FEC monitoring system for equids. In 
addition, the optimisation and validation work could be repeated for other host 
species, both domestic and exotic, to expand the range of usefulness of the system. 
In premises where cyathostomin infection is adequately controlled with a system of 
FEC testing and pasture management, there is the potential for large strongyles such 
as S. vulgaris to become problematic once again (Nielsen et al., 2012). DNA 
extraction and sequencing from faecal samples could offer a differential diagnosis to 
monitor whether these parasites are present, which would offer peace of mind that a 
zero anthelmintic regime is not storing up potential problems for the future.  





In conclusion, the work performed hitherto has developed the FECPAK
G2 
for use in 
equids, which will support TST in the future for helminth control. A pipeline has 
been established for monitoring both equid FECs and changes in their nemabiomes, 
with both techniques highly portable and therefore usable in the field for both 
domestic and exotic equids. Given these developments, despite the absence of 
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7.1 STANDARD FECPAK G1 PROTOCOL 
Throughout the optimisation and validation work, control values were obtained by 
performing a number of FECPAK
G1
 (G1) counts on the slurry and taking the mean 
value. The protocol is described below: 
1. Dilute sample in a 1:4 ratio with water in a Ziploc bag and mix until a 
uniform slurry is produced. 
2. Pour the slurry into the G1 measuring cylinder up to the 45 ml mark.  
3. Add saturated NaCl solution was added up to the 230 ml mark, and stopper 
the cylinder.  
4. Invert three times to mix, and then pour approximately half of the resulting 
liquid through a dampened 670 µm sieve into a jug. 
5. Fill a FECPAK slide, using a Pasteur pipette, with an aliquot of this liquid. 






7.2 STANDARD RESISTANCE TESTING PROTOCOL 
During the optimisation phase, a protocol for resistance testing was developed, 
which gives a sensitivity of 4.6 epg. This protocol is described below: 
1. Dilute sample in a 1:4 ratio with water in a Ziploc bag and mix until a 
uniform slurry is produced. 
2. Scoop 20 ml slurry into a FECPAK sedimentor, top up with water. 
3. Pre-filter this liquid by pouring into a FECPAK cylinder fitted with a 1,000 
µm (white) filter, and invert three times to mix. 
4. Pour the liquid back into the sedimentor through the hole in the top of the 
cylinder, and leave to sediment for 30 minutes. 
5. Discard the supernatant and dilute the sediment with 80 ml of saturated NaCl 
solution. 
6. Transfer into a FECPAK cylinder fitted with 425 µm and 250 µm (black) 
filters.  
7. Fill 5 FECPAK slides from the centre hole in the cylinder using a Pasteur 
pipette, inverting to mix between sub-samples. 
8. Count using a microscope at 100 × magnification. On each slide, one egg 







7.3 CTAB DNA EXTRACTION PROTOCOL 
1. Place the sample in a 2 ml tube. To each tube, add one 1.5 – 2 mm glass 
bead, and 600 µl lysis buffer. 
2. Bead-beat at 50 bps for 3 minutes, using the Tissue Lyser (QiAgen), and 
spin briefly to collect the material at the bottom of the tube. 
3. Incubate at 95ºC for 10 minutes. 
4. Centrifuge at 500 × g for 1 minute. 
5. To each tube, add 60 µl 3M potassium acetate, and mix gently by inversion. 
6. Incubate on ice for 5 minutes. 
7. Centrifuge at 17,000 × g for 5 minutes. 
8. Recover 400 µl liquid into new 2 ml tubes (or as much as possible if there 
isn’t 400 µl)  
9. To each tube, add 50 µl 5M NaCl and 50 µl CTAB/NaCl pre-heated to 65ºC 
by microwaving on full power for 30 seconds.  
10. Vortex to mix. 
11. Incubate at 60ºC for 5 minutes, vortex and incubate for a further 5 minutes. 
12. To each tube, add 300 µl Chloroform:Isoamyl alcohol 24:1, and mix well to 
form an emulsion. 
13. Centrifuge at 17,000 × g for 5 minutes. 
14. Transfer 300 µl of the supernatant into a new 1.5 ml tube add 300 µl 
isopropranol, and mix by inversion. 
15. Centrifuge at 17,000 × g for 5 minutes, and discard the supernatant. 
16. Wash each pellet with 500 µl fresh 70% ethanol and centrifuge at 17,000 × g 





17. Discard the ethanol and dry the pellets at room temperature in a fume hood 
for two to three hours. 
18. To each tube, add 50 µl nuclease-free water and incubate on ice for 30 
minutes. 
19. Vortex  to resuspend the DNA. 






7.4 FINAL PCR PROTOCOL 
Positive control: 
1 - 4 µl Template (depending on what’s being used) 
1 µl Forward primer (Avramenko) 
1 µl Reverse primer (Avramenko) 
13 µl MyFi 2x mix (Bioline.com) 
Nuclease-free water to 25 µl  
 
Negative control: 
1 µl Forward primer (Avramenko) 
1 µl Reverse primer (Avramenko) 
13 µl MyFi 2x mix (Bioline.com) 
10 µl Nuclease-free water 
 
Samples and zero FEC negative control: 
1 µl Template  
1 µl Forward primer (Avramenko) 
1 µl Reverse primer (Avramenko) 
13 µl MyFi 2x mix (Bioline.com) 







Initial denaturation 95ºC 1 minute 
Denaturation  95ºC 15 seconds } 
Annealing  55ºC 15 seconds } 35 cycles 
Extension  72ºC 10 seconds } 






7.5 BARCODE PRIMERS 
Table 7-1 Barcodes allocated to each faecal DNA sample 
DNA Sample Barcode 
Widget pre 1 
Widget post 2 
Klettur pre 3 
Klettur post 4 
Major pre 5 
Major post 6 
Gertie pre 7 
Gertie post 8 
Seren pre 9 
Seren post 10 
Jigsaw pre 11 
Jigsaw post 12 
Hope pre 13 
Hope post 14 
Billee pre 15 
Billee post 16 
Duke pre 17 
Duke post 18 
Sox pre 19 
Sox post 20 
Topaz pre 21 
Topaz post 22 
Mary pre 23 
Mary post 24 
Yoyo pre 25 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































7.6 12 ML VALIDATION FIGURES 
Table 7-2 Validation results, 12 ml protocol showing mean of G1 control counts (four per horse) and 
mean of G2 Micro-I counts (four per horse). Notes show which results were included in the mean 
percentage accuracies. 
Horse G1 epg G2 epg G2 % of G1 Notes     
Billee 606 505 83 sedimentor   
Wellie 212.5 193.5 91 sedimentor   
Dafydd 237.5 193.5 81 sedimentor   
Buddy 662.5 791 119 sedimentor   
Holly 875 722 83 sedimentor   
Meg 663 456 69 sedimentor   
Jack 794 823 104 sedimentor   
Lily 850 946 111 sedimentor   
Phoebe 1769 2150 122 sedimentor   
Bronwen 219 312 142 sedimentor   
Gola 331 269 81 sedimentor   
Fluga 244 161 66 sedimentor   
Topaz 1713 1527 89 sedimentor   
Yoyo 394 344 87 sedimentor   
Linus 163 194 119 sedimentor   
Diplomat 394 151 38 old   
Buddy 244 97 40 old   
Sven 269 108 40 old   
Imogen 113 11 10 old   
Onyx 588 462 79 old   
Thomas 138 97 70 old   
Rose 600 344 57 old   
Seren 213 129 61 old   
Polly 700 301 43 old   
Sam 738 602 82 sedimentor   
Flyer 188 194 103 sedimentor   
Monarch 413 215 52      scoop  
Brooklyn 456 409 90 scoop   
Ted 406 215 53 scoop   
Mundana 300 108 36 scoop   
Dusty 288 204 71 scoop   
Sioned 613 516 84 scoop   
Blackberry 131 118 90 scoop   
Don 1413 1011 72 scoop   
Fudge 625 58 58 scoop   
Cadno 300 129 43 scoop   
Harry 1125 570 51 scoop   





Napoleon 356 301 85 scoop   
Ellie 675 430 64 scoop   
Mean percentage accuracy measured with sedimentor  96 






7.7 REPEAT IMAGING OF CASSETTES 
Table 7-3 Repeat images from cassettes obtained using timed capture software. Eight repeat images 
were produced for each cassette, the numbers represent the eggs seen in each of the two wells for each 
consecutive image produced. 
Sample 1 20/6/17 Sample 2 20/6/17 Sample 1 7/9/17 Sample 2 7/9/17 Sample 3 7/9/17 
Well 1 Well 2 Well 1 Well 2 Well 1 Well 2 Well 1 Well 2 Well 1 Well 2 
0 6 0 0 5 2 2 7 4 4 
0 5 0 1 5 2 2 7 4 4 
1 3 0 3 5 3 2 7 4 4 
1 5 0 4 5 3 2 7 4 4 
1 5 0 1 5 3 2 6 4 4 
0 5 0 4 5 3 2 7 4 4 
0 5 0 4 5 3 2 7 4 4 
0 5 0 4 5 2 2 7 4 4 
 
Sample 4 7/9/17 Sample 5 7/9/17 Sample 6 7/9/17 Sample 1 13/9/17 Sample 1 14/9/17 
Well 1 Well 2 Well 1 Well 2 Well 1 Well 2 Well 1 Well 2 Well 1 Well 2 
1 2 1 1 1 0 4 2 4 3 
0 2 1 1 1 0 4 2 6 3 
0 2 1 1 1 0 4 2 6 3 
0 2 1 1 1 0 4 2 7 3 
0 2 1 1 1 0 4 2 7 3 
0 2 2 1 1 0 4 2 7 3 
0 2 2 1 1 0 4 2 7 3 
0 2 2 1 1 0 4 2 8 3 
 
